0001493152-22-013530.txt : 20220516 0001493152-22-013530.hdr.sgml : 20220516 20220516083109 ACCESSION NUMBER: 0001493152-22-013530 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iveda Solutions, Inc. CENTRAL INDEX KEY: 0001397183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202222203 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41345 FILM NUMBER: 22925719 BUSINESS ADDRESS: STREET 1: 1744 S. VAL VISTA DRIVE STREET 2: STE. 213 CITY: MESA STATE: AZ ZIP: 85204 BUSINESS PHONE: 480 338-1576 MAIL ADDRESS: STREET 1: 1744 S. VAL VISTA DRIVE STREET 2: STE. 213 CITY: MESA STATE: AZ ZIP: 85204 FORMER COMPANY: FORMER CONFORMED NAME: Iveda Corp DATE OF NAME CHANGE: 20090916 FORMER COMPANY: FORMER CONFORMED NAME: Charmed Homes Inc. DATE OF NAME CHANGE: 20070420 10-Q 1 form10-q.htm
0001397183 false Q1 2022 --12-31 0001397183 2022-01-01 2022-03-31 0001397183 IVDA:CommonStock000001ParValuePerShareMember 2022-01-01 2022-03-31 0001397183 IVDA:CommonStockPurchaseWarrantsMember 2022-01-01 2022-03-31 0001397183 2022-05-06 0001397183 2022-03-31 0001397183 2021-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2022-03-31 0001397183 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001397183 2021-01-01 2021-03-31 0001397183 IVDA:EquipmentSalesMember 2022-01-01 2022-03-31 0001397183 IVDA:EquipmentSalesMember 2021-01-01 2021-03-31 0001397183 IVDA:ServiceRevenueMember 2022-01-01 2022-03-31 0001397183 IVDA:ServiceRevenueMember 2021-01-01 2021-03-31 0001397183 IVDA:OtherRevenueMember 2022-01-01 2022-03-31 0001397183 IVDA:OtherRevenueMember 2021-01-01 2021-03-31 0001397183 us-gaap:CommonStockMember 2020-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001397183 us-gaap:RetainedEarningsMember 2020-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001397183 2020-12-31 0001397183 us-gaap:CommonStockMember 2021-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001397183 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001397183 2021-01-01 2021-12-31 0001397183 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001397183 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001397183 us-gaap:CommonStockMember 2022-03-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001397183 us-gaap:RetainedEarningsMember 2022-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001397183 2021-03-31 0001397183 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember IVDA:CustomerOneMember 2021-01-01 2021-12-31 0001397183 IVDA:CustomerOneMember 2021-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TwoCustomersMember 2022-01-01 2022-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TwoCustomersMember 2021-01-01 2021-12-31 0001397183 IVDA:ChunghwaTelecomMember 2022-01-01 2022-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember IVDA:TwoCustomersMember 2022-01-01 2022-03-31 0001397183 IVDA:TaiwanStockMember 2022-01-01 2022-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanStockMember IVDA:TwoCustomersMember 2022-01-01 2022-03-31 0001397183 IVDA:ChunghwaTelecomMember 2021-01-01 2021-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember IVDA:TwoCustomersMember 2021-01-01 2021-12-31 0001397183 IVDA:TaiwanStockMember 2021-01-01 2021-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanStockMember IVDA:TwoCustomersMember 2021-01-01 2021-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:OtherCustomersMember srt:MinimumMember 2022-01-01 2022-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:OtherCustomersMember srt:MinimumMember 2021-01-01 2021-12-31 0001397183 country:US 2022-01-01 2022-03-31 0001397183 country:US 2022-03-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2022-01-01 2022-03-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2022-03-31 0001397183 IVDA:DebentureAgreementMember IVDA:MrGregoryOmiMember 2014-08-28 0001397183 IVDA:DebentureAgreementMember IVDA:MrGregoryOmiMember us-gaap:ExtendedMaturityMember 2014-08-01 2014-08-28 0001397183 IVDA:DebentureAgreementMember IVDA:MrGregoryOmiMember 2014-08-01 2014-08-28 0001397183 IVDA:DebentureAgreementMember IVDA:MrRobertGillenMember 2012-11-19 0001397183 IVDA:DebentureAgreementMember IVDA:MrRobertGillenMember 2012-11-01 2012-11-19 0001397183 IVDA:DebentureAgreementMember IVDA:MrRobertGillenMember 2013-06-19 2013-06-20 0001397183 IVDA:DebentureAgreementMember IVDA:MrRobertGillenMember us-gaap:ExtendedMaturityMember 2013-06-19 2013-06-20 0001397183 IVDA:DebentureAgreementMember IVDA:MrRobertGillenMember 2013-06-20 0001397183 IVDA:MrGregoryOmiMember 2022-03-31 0001397183 IVDA:MrGregoryOmiMember 2021-12-31 0001397183 IVDA:MrRobertGillenMember 2022-03-31 0001397183 IVDA:MrRobertGillenMember 2021-12-31 0001397183 IVDA:DebentureAgreementMember IVDA:VariousShareholdersMember 2019-02-01 2019-02-28 0001397183 IVDA:DebentureAgreementMember IVDA:VariousShareholdersMember 2022-01-01 2022-03-31 0001397183 IVDA:DebentureAgreementMember IVDA:VariousShareholdersMember 2019-02-28 0001397183 IVDA:ShanghaiBankMember 2022-01-01 2022-03-31 0001397183 IVDA:HuaNanBankMember 2022-01-01 2022-03-31 0001397183 IVDA:VariousShareholdersMember 2022-03-31 0001397183 IVDA:VariousShareholdersMember 2021-12-31 0001397183 IVDA:ShanghaiBankMember 2022-03-31 0001397183 IVDA:ShanghaiBankMember 2021-12-31 0001397183 IVDA:HuaNanBankMember 2022-03-31 0001397183 IVDA:HuaNanBankMember 2021-12-31 0001397183 IVDA:ShanghaiBankMember srt:MinimumMember 2022-03-31 0001397183 IVDA:ShanghaiBankMember srt:MaximumMember 2022-03-31 0001397183 IVDA:ShanghaiBankMember srt:MinimumMember 2022-01-01 2022-03-31 0001397183 IVDA:ShanghaiBankMember srt:MaximumMember 2022-01-01 2022-03-31 0001397183 us-gaap:SeriesAPreferredStockMember 2022-03-31 0001397183 IVDA:TwoThousandNineStockOptionPlanMember 2009-10-15 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2011-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2012-12-31 0001397183 IVDA:TwoThousandTwentyStockOptionPlanMember srt:MaximumMember 2020-12-31 0001397183 IVDA:TwoThousandTwentyStockOptionPlanMember 2021-12-31 0001397183 2019-12-31 0001397183 2020-01-01 2020-12-31 0001397183 srt:MinimumMember 2021-01-01 2021-12-31 0001397183 srt:MaximumMember 2021-01-01 2021-12-31 0001397183 srt:MinimumMember 2020-01-01 2020-12-31 0001397183 srt:MaximumMember 2020-01-01 2020-12-31 0001397183 srt:MinimumMember 2022-03-31 0001397183 srt:MaximumMember 2022-03-31 0001397183 us-gaap:WarrantMember 2021-12-31 0001397183 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001397183 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001397183 us-gaap:WarrantMember srt:MinimumMember 2021-01-01 2021-12-31 0001397183 us-gaap:WarrantMember srt:MaximumMember 2021-01-01 2021-12-31 0001397183 us-gaap:WarrantMember srt:MinimumMember 2020-01-01 2020-12-31 0001397183 us-gaap:WarrantMember srt:MaximumMember 2020-01-01 2020-12-31 0001397183 IVDA:UsBasedSegmentMember 2021-12-31 0001397183 us-gaap:DomesticCountryMember 2021-12-31 0001397183 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001397183 stpr:AZ 2022-03-31 0001397183 2019-01-01 2019-12-31 0001397183 2018-12-31 0001397183 2018-01-01 2018-12-31 0001397183 2017-12-31 0001397183 2017-01-01 2017-12-31 0001397183 2016-12-31 0001397183 2016-01-01 2016-12-31 0001397183 2015-12-31 0001397183 2015-01-01 2015-12-31 0001397183 2014-12-31 0001397183 2014-01-01 2014-12-31 0001397183 2013-12-31 0001397183 2013-01-01 2013-12-31 0001397183 2012-12-31 0001397183 2012-01-01 2012-12-31 0001397183 2011-12-31 0001397183 2011-01-01 2011-12-31 0001397183 2010-12-31 0001397183 2010-01-01 2010-12-31 0001397183 2009-12-31 0001397183 2009-01-01 2009-12-31 0001397183 2008-12-31 0001397183 2008-01-01 2008-12-31 0001397183 2007-12-31 0001397183 2007-01-01 2007-12-31 0001397183 2006-12-31 0001397183 2006-01-01 2006-12-31 0001397183 2005-12-31 0001397183 2005-01-01 2005-12-31 0001397183 IVDA:MegasysMember 2021-01-01 2021-12-31 0001397183 IVDA:UnderwritingAgreementMember us-gaap:SubsequentEventMember 2022-04-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

 

For the transition period from __________ to ____________

 

Commission File No. 000-53285

 

IVEDA SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-2222203
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
1744 S Val Vista, Suite 213    
Mesa, Arizona   85204
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (480) 307-8700

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

(Check one):

 

  Large accelerated filer Accelerated filer
  Non-accelerated filer Smaller reporting company
  (Do not check if a smaller reporting company) Emerging growth company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which
registered
Common Stock, $0.00001 par value per share   IVDA   The Nasdaq Stock Market. LLC
Common Stock Purchase Warrants   IVDAW   The Nasdaq Stock Market. LLC

 

Class   Outstanding as of May 6, 2022
Common Stock, $0.00001 par value per share   11,561,647

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
  PART I - FINANCIAL INFORMATION  
ITEM 1. FINANCIAL STATEMENTS 3
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 21
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 28
ITEM 4. CONTROLS AND PROCEDURES 28
  PART II - OTHER INFORMATION  
ITEM 1. LEGAL PROCEEDINGS 29
ITEM 1A. RISK FACTORS 29
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 29
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 29
ITEM 4. MINE SAFETY DISCLOSURES 29
ITEM 5. OTHER INFORMATION 29
ITEM 6. EXHIBITS 29
SIGNATURES 30

 

2

 

 

PART 1 – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

MARCH 31, 2021 AND DECMBER 31, 2021

 

   March 31, 2022   December 31, 2021 
         
ASSETS          
CURRENT ASSETS          
Cash and Cash Equivalents  $746,931   $1,385,275 
Restricted Cash   138,118    142,688 
Accounts Receivable, Net   146,696    492,752 
Inventory, Net   576,190    344,654 
Other Current Assets   186,355    310,657 
Total Current Assets   1,794,290    2,676,026 
           
PROPERTY AND EQUIPMENT, NET   37,705    38,189 
           
OTHER ASSETS          
Intangible Assets, Net   -    - 
Other Assets   256,547    273,419 
Total Other Assets   256,547    273,419 
           
Total Assets  $2,088,543   $2,987,634 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
CURRENT LIABILITIES          
Accounts and Other Payables  $2,991,729   $2,955,826 
Due to Related Parties   300,000    300,000 
Short Term Debt   224,648    50,000 
Current Portion of Long-Term Debt   116,432    120,284 
Total Current Liabilities   3,632,809    3,426,110 
           
LONG-TERM DEBT   298,843    338,803 
LONG-TERM DIVIDENDS PAYABLE   -    - 
           
STOCKHOLDERS’ EQUITY          
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively   -    - 
           
Common Stock, $0.00001 par value; 37,500,000 shares authorized; 11,561,647 and 9,668,369, shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively   116    97 
Additional Paid-In Capital   47,724,107    40,727,518 
Subscription Receivable   (7,370,350)   - 
Accumulated Comprehensive Loss   (168,783)   (143,493)
Accumulated Deficit   (42,028,199)   (41,361,401)
Total Stockholders’ Equity (Deficit)   (1,843,109)   (777,279)
           
Total Liabilities and Stockholders’ Equity  $2,088,543   $2,987,634 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

3

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021

 

   2022   2021 
         
REVENUE          
Equipment Sales  $189,521   $304,105 
Service Revenue   41,336    28,298 
Other Revenue   -    177 
TOTAL REVENUE   230,857    332,580 
           
COST OF REVENUE   90,310    217,551 
           
GROSS PROFIT   140,547    115,029 
           
OPERATING EXPENSES          
General & Administrative   792,164    567,649 
Total Operating Expenses   792,164    567,649 
           
LOSS FROM OPERATIONS   (651,616)   (452,620)
           
OTHER INCOME (EXPENSE)          
Miscellaneous Income (Expense)   172    -
Interest Income   616    38 
Interest Expense   (12,833)   (182,132)
           
Total Other Income (Expense)   (12,045)   (182,094)
           
LOSS BEFORE INCOME TAXES   (663,662)   (634,714)
           
BENEFIT (PROVISION) FOR INCOME TAXES   (3,136)   - 
           
NET LOSS  $(666,798)  $(634,714)
           
BASIC AND DILUTED LOSS PER SHARE  $(0.07)  $(0.09)
           
WEIGHTED AVERAGE SHARES   9,672,508    7,209,589 

 

*All share amounts and per share amounts reflect a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on March 31, 2022.

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

4

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

                                    
   Common
Shares
   Common
Stock
Amount
   Preferred
Shares
   Additional
Paid-in-Capital
   Accumulated
Deficit
   Accumulated
Other
Comprehensive
Income (loss)
   Total
Stockholders’
Equity(Deficit)
 
BALANCE AT December 31, 2020   6,583,924   $66 -  257   $34,769,076   $(38,322,456)  $(153,254)  $(3,706,568)
                                    
Common Stock Issued for Cash   757,655    8         2,661,992              2,662,000 
Costs of Capital                  (2,091,101)             (2,091,101)
Stock Based Compensation                  801,908              801,908 
Common Stock for Accounts Payable   27,896    1         99,789              99,789 
Common Stock for Costs of Financing   628,750    6         1,932,730              1,932,736 
Warrants for Services                  148,480              148,480 
Warrants for Interest Expense                  69,729              69,729 
Convertible Debenture Value                  69,729              69,729 
Preferred Stock - Series B for Dividend             2    23,750              23,750 
Preferred Stock - Series B Shares and Dividend Payable to Common Stock   1,090,015    11    (259)   432,165              432,176 
Dividends - P/S Series B                       (40,301)        (40,301)
Conversion of Debt & Interest to Common Stock   439,527    4         1,294,576              1,294,580 
Exercise of options and warrants   140,602    1         514,696              514,697 
Net Loss        - -            (2,998,644)        (2,998,644)
Comprehensive Loss                            9,761    9,761 
                                    
BALANCE AT December 31, 2021   9,668,369    97 -  0   $40,727,518   $(41,361,401)  $(143,493)  $(777,279)
                                    
Costs of Capital                  (1,105,142)             (1,105,142)
Stock Based Compensation                  67,500              67,500 
Common Stock issued for conversion error   64    -         -              - 
Exercise of options and warrants   8,214    -         23,000              23,000 
Common Stock Offering for Cash   1,885,000    19         8,011,231              8,011,250 
Subscription Receivable                  (7,370,350)               
Net Loss        - -            (666,798)        (666,798)
Comprehensive Loss                            (25,290)   (25,290)
                                    
BALANCE AT March 31, 2022   11,561,647   $116 -  0   $40,353,757   $(42,028,199)  $(168,783)  $(1,843,109)

 

*All share amounts and per share amounts reflect a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on March 31, 2022.

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

5

 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDING MARCH 31, 2022 AND 2021

 

   2022   2021 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(666,798)  $(634,714)
Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities          
Depreciation and Amortization   4,657    5,000 
Interest Value of Convertible Debt Issued          
Stock Option Compensation   67,500      
Common Stock Warrants Issued for Services        

11,475

 
Common Stock Warrants Issued for Interest        

139,458

 
(Increase) Decrease in Operating Assets          
Accounts Receivable   330,272   (13,840)
Inventory   (242,576)   (24,454)
Other Current Assets   31,085    (162,628)
Other Assets   8,302    4,722 
Increase (Decrease) in Accounts and Other Payables   (302,666)   186,897 
Net Cash Used in Operating Activities   (770,224)   (488,084)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of Property and Equipment   (4,696)   -
Net Cash Provided by (Used in) Investing Activities   (4,696)   -
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Changes in Restricted Cash   -    73,661
Proceeds from (Payments on) Short-Term Notes Payable/Debt   174,648    203,194 
Proceeds from (Payments to) Due to Related Parties   -    (37,177)
Proceeds from (Payments to) Long-Term Debt   (29,108)   - 
Payments for Deferred Finance Costs   -    - 
Common Stock Issued, Net of (Cost of Capital)   -    815,001 
           
Net Cash Provided by Financing Activities   145,540    1,054,679 
           
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (8,964)   1,528
           
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (638,344)   568,123 
           
Cash and Cash Equivalents- Beginning of Period   1,385,275    249,521 
           
CASH AND CASH EQUIVALENTS - END OF PERIOD  $746,931   $817,644 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

6

 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

FOR THE THREE MONTHS ENDING MARCH 31, 2022 AND 2021

 

   2022   2021 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Interest Paid  $1,013   $330 
Income Tax Paid  $-   $- 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Common Stock issued for Consulting Agreements related to Cost of Capital  $-   $1,895,000 
Dividends Paid with Series B Preferred Stock  $-   $23,750 
Warrants Issued for Interest  $-   $139,458 
Warrants Issued for Services  $-   $11,475 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

7

 

 

IVEDA SOLUTIONS, INC.

 

NOTES TO THE (UNAUDITED) CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  Object Search
  Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  License Plate Recognition (100+ Countries), includes make and model
  Intrusion Detection
  Weapon Detection
  Fire Detection
  People Counting
  Vehicle Counting
  Temperature Detection
  Public Health Analytics (Facemask Detection,
  QR and Barcode Detection

 

Key Features

 

  Live Camera View
  Live Tracking
  Abnormality Detection – Vehicle/Person wrong direction detection
  Vehicle/Person Loitering Detection
  Fall Detection
  Illegal Parking Detection
  Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after-the-fact.

 

Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.

 

8

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.

 

Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central device management. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.

 

Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.

 

In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

Our Taiwan-based subsidiary Iveda Taiwan, formerly known as MEGAsys, our wholly-owned subsidiary, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and safe city. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Taiwan-based Sole Vision Technologies (dba Iveda Taiwan). We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

9

 

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We generated accumulated losses of approximately $42 million from January 2005 through March 31, 2021 and have insufficient working capital and cash flows to support operations. These factors raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty.

 

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the three months ended March 31, 2022 and year ended December 31, 2021.

 

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

10

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable, and the amount can be reliably estimated.

 

  The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, annual license revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

11

 

 

Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. One customer (Chunghwa Telecom) represented approximately 95% of total accounts receivable of $492,752 as of December 31, 2021. This customer is a longtime customer, and we don’t expect any problem with collectability of these accounts receivable.

 

We had revenue from two customers with greater than 10% of total revenues during the three months ended March 31, 2022 and the year ended December 31, 2021 that represented approximately 39% and 55% of total revenues, respectively. We had $58,086 revenues (25%) from Chunghwa Telecom and $29,013 revenues (13%) from Taiwan Stock Exchange Corporation of total revenues of $230,857 for the three months ended March 31, 2022.

We had $786,686 revenues (41%) from Chunghwa Telecom and $260,946 revenues (14%) from Taiwan Stock Exchange Corporation of total revenues of $1,917,848 for the year ended December 31, 2021.

 

No other customers represented greater than 10% of total revenues in the three months ended March 31, 2022 and year ended December 31, 2021.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of March 31, 2022 and December 31, 2021 no allowance for uncollectible accounts was deemed necessary for our U.S.-based segment.

 

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 

Other Current Assets

 

Other current assets represent cash paid in advance to insurance companies and vendors for service coverage extending into subsequent periods.

 

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 as of March 31, 2022 and December 31, 2021.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended March 31, 2022 was $4,657 and for the year ended December 31, 2021 was $15,016.

 

12

 

 

Intangible Assets

 

Intangible assets consist of trademarks and other intangible assets associated with the purchase price allocation of Iveda Taiwan. Such assets are fully amortized at December 31, 2021.

 

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2021, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2021.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2017 to 2021 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2017 to 2021 are open to examination by the Taiwan Ministry of Finance.

 

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

Accounts and Other Payables

   March 31, 2022   December 31, 2021 
         
Accounts Payable  $138,228   $62,889 
Accrued Expenses   2,757,814    2,834,726 
Deferred Revenue and Customer Deposits   95,687    58,211 
Accounts and Other Payables  $2,991,729   $2,955,826 

 

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

13

 

 

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of March 31, 2021 and December 31, 2021, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $67,500 and $801,908 of stock-based compensation expense for the three months ended March 31, 2022 and December 31, 2021, respectively.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2022 and December 31, 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

   March 31, 2022 (Unaudited) 
   Net Revenue   Net Assets (Liabilities) 
United States  $7,882   $(2,606,975)
Republic of China (Taiwan)  $324,698   $763,867 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

Reclassification

 

Certain amounts in 2021 have been reclassified to conform to the 2022 presentation.

 

New Accounting Standards

 

No new relevant accounting standards

 

14

 

 

NOTE 2 RELATED PARTIES

   March 31, 2022 (Unaudited)   December 31, 2021 
         
On August 28, 2014, we entered into a debenture agreement with Mr. Gregory Omi, formerly a member of our Board of Directors of the company for $200,000, at 9.5% interest per annum with interest and principal payable on the extended maturity date of December 31, 2016. As consideration for the extension of the debenture, we granted Mr. Omi options to purchase 2,500 shares of our common stock with an exercise price of $6.16 per share. This debenture was extended to December 31, 2022. Mr. Omi is currently the CTO of the company.   200,000    200,000 
           
On November 19, 2012, we entered into a convertible debenture agreement with Mr. Robert Gillen, a member of our Board of Directors, for $100,000 (the “Gillen I Debenture”), under his company Squirrel-Away, LLC. Under the original terms of the agreement, interest is payable at 10% per annum and became due on December 19, 2014. Gillen I Debenture was extended to January 5, 2015. On June 20, 2013, interest of $5,000 was paid on the debenture. As consideration for agreeing to extend the maturity date of the debenture to December 31, 2015, we granted Mr. Gillen options to purchase 1,250 shares of common stock at an exercise price of $6.16 per share This debenture was extended to December 31, 2022.  $100,000   $100,000 
           
Total Due to Related Parties  $300,000    300,000 
Less Current Portion   (300,000)   (300,000)
Total Long-Term  $-   $- 

 

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

 

The short-term debt balances were as follows:

 

   March 31, 2022 (Unaudited)    December 31, 2021 
          
Debenture agreements with a shareholder at 10% interest rate beginning in February 2019 - December 2019, one year maturity, were due February 2020 – December 2020, principal and interest convertible at $2.80 per share into common stock at the option of the holder until repaid. All principal and accrued interest converted during 2021 except one remaining $50,000 debenture and accrued interest of $12,079.  $50,000    $50,000 
Loan Agreement with Shanghai Bank at 2.68% interest rate per annum due January 2023.   69,850     - 
Loan agreement with Hua Nam bank at 2,42% interest rate per annum due September 2022.   104,789     - 
            
Balance at end of period  $224,648    $50,000 

 

Long-term debt balances were as follows:

 

   March 31, 2022
(Unaudited)
   December 31. 2021 
         
Loans from Shanghai Bank with interest rates 1.00% - 1.5% per annum due February 2024November 2026   415,275    469,087 
           
Current Portion of Long-term debt   (116,432)   (120,284)
           
Balance at end of period  $298,843   $338,803 

 

15

 

 

NOTE 4 PREFERRED STOCK

 

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share, 1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

 

NOTE 5 EQUITY

 

Common Stock

 

We are authorized to issue up to 37,500,000 shares of common stock, par value $0.00001 per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

 

NOTE 6 STOCK OPTION PLAN AND WARRANTS

 

Stock Options

 

On October 15, 2009, we adopted the 2009 Stock Option Plan (the “2009 Option Plan”), with an aggregate number of 187,500 shares of common stock issuable under the plan. The purpose of the 2009 Option Plan was to assume options that were already issued in the 2006 and 2008 Option plans under Iveda Corporation after the merger with Charmed Homes.

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 125,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 1,625,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020.

 

We adopted a new plan called Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan will have a maximum of 10 million option shares authorized with similar terms and conditions to the 2010 Option Plan. This plan has not been approved by the shareholders.

 

As of December 31, 2021, there were 893,438 options outstanding under all the option plans.

 

16

 

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2021, we had approximately $4,500 unrecognized stock-based compensation.

 

Stock option transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   952,025   $5.76    842,650   $6.24 
Granted   141,875    11.76    312,500    2.96 
Exercised   (62,500)   4.72    (158,750)   1.28 
Forfeited or Canceled   (137,963)   7.44    (44,375)   8.96 
Outstanding at End of Year   893,438    6.80    952,025    5.76 
                     
Options Exercisable at Year-End   891,563    6.80    952,025    5.76 
                     
Weighted-Average Fair Value of Options Granted During the Year  $5.68        $2.00      

 

Information with respect to stock options outstanding and exercisable at December 31, 2021 is as follows:

 

   Options Outstanding   Options Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average
Remaining
Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$0.32 - $16.24   893,438    6.2   $6.80    891,563   $6.80 

 

17

 

 

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021   2020 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   1.00%   0.18%

 

Warrant transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   543,754   $3.04    695,439   $3.04 
Granted   509,732    2.96    123,732    2.80 
Exercised   (78,102)   2.80           
Forfeited or Canceled   (103,125)   2.80    (275,416)   2.88 
Outstanding at End of Year   872,259    3.04    543,754    3.04 
                     
Warrant Exercisable at Year-End   872,259    3.04    543,754    3.04 
                     
Weighted-Average Fair Value of Warrants Granted During the Year  $1.12 - $3.92        $0.80 - $2.08      

 

Information with respect to warrants outstanding and exercisable at December 31, 2021 is as follows:

 

   Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average Remaining Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$2.80 - $13.20   872,259    1.5   $3.04    872,259   $3.04 

 

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021    2020 
Expected Life   1.5 yrs     1.5 yrs 
Dividend Yield   0%    0%
Expected Volatility   90%    90%
Risk-Free Interest Rate   0.18 - 1.00%    0.19 - 1.59%

 

18

 

 

NOTE 7 INCOME TAXES

 

U.S. Federal Corporate Income Tax

 

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2021   2020 
Tax Operating Loss Carryforward - USA  $10,800,000   $9,800,000 
Other   -    - 
Valuation Allowance - USA   (10,800,000)   (9,800,000)
 Deferred Tax Assets, Net  $-   $- 

 

The valuation allowance increased approximately $0.5 million, primarily as a result of the increased net operating losses of our U.S.- based segment.

 

As of December 31, 2021, we had federal net operating loss carryforwards for income tax purposes of approximately $29 million which will begin to expire in 2025. We also have Arizona net operating loss carryforwards for income tax purposes of approximately $2.0 million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.

 

Year Ending  Net Operating   Year of 
December 31,  Loss:   Expiration 
2021  $1,000,000    2041 
2020   590,000    2040 
2019   260,000    2039 
2018   160,000    2038 
2017   140,000    2037 
2016   1,640,000    2036 
2015   3,400,000    2035 
2014   5,230,000    2034 
2013   5,600,000    2033 
2012   2,850,000    2032 
2011   2,427,000    2031 
2010   1,799,000    2030 
2009   1,750,000    2029 
2008   1,308,000    2028 
2007   429,000    2027 
2006   476,000    2026 
2005   414,000    2025 

 

Taiwan (Republic of China) Corporate Tax

 

Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year.

 

According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.

 

19

 

 

NOTE 8 EARNINGS (LOSS) PER SHARE

 

The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”

 

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the three months ended March 31, 2022 and 2021 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the Three months ended March 31, 2022 and 2021.

 

   March 31, 2022
(Unaudited)
   March 31, 2021 (Unaudited) 
         
Basic EPS          
Net Loss  $(666,798)  $(634,714)
Weighted Average Shares   9,672,508    7,209,589 
Basic Loss Per Share  $(0.07)  $(0.09)

 

NOTE 9 CONTINGENT LIABILITIES—TAIWAN

 

Pursuant to certain contracts with Siemens, Chung-Hsin Electric and Machinery Manufacturing Corp, Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2021 is $61,435.

 

NOTE 10 SUBSEQUENT EVENTS

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements

 

On April 5, 2022 we closed the Stock and Warrant Offering that was committed to by Underwriting Agreement effective March 31, 2022 for $8,011,250.

 

20

 

 

Item 2. Financial Information.

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and associated notes appearing elsewhere in this Form 10-Q Quarterly Report and with our audited consolidated financial statements for the year ended December 31, 2021 included in this Form 10-Q Quarterly Report.

 

Note Regarding Forward-Looking Information

 

This Report on Form 10-Q Quarterly Report contains forward looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this Form 10-Q Quarterly Report, including statements regarding future events, our future financial performance, business strategy, and plans and objectives for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the risks outlined under “Risk Factors”, “Liquidity and Capital Resources” with respect to our ability to continue to generate cash from operations or new investment, or elsewhere in this Report on Form 10-Q Quarterly Report or discussed in our audited consolidated financial statements for the year ended December 31, 2021, which may cause our or our industry’s actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time, and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.

 

Overview

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

21

 

 

AI Functions

 

  Object Search
  Face Search (No Database Required)
  Face Recognition (from a Database)
  License Plate Recognition (100+ Countries), includes make and model
  Intrusion Detection
  Weapon Detection
  Fire Detection
  People Counting
  Vehicle Counting
  Temperature Detection
  Public Health Analytics (Facemask Detection,
  QR and Barcode Detection

 

Key Features

 

  Live Camera View
  Live Tracking
  Abnormality Detection – Vehicle/Person wrong direction detection
  Vehicle/Person Loitering Detection
  Fall Detection
  Illegal Parking Detection
  Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after the fact.

 

Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.

 

22

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.

 

Cerebro’s roadmap includes a dashboard for all Iveda’s platforms for central device management. Cerebro is system-agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors, and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.

 

Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.

 

In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

We license our platform and sell IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal customer base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

Iveda Taiwan, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

In April, 2011, we completed our acquisition of Iveda Taiwan, a company founded in 1998 by a group of sales and research and development professionals from Taiwan Panasonic Company. Iveda Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City initiatives in Taiwan and other neighboring countries. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers. Iveda Taiwan also houses the application engineering team that supports Sentir implementation for our service provider customers in Asia. The Company depends on Iveda Taiwan as the majority of the company’s revenues have come from Iveda Taiwan since the acquisition in April 2011. For the years ended December 31, 2021 and 2020, Iveda Taiwan’s operations accounted for 93% and 71% of our total revenue, respectively.

 

23

 

 

The acquisition of Iveda Taiwan provided the following benefits to our business:

 

  An established presence and credibility in Asia and access to the Asian market.
     
  Relationships in Asia for cost-effective research and development of new product offerings and securing the best pricing for end user devices.
     
  Sourcing of products directly using Iveda Taiwan’s product sourcing expertise to enhance our custom integration capabilities.
     
  Enhancements to the global distribution potential for our products and services.

 

In November 2012, we signed a cooperation agreement with ITRI, a research and development organization based in Taiwan. Together with ITRI, we have developed cloud-video services. Pursuant to the cooperation agreement, we licensed, through our subsidiary, Sole-Vision Technologies, Inc., the right to use U.S. Patent No. 8,719,442 (as well as its Taiwanese and Chinese counterparts) with respect to the development of cloud-video technologies.

 

In June and August 2014, in collaboration with our local partner in the Philippines, we shipped our ZEE cloud plug-and-play cameras for delivery to the Philippine Long Distance Telephone Company (“PLDT”) for distribution to its customers with a cloud video surveillance service offering, utilizing our Sentir platform.

 

Critical Accounting Policies and Estimates

 

Management’s Discussion and Analysis of Financial Conditions and Results of Operations is based upon our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. A description of our critical accounting policies and related judgments and estimates that affect the preparation of our financial statements is set forth in our audited consolidated financial statements for the year ended December 31, 2020. Such policies are unchanged.

 

New Accounting Standards

 

There were no new standards recently issued which would have an impact on our operations or disclosures.

 

Results of Operations for the Three Months Ended March 31, 2022 Compared with the Three Months Ended March 31, 2021

 

Net Revenue

 

We recorded net consolidated revenue of $0.23 million for the three months ended March 31, 2022, compared with $0.33 million for the three months ended March 31, 2021, a decrease of ($0.1) million, or (31%). For the three months ended March 31, 2022, our recurring service revenue was $41,336, or 18% of net revenue, and our equipment sales and installation revenue was $189,521, or 82% of net revenue. In fiscal 2021, our recurring service revenue was $28,298, or 9% of consolidated net revenue, and our equipment sales and installation revenue was $304,105, or 91% of net revenue. The decrease in total revenue in 2021 compared with the same period in fiscal 2020 is attributable primarily to decreased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term contracts awarded and started during 2021.

 

24

 

 

Cost of Revenue

 

Total cost of revenue was $0.09 million (39% of revenue; gross margin of 61%) for the three months ended March 31, 2022, compared with $0.02 million (65% of revenue; 35% gross margin) for the three months ended March 31, 2021, a decrease of ($0.10 million), or (58%). The decrease in cost of revenue was primarily driven by decreased Iveda Taiwan revenue. The increase in overall gross margin was also primarily attributed to increased margin Iveda Taiwan revenue as a result of additional long-term contracts awarded and started during 2021.

 

Operating Expenses

 

Operating expenses were $0.8 million for the three months ended March 31, 2022, compared with $0.6 million for the three months ended March 31, 2021, an increase of $0.2 million, or 40%. This net increase in operating expenses in 2022 compared with 2021 is due primarily related to a ramp up in personnel in the US based administrative, sales and technical support personnel as well as research and development expenses for IvedaAI.

 

Loss from Operations

 

Loss from operations increased to $0.65 million for the three months ended March 31, 2022, compared with $0.45 million for the three months ended March 31, 2021, an increase of $0.2 million, or 44%. A majority of the increase in loss from operations was primarily due to increased operating expenses.

 

Other Expense-Net

 

Other expense-net was $12,045 for the three months ended March 31, 2022, compared with $182,094 for the three months ended March 31, 2021, a decrease of $170,048, or 93%. The majority of the other expense for 2021 was interest expense accrued for convertible debentures, valuation of the convertible debenture features and the value of warrants given as incentive for the convertible debentures during 2021.

 

Net Loss

 

Net loss was $0.67 million for the three months ended March 31, 2022, compared with $0.63 million for the three months ended March 31, 2021. The increase of $0.32 million, or 5%, in net loss was caused primarily by a increase in operating expenses related to a ramp up in personnel in the US-based administrative, sales and technical support personnel as well as research and development expenses for IvedaAI.

 

Liquidity and Capital Resources

 

As of March 31, 2022, we had cash and cash equivalents of $0.75 million compared to $0.82 million as of March 31, 2021. This decrease in our cash and cash equivalents is primarily a result of the operating losses during the three months ended March 31, 2022. There are no legal or economic factors that materially impact our ability to transfer funds between our U.S.-based and Taiwan-based segments.

 

Net cash used in operating activities during the three months ended March 31, 2022 was $0.77 million compared to $0.16 million net cash used during the three months ended March 31, 2021. Net cash used in operating activities for the three months ended March 31, 2022 consisted primarily of the $0.67 million net loss including $0.07 million of non-cash charges (primarily stock option compensation), $0.24 of inventory and a decrease by $0.3 million in additional accrued expenses offset by a decrease of $0.3 million in accounts receivable. Cash used in operating activities for the three months ended March 31, 2021 consisted primarily of the $0.44 million net loss, $0.1 increase in inventory and offset by $0.18 million in additional accrued expenses.

 

Net cash used in investing activities for the three months ended March 31, 2022 was $4,696. Net cash used by investing activities during the nine months ended March 31, 2021 was $2,466.

 

Net cash provided by financing activities for the three months ended March 31, 2022 was $0.15 million compared with $0.63 million provided during the three months ended March 31, 2021. Net cash provided by financing activities in 2022 is primarily a result of the proceeds from bank loans in Taiwan for the three months ended March 31, 2022. Net cash provided by financing activities in 2020 consisted primarily of $0.63 million common stock sold at the U.S based operations.

 

25

 

 

We have experienced significant operating losses since our inception. At March 31, 2022, we had approximately $29 million in net operating loss carryforwards available for federal income tax purposes, which will begin to expire in 2025. We did not recognize any benefit from the federal net operating loss carryforwards in 2021 or 2020. We also had approximately $2.0 million in state net operating loss carryforwards, which expire after five years.

 

We have limited liquidity and have not yet established a stabilized source of revenue sufficient to cover operating costs, based on our current estimated burn rate. Accordingly, our continuation as a going concern is dependent upon our ability to generate greater revenue through increased sales and/or our ability to raise additional funds through the capital markets. No assurance can be given that we will be successful in future financing and revenue-generating efforts. Even if funding is available, we cannot assure investors that it will be available on terms that are favorable to our existing stockholders. Additional funding may be achieved through the issuance of equity or debt securities that could be significantly dilutive to the percentage ownership of our existing stockholders. In addition, these newly issued securities may have rights, preferences, or privileges senior to those of our existing stockholders. Accordingly, such a financing transaction could materially and adversely impact the price of our common stock.

 

Substantially all of our cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (“Central Deposit Insurance Corporation”) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.

 

Our accounts receivable are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we generally do not require collateral in exchange for our products and services provided on credit.

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Payment terms for our U.S.-based segment require prepayment for most products before they are shipped and monthly Sentir licensing fees, which are due in advance on the first day of each month. For our U.S.-based segment, accounts receivable that are more than 120 days past due are considered delinquent. Payment terms for our Taiwan-based segment vary based on our agreements with our customers. Generally, we receive payment for our products and services within one year of commencing the project, except that we retain 5% of the total payment amount and release such amount one year after the completion of the project. For our U.S.-based segment, we had no doubtful accounts receivable allowances for the three months ended March 31, 2022 and year ended December 31, 2021. For our Taiwan-based segment, we set up no doubtful accounts receivable allowances for the three months ended March 31, 2022 and year ended December 31, 2021. We deem the rest of our accounts receivable to be collectible based on certain factors, including the nature of the customer contracts and past experience with similar customers. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer, and we generally do not charge interest on past due receivables.

 

The COVID-19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where the Company has offices, employees, customers, vendors and other suppliers and business partners.

 

Like most businesses, the COVID-19 pandemic and efforts to mitigate the same began to have impacts on our business in March 2020. By that time, much of our first fiscal quarter was completed. During the remainder of 2020 and the first quarter of 2021, the Company observed decreases in demand from certain customers, including primarily municipalities and commercial customers in Taiwan as well as delays in project timelines in Taiwan. The Company estimates that the COVID-19 pandemic resulted in decreases of approximately $1.2 million revenues and $0.3 million gross profit contribution for the year ended March 31, 2021 and $0.2 million revenues and $0.05 million gross profit contribution for the three months ended March 31, 2021. However, the Company is beginning to experience an increase in demand for the twelve months ended March 31, 2022, compared to the last half of 2020.

 

26

 

 

Given the fact that the Company’s products are sold through a variety of distribution channels, the Company expects its sales will experience more volatility as a result of the changing and less predictable operational needs of many customers as a result of the COVID-19 pandemic. The Company is aware that many companies, including many of its suppliers and customers, are reporting or predicting negative impacts from COVID-19 on future operating results. Although the Company observed significant declines in demand for its products from certain customers during 2020 and the first quarter of 2021, the Company believes that the impact of the COVID-19 remains too fluid and unknown, hindering the Company from determining the long-term demand for current products. The Company also cannot be certain how demand may shift over time as the impacts of the COVID-19 pandemic may go through several phases of varying severity and duration.

 

The Company does not expect there to be material changes to its assets on its balance sheet or its ability to timely account for those assets. The Company has also reviewed the potential impacts on future risks to the business as it relates to collections, returns and other business-related items.

 

To date, travel restrictions and border closures have not materially impacted its ability to obtain inventory or manufacture or deliver products or services to customers. However, if such restrictions become more severe, they could negatively impact those activities in a way that would harm the business over the long term. Travel restrictions impacting people can restrain our ability to assist its customers and distributors as well as impact its ability to develop new distribution channels, but at present the Company does not expect these restrictions on personal travel to be material to our business operations or financial results. The Company has taken steps to restrain and monitor its operating expenses and therefore it does not expect any such impacts to materially change the relationship between costs and revenues.

 

Like most companies, the Company has taken a range of actions with respect to how it operates to assure it complies with government restrictions and guidelines as well as best practices to protect the health and well-being of its employees and its ability to continue operating its business effectively. To date, the Company has been able to operate its business effectively using these measures and to maintain internal controls as documented and posted. The Company also has not experienced challenges in maintaining business continuity and does not expect to incur material expenditures to do so. However, the impacts of COVID-19 and efforts to mitigate the same have remained unpredictable and it remains possible that challenges may arise in the future.

 

The actions the Company has taken so far during the COVID-19 pandemic include, but are not limited to, requiring all employees who can work from home to work from home and increasing its IT networking capability to best assure employees can work effectively outside the office.

 

The Company currently believes revenue for the year ending December 31, 2021 has been impacted due to the conditions noted. Based on the Company’s current cash position and its projected cash flow from operations, the Company believes that it will have sufficient capital and or have access to sufficient capital through public and private equity and debt offerings to sustain operations for a period of one year following the date of this filing. If business interruptions resulting from the COVID-19 pandemic were to be prolonged or expanded in scope, the business, financial condition, results of operations and cash flows would be negatively impacted. The Company will continue to actively monitor this situation and will implement actions necessary to maintain business continuity.

 

Effects of Inflation

 

For the periods for which financial information is presented, we do not believe that the current levels of inflation in the United States have had a significant impact on our operations. Likewise, we do not believe that the current levels of inflation in Taiwan have had a significant impact on the operations of Iveda Taiwan.

 

Off Balance Sheet Arrangements

 

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market, or credit risk that could arise if we had engaged in such relationships.

 

27

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by 17 C.F.R. 229 (10)(f)(i) and are not required to provide information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer, as of March 31, 2022, concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act was recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in our internal control over financial reporting identified by management’s evaluation pursuant to Rule 13a-15(d) or 15d-15(d) of the Exchange Act during the most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors, and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management or Board override of the control.

 

The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

28

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We may be subject to legal proceedings in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not aware of any legal proceedings to which we are a party that we believe could have a material adverse effect on us.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined by 17 C.F.R. 229 (10)(f)(i) and are not required to provide information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Set forth below are the sales of all securities by the Company during the quarter ended March 31, 2022, which were not registered under the Securities Act. The Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and/or Regulation S under the Securities Act.

 

During March 2022 the company sold 65,714 shares of common stock from a warrant exercise at $0.35 per common share for $23,000 to one shareholder.

 

ITEM 3. DEFAULT UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

Not applicable.

 

ITEM 6. EXHIBITS.

 

Exhibit   Description
     
31.1   Certificate of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)
31.2   Certificate of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)
32.1   Certificate of Principal Executive Officer Pursuant to Section 1350
32.2   Certificate of Principal Financial Officer Pursuant to Section 1350
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  IVEDA SOLUTIONS, INC.
   
Date: May 16, 2022 /s/ David Ly
  David Ly
  Chief Executive Officer and Chairman
(Principal Executive Officer)
   
  /s/ Robert J. Brilon
  Robert J. Brilon
  Chief Financial Officer
(Principal Financial and Accounting Officer)

 

30

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

EXCHANGE ACT RULE 13a-14(a) or RULE 15d-14(a)

 

(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, David Ly, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Iveda Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 16, 2022  
   
/s/ David Ly  
David Ly  
Chief Executive Officer and Chairman  
(Principal Executive Officer)  

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

EXCHANGE ACT RULE 13a-14(a) or RULE 15d-14(a)

 

(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, Robert J. Brilon, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Iveda Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 16, 2022  
   
/s/ Robert J. Brilon  
Robert J. Brilon  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. § 1350

 

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, David Ly, Chief Executive Officer (principal executive officer) of Iveda Solutions, Inc. (the “Registrant”), certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 Chief Executive Officer and Chairman of the Sarbanes-Oxley Act of 2002, that, based upon a review of the Quarterly Report on Form 10-Q for the period ended March 31, 2022 of the Registrant (the “Report”):

 

  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Registrant.

 

Date: May 16, 2022  
   
/s/ David Ly  
David Ly  
Chief Executive Officer and Chairman  
(Principal Executive Officer)  

 

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Iveda Solutions, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. §1350

 

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, Robert J. Brilon, President and Chief Financial Officer (principal financial officer) of Iveda Solutions, Inc. (the “Registrant”), certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon a review of the Quarterly Report on Form 10-Q for the period ended March 31, 2022 of the Registrant (the “Report”):

 

  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Registrant.

 

Date: May 16, 2022  
   
/s/ Robert J. Brilon  
Robert J. Brilon  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  

 

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Iveda Solutions, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EX-101.SCH 6 ivda-20220331.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SHORT-TERM AND LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - EQUITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - STOCK OPTION PLAN AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - EARNINGS (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - CONTINGENT LIABILITIES—TAIWAN link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - CONTINGENT LIABILITIES—TAIWAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ivda-20220331_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 ivda-20220331_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 ivda-20220331_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Common Stock, $0.00001 Par Value Per Share [Member] Common Stock Purchase Warrants [Member] Series B Preferred Stock [Member] Product and Service [Axis] Equipment Sales [Member] Service Revenue [Member] Other Revenue [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer One [Member] Revenue Benchmark [Member] Two Customers [Member] Legal Entity [Axis] Chunghwa Telecom [Member] Taiwan stock [Member] Other Customers [Member] Statistical Measurement [Axis] Minimum [Member] Geographical [Axis] UNITED STATES Republic of China (Taiwan) [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Debenture Agreement [Member] Related Party [Axis] Mr Gregory Omi [Member] Loan Restructuring Modification [Axis] Extended Maturity [Member] Mr Robert Gillen [Member] Various Shareholders [Member] Shanghai bank [Member] Hua Nan Bank [Member] Maximum [Member] Series A Preferred Stock [Member] Plan Name [Axis] 2009 Stock Option Plan [Member] 2010 Stock Option Plan [Member] 2020 Stock Option Plan [Member] Award Type [Axis] Warrant [Member] Segments [Axis] US Based Segment [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] ARIZONA Megasys [Member] Underwriting agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and Cash Equivalents Restricted Cash Accounts Receivable, Net Inventory, Net Other Current Assets Total Current Assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Intangible Assets, Net Other Assets Total Other Assets Total Assets LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts and Other Payables Due to Related Parties Short Term Debt Current Portion of Long-Term Debt Total Current Liabilities LONG-TERM DEBT LONG-TERM DIVIDENDS PAYABLE STOCKHOLDERS’ EQUITY Preferred Stock, $0.00001 par value; 12,500,000 shares authorized Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively Common Stock, $0.00001 par value; 37,500,000 shares authorized; 11,561,647 and 9,668,369, shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively Additional Paid-In Capital Subscription Receivable Accumulated Comprehensive Loss Accumulated Deficit Total Stockholders’ Equity (Deficit) Total Liabilities and Stockholders’ Equity Preferred Stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding REVENUE TOTAL REVENUE COST OF REVENUE GROSS PROFIT OPERATING EXPENSES General & Administrative Total Operating Expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Miscellaneous Income (Expense) Interest Income Interest Expense Total Other Income (Expense) LOSS BEFORE INCOME TAXES BENEFIT (PROVISION) FOR INCOME TAXES NET LOSS BASIC AND DILUTED LOSS PER SHARE WEIGHTED AVERAGE SHARES Beginning balance, value Beginning balance, shares Common Stock Offering for Cash Common Stock Offering for Cash, shares Costs of Capital Stock Based Compensation Common Stock for Accounts Payable Common stock for accounts payable, shares Common Stock for Costs of Financing Common stock for costs of Financing, shares Warrants for Services Warrants for Interest Expense Convertible Debenture Value Preferred Stock - Series B for Dividend Preferred Stock - Series B for Dividend, shares Preferred Stock - Series B Shares and Dividend Payable to Common Stock Preferred Stock - Series B Shares and Dividend Payable to Common Stock, shares Dividends - P/S Series B Conversion of Debt & Interest to Common Stock Conversion of Debt & Interest to Common Stock, shares Exercise of options and warrants Exercise of options and warrants, shares Net Loss Comprehensive Loss Common Stock issued for conversion error Common Stock issued for conversion error, shares Subscription Receivable Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities Depreciation and Amortization Interest Value of Convertible Debt Issued Stock Option Compensation Common Stock Warrants Issued for Services Common Stock Warrants Issued for Interest (Increase) Decrease in Operating Assets Accounts Receivable Inventory Other Current Assets Other Assets Increase (Decrease) in Accounts and Other Payables Net Cash Used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of Property and Equipment Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Changes in Restricted Cash Proceeds from (Payments on) Short-Term Notes Payable/Debt Proceeds from (Payments to) Due to Related Parties Proceeds from (Payments to) Long-Term Debt Payments for Deferred Finance Costs Common Stock Issued, Net of (Cost of Capital) Net Cash Provided by Financing Activities EFFECT OF EXCHANGE RATE CHANGES ON CASH NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents- Beginning of Period CASH AND CASH EQUIVALENTS - END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Interest Paid Income Tax Paid SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Common Stock issued for Consulting Agreements related to Cost of Capital Dividends Paid with Series B Preferred Stock Warrants Issued for Interest Warrants Issued for Services Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTIES Debt Disclosure [Abstract] SHORT-TERM AND LONG-TERM DEBT Equity [Abstract] PREFERRED STOCK EQUITY Share-Based Payment Arrangement [Abstract] STOCK OPTION PLAN AND WARRANTS Income Tax Disclosure [Abstract] INCOME TAXES Earnings Per Share [Abstract] EARNINGS (LOSS) PER SHARE Commitments and Contingencies Disclosure [Abstract] CONTINGENT LIABILITIES—TAIWAN Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of Operations Consolidation Going Concern Impairment of Long-Lived Assets Basis of Accounting Use of Estimates Revenue and Expense Recognition Comprehensive Loss Concentrations Cash and Cash Equivalents Accounts Receivable Deposits – Current Other Current Assets Inventories Property and Equipment Intangible Assets Deposits—Long-Term Income Taxes Restricted Cash Accounts and Other Payables Deferred Revenue Stock-Based Compensation Fair Value of Financial Instruments Segment Information Reclassification New Accounting Standards SCHEDULE OF ACCOUNTS AND OTHER PAYABLES SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS SCHEDULE OF RELATED PARTY TRANSACTIONS SCHEDULE OF SHORT-TERM DEBT SCHEDULE OF LONG-TERM DEBT SCHEDULE OF STOCK OPTION TRANSACTIONS SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL SCHEDULE OF WARRANT TRANSACTIONS SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SUMMARY OF OPERATING LOSS CARRYFORWARDS SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED Accounts Payable Accrued Expenses Deferred Revenue and Customer Deposits Accounts and Other Payables Net Revenue Net Assets (Liabilities) Schedule of Product Information [Table] Product Information [Line Items] Accumulated deficit CDIC insurance limit Percentage of concentration risk Account receivable Revenues Inventory reserve Depreciation expense Stock-based compensation expense Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Debt instrument, face amount Debt instrument, interest rate Debt instrument, maturity date Share based compesatio, award option Share price Interest expense Total Due to Related Parties Less Current Portion Total Long-Term Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Interest rate Debt instrument, maturity date Debt Instrument, Convertible, Conversion Price Debt principal amount Accrued interest Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Debt interest rate Debt Instrument, Maturity Date, Description Long Term Debt Current Portion of Long-term debt Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, par value Shares, Outstanding at Beginning of Year Weighted-Average Exercise Price, Outstanding at Beginning of Year Shares, Granted Weighted-Average Exercise Price, Granted Shares, Exercised Weighted-Average Exercise Price, Exercised Shares, Forfeited or Canceled Weighted-Average Exercise Price, Forfeited or Canceled Shares, Outstanding at End of Year Weighted-Average Exercise Price, Outstanding at End of Year Shares, Options Exercisable at End of Year Weighted-Average Exercise Price, Options Exercisable at End of Year Weighted-Average Fair Value of Options Granted During the Period Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Options Outstanding, Weighted-Average Exercise Price Options Exercisable, Number Exercisable Options Exercisable, Weighted-Average Exercise Price Expected Life Dividend Yield Expected Volatility Risk-Free Interest Rate Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Shares, Outstanding at Beginning of Year Weighted-Average Exercise Price, Outstanding at Beginning of Year Shares, Granted Weighted-Average Exercise Price, Granted Shares, Exercised Weighted-Average Exercise Price, Exercised Shares, Forfeited or Canceled Weighted-Average Exercise Price, Forfeited or Canceled Shares, Outstanding at End of Year Weighted-Average Exercise Price, Outstanding at End of Year Shares, Options Exercisable at End of Year Weighted-Average Exercise Price, Options Exercisable at End of Year Weighted-Average Fair Value of Options Granted During the Period Range of Exercise Prices Warrants Outstanding, Number Outstanding Warrants Outstanding, Weighted-Average Remaining Contractual Life Warrants Outstanding, Weighted-Average Exercise Price Warrants Exercisable, Number Exercisable Warrants Exercisable, Weighted-Average Exercise Price Number of shares authorized under plan Options outstanding Unrecognized stock- based compensation Tax Operating Loss Carryforward - USA Other Valuation Allowance - USA  Deferred Tax Assets, Net Net Operating Loss Year of Expiration Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Valuation allowance increased Operating loss carryforwards Operating loss carryforward, limitations on use Taiwan corporate tax rate Basic EPS Weighted Average Shares Basic Loss Per Share Concentration risk, credit risk, financial instrument Subsequent Event [Table] Subsequent Event [Line Items] Stock and warrant offering Long term dividend payable Miscellaneous income expense Debenture Agreement [Member] Various Shareholders [Member] Debenture and accrued interest. Hua Nan Bank [Member] Shanghai bank [Member] Common Stock for Costs of Financing. Stock issued during period shares common stock for costs of financing shares Warrants for Interest Expense. Adjustments to convertible debenture valuation. Dividends - P/S Series B Conversion of Debt & Interest to Common Stock. Stock issued during period shares conversion of convertible securities interest to common stock shares 2009 Stock Option Plan [Member]. 2010 Stock Option Plan [Member] Stock issued during period value common stock issued for conversion error 2020 Stock Option Plan [Member] Stock issued during period shares common stock issued for conversion error Interest value of convertible debt issued Common stock warrants issued for interest value Proceeds from restricted cash Common stock issued for consulting agreements related to cost of capital Dividends paid with series B preferred stock Warrants issued for services Warrants issued for interest Nature of operations [Policy Text Block] Going concern [Policy Text Block] Current deposits [Policy Text Block] Other current assets [Policy Text Block] Long term deposits [Policy Text Block] Accounts and other payables [Policy Text Block] Schedule of warrant transactions [Table Text Block] Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average ExercisePrice. Republic of China (Taiwan) [Member]. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, Granted. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, forfeited. Non option equity instruments exercisable number. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average ExercisePrice. Summary of warrants outstanding and exercisable information [Table Text Block] Schedule of warrants outstanding and exercisable [Table Text Block] Customer One [Member] Other Customers [Member] Chunghwa Telecom [Member] Taiwan stock [Member] US Based Segment [Member] Year of Expiration. Taiwan corporate tax rate. Megasys [Member] Two customers [Member] MEGA sys Directors [Member] Mr Gregory Omi [Member] Mr Robert Gillen [Member] Stock and warrant offering Underwriting agreement [Member] Common Stock, $0.00001 Par Value Per Share [Member] Common Stock Purchase Warrants [Member] Assets, Current Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment Assets Liabilities, Current Stockholders' Equity Note, Subscriptions Receivable Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Income Tax Expense (Benefit) Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Noncurrent Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities ProceedsFromRestrictedCash Payment of Financing and Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations DividendsPaidWithSeriesBPreferredStock WarrantsIssuedForInterest WarrantsIssuedForServices Comprehensive Income, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Other current assets [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Accounts and other payables [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net EX-101.PRE 10 ivda-20220331_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - shares
3 Months Ended
Mar. 31, 2022
May 06, 2022
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-53285  
Entity Registrant Name IVEDA SOLUTIONS, INC.  
Entity Central Index Key 0001397183  
Entity Tax Identification Number 20-2222203  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 1744 S Val Vista  
Entity Address, Address Line Two Suite 213  
Entity Address, City or Town Mesa  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85204  
City Area Code (480)  
Local Phone Number 307-8700  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   11,561,647
Common Stock, $0.00001 Par Value Per Share [Member]    
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol IVDA  
Security Exchange Name NASDAQ  
Common Stock Purchase Warrants [Member]    
Title of 12(b) Security Common Stock Purchase Warrants  
Trading Symbol IVDAW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and Cash Equivalents $ 746,931 $ 1,385,275
Restricted Cash 138,118 142,688
Accounts Receivable, Net 146,696 492,752
Inventory, Net 576,190 344,654
Other Current Assets 186,355 310,657
Total Current Assets 1,794,290 2,676,026
PROPERTY AND EQUIPMENT, NET 37,705 38,189
OTHER ASSETS    
Intangible Assets, Net
Other Assets 256,547 273,419
Total Other Assets 256,547 273,419
Total Assets 2,088,543 2,987,634
CURRENT LIABILITIES    
Accounts and Other Payables 2,991,729 2,955,826
Due to Related Parties 300,000 300,000
Short Term Debt 224,648 50,000
Current Portion of Long-Term Debt 116,432 120,284
Total Current Liabilities 3,632,809 3,426,110
LONG-TERM DEBT 298,843 338,803
LONG-TERM DIVIDENDS PAYABLE
STOCKHOLDERS’ EQUITY    
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
Common Stock, $0.00001 par value; 37,500,000 shares authorized; 11,561,647 and 9,668,369, shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 116 97
Additional Paid-In Capital 47,724,107 40,727,518
Subscription Receivable (7,370,350)
Accumulated Comprehensive Loss (168,783) (143,493)
Accumulated Deficit (42,028,199) (41,361,401)
Total Stockholders’ Equity (Deficit) (1,843,109) (777,279)
Total Liabilities and Stockholders’ Equity $ 2,088,543 $ 2,987,634
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Preferred Stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 12,500,000 12,500,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 37,500,000 37,500,000
Common stock, shares issued 11,561,647 9,668,369
Common stock, shares outstanding 11,561,647 9,668,369
Series B Preferred Stock [Member]    
Preferred Stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 500 500
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
REVENUE    
TOTAL REVENUE $ 230,857 $ 332,580
COST OF REVENUE 90,310 217,551
GROSS PROFIT 140,547 115,029
OPERATING EXPENSES    
General & Administrative 792,164 567,649
Total Operating Expenses 792,164 567,649
LOSS FROM OPERATIONS (651,616) (452,620)
OTHER INCOME (EXPENSE)    
Miscellaneous Income (Expense) 172
Interest Income 616 38
Interest Expense (12,833) (182,132)
Total Other Income (Expense) (12,045) (182,094)
LOSS BEFORE INCOME TAXES (663,662) (634,714)
BENEFIT (PROVISION) FOR INCOME TAXES (3,136)
NET LOSS $ (666,798) $ (634,714)
BASIC AND DILUTED LOSS PER SHARE $ (0.07) $ (0.09)
WEIGHTED AVERAGE SHARES 9,672,508 7,209,589
Equipment Sales [Member]    
REVENUE    
TOTAL REVENUE $ 189,521 $ 304,105
Service Revenue [Member]    
REVENUE    
TOTAL REVENUE 41,336 28,298
Other Revenue [Member]    
REVENUE    
TOTAL REVENUE $ 177
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 66 $ 34,769,076 $ (38,322,456) $ (153,254) $ (3,706,568)
Beginning balance, shares at Dec. 31, 2020 6,583,924 257        
Common Stock Offering for Cash $ 8   2,661,992     2,662,000
Common Stock Offering for Cash, shares 757,655          
Costs of Capital     (2,091,101)     (2,091,101)
Stock Based Compensation     801,908     801,908
Common Stock for Accounts Payable $ 1   99,789     99,789
Common stock for accounts payable, shares 27,896          
Common Stock for Costs of Financing $ 6   1,932,730     1,932,736
Common stock for costs of Financing, shares 628,750          
Warrants for Services     148,480     148,480
Warrants for Interest Expense     69,729     69,729
Convertible Debenture Value     69,729     69,729
Preferred Stock - Series B for Dividend     23,750     23,750
Preferred Stock - Series B for Dividend, shares   2        
Preferred Stock - Series B Shares and Dividend Payable to Common Stock $ 11   432,165     432,176
Preferred Stock - Series B Shares and Dividend Payable to Common Stock, shares 1,090,015 (259)        
Dividends - P/S Series B       (40,301)   (40,301)
Conversion of Debt & Interest to Common Stock $ 4   1,294,576     1,294,580
Conversion of Debt & Interest to Common Stock, shares 439,527          
Exercise of options and warrants $ 1   514,696     $ 514,697
Exercise of options and warrants, shares 140,602         62,500
Net Loss   (2,998,644)   $ (2,998,644)
Comprehensive Loss         9,761 9,761
Ending balance, value at Dec. 31, 2021 $ 97 40,727,518 (41,361,401) (143,493) (777,279)
Ending balance, shares at Dec. 31, 2021 9,668,369 0        
Common Stock Offering for Cash $ 19   8,011,231     8,011,250
Common Stock Offering for Cash, shares 1,885,000          
Costs of Capital     (1,105,142)     (1,105,142)
Stock Based Compensation     67,500     67,500
Exercise of options and warrants   23,000     23,000
Exercise of options and warrants, shares 8,214          
Net Loss   (666,798)   (666,798)
Comprehensive Loss         (25,290) (25,290)
Common Stock issued for conversion error      
Common Stock issued for conversion error, shares 64          
Subscription Receivable     (7,370,350)      
Ending balance, value at Mar. 31, 2022 $ 116 $ 40,353,757 $ (42,028,199) $ (168,783) $ (1,843,109)
Ending balance, shares at Mar. 31, 2022 11,561,647 0        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES      
Net Loss $ (666,798) $ (634,714) $ (2,998,644)
Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities      
Depreciation and Amortization 4,657 5,000  
Stock Option Compensation 67,500   801,908
Common Stock Warrants Issued for Services   11,475  
Common Stock Warrants Issued for Interest   139,458  
(Increase) Decrease in Operating Assets      
Accounts Receivable 330,272 (13,840)  
Inventory (242,576) (24,454)  
Other Current Assets 31,085 (162,628)  
Other Assets 8,302 4,722  
Increase (Decrease) in Accounts and Other Payables (302,666) 186,897  
Net Cash Used in Operating Activities (770,224) (488,084)  
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of Property and Equipment (4,696)  
Net Cash Provided by (Used in) Investing Activities (4,696)  
CASH FLOWS FROM FINANCING ACTIVITIES      
Changes in Restricted Cash 73,661  
Proceeds from (Payments on) Short-Term Notes Payable/Debt 174,648 203,194  
Proceeds from (Payments to) Due to Related Parties (37,177)  
Proceeds from (Payments to) Long-Term Debt (29,108)  
Payments for Deferred Finance Costs  
Common Stock Issued, Net of (Cost of Capital) 815,001  
Net Cash Provided by Financing Activities 145,540 1,054,679  
EFFECT OF EXCHANGE RATE CHANGES ON CASH (8,964) 1,528  
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (638,344) 568,123  
Cash and Cash Equivalents- Beginning of Period 1,385,275 249,521 249,521
CASH AND CASH EQUIVALENTS - END OF PERIOD 746,931 817,644 $ 1,385,275
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION      
Interest Paid 1,013 330  
Income Tax Paid  
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES      
Common Stock issued for Consulting Agreements related to Cost of Capital 1,895,000  
Dividends Paid with Series B Preferred Stock 23,750  
Warrants Issued for Interest 139,458  
Warrants Issued for Services $ 11,475  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  Object Search
  Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  License Plate Recognition (100+ Countries), includes make and model
  Intrusion Detection
  Weapon Detection
  Fire Detection
  People Counting
  Vehicle Counting
  Temperature Detection
  Public Health Analytics (Facemask Detection,
  QR and Barcode Detection

 

Key Features

 

  Live Camera View
  Live Tracking
  Abnormality Detection – Vehicle/Person wrong direction detection
  Vehicle/Person Loitering Detection
  Fall Detection
  Illegal Parking Detection
  Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after-the-fact.

 

Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.

 

Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central device management. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.

 

Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.

 

In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

Our Taiwan-based subsidiary Iveda Taiwan, formerly known as MEGAsys, our wholly-owned subsidiary, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and safe city. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Taiwan-based Sole Vision Technologies (dba Iveda Taiwan). We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We generated accumulated losses of approximately $42 million from January 2005 through March 31, 2021 and have insufficient working capital and cash flows to support operations. These factors raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty.

 

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the three months ended March 31, 2022 and year ended December 31, 2021.

 

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable, and the amount can be reliably estimated.

 

  The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, annual license revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

 

Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. One customer (Chunghwa Telecom) represented approximately 95% of total accounts receivable of $492,752 as of December 31, 2021. This customer is a longtime customer, and we don’t expect any problem with collectability of these accounts receivable.

 

We had revenue from two customers with greater than 10% of total revenues during the three months ended March 31, 2022 and the year ended December 31, 2021 that represented approximately 39% and 55% of total revenues, respectively. We had $58,086 revenues (25%) from Chunghwa Telecom and $29,013 revenues (13%) from Taiwan Stock Exchange Corporation of total revenues of $230,857 for the three months ended March 31, 2022.

We had $786,686 revenues (41%) from Chunghwa Telecom and $260,946 revenues (14%) from Taiwan Stock Exchange Corporation of total revenues of $1,917,848 for the year ended December 31, 2021.

 

No other customers represented greater than 10% of total revenues in the three months ended March 31, 2022 and year ended December 31, 2021.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of March 31, 2022 and December 31, 2021 no allowance for uncollectible accounts was deemed necessary for our U.S.-based segment.

 

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 

Other Current Assets

 

Other current assets represent cash paid in advance to insurance companies and vendors for service coverage extending into subsequent periods.

 

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 as of March 31, 2022 and December 31, 2021.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended March 31, 2022 was $4,657 and for the year ended December 31, 2021 was $15,016.

 

 

Intangible Assets

 

Intangible assets consist of trademarks and other intangible assets associated with the purchase price allocation of Iveda Taiwan. Such assets are fully amortized at December 31, 2021.

 

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2021, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2021.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2017 to 2021 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2017 to 2021 are open to examination by the Taiwan Ministry of Finance.

 

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

Accounts and Other Payables

   March 31, 2022   December 31, 2021 
         
Accounts Payable  $138,228   $62,889 
Accrued Expenses   2,757,814    2,834,726 
Deferred Revenue and Customer Deposits   95,687    58,211 
Accounts and Other Payables  $2,991,729   $2,955,826 

 

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

 

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of March 31, 2021 and December 31, 2021, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $67,500 and $801,908 of stock-based compensation expense for the three months ended March 31, 2022 and December 31, 2021, respectively.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2022 and December 31, 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

   March 31, 2022 (Unaudited) 
   Net Revenue   Net Assets (Liabilities) 
United States  $7,882   $(2,606,975)
Republic of China (Taiwan)  $324,698   $763,867 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

Reclassification

 

Certain amounts in 2021 have been reclassified to conform to the 2022 presentation.

 

New Accounting Standards

 

No new relevant accounting standards

 

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTIES
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTIES

NOTE 2 RELATED PARTIES

   March 31, 2022 (Unaudited)   December 31, 2021 
         
On August 28, 2014, we entered into a debenture agreement with Mr. Gregory Omi, formerly a member of our Board of Directors of the company for $200,000, at 9.5% interest per annum with interest and principal payable on the extended maturity date of December 31, 2016. As consideration for the extension of the debenture, we granted Mr. Omi options to purchase 2,500 shares of our common stock with an exercise price of $6.16 per share. This debenture was extended to December 31, 2022. Mr. Omi is currently the CTO of the company.   200,000    200,000 
           
On November 19, 2012, we entered into a convertible debenture agreement with Mr. Robert Gillen, a member of our Board of Directors, for $100,000 (the “Gillen I Debenture”), under his company Squirrel-Away, LLC. Under the original terms of the agreement, interest is payable at 10% per annum and became due on December 19, 2014. Gillen I Debenture was extended to January 5, 2015. On June 20, 2013, interest of $5,000 was paid on the debenture. As consideration for agreeing to extend the maturity date of the debenture to December 31, 2015, we granted Mr. Gillen options to purchase 1,250 shares of common stock at an exercise price of $6.16 per share This debenture was extended to December 31, 2022.  $100,000   $100,000 
           
Total Due to Related Parties  $300,000    300,000 
Less Current Portion   (300,000)   (300,000)
Total Long-Term  $-   $- 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
SHORT-TERM AND LONG-TERM DEBT
3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
SHORT-TERM AND LONG-TERM DEBT

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

 

The short-term debt balances were as follows:

 

   March 31, 2022 (Unaudited)    December 31, 2021 
          
Debenture agreements with a shareholder at 10% interest rate beginning in February 2019 - December 2019, one year maturity, were due February 2020 – December 2020, principal and interest convertible at $2.80 per share into common stock at the option of the holder until repaid. All principal and accrued interest converted during 2021 except one remaining $50,000 debenture and accrued interest of $12,079.  $50,000    $50,000 
Loan Agreement with Shanghai Bank at 2.68% interest rate per annum due January 2023.   69,850     - 
Loan agreement with Hua Nam bank at 2,42% interest rate per annum due September 2022.   104,789     - 
            
Balance at end of period  $224,648    $50,000 

 

Long-term debt balances were as follows:

 

   March 31, 2022
(Unaudited)
   December 31. 2021 
         
Loans from Shanghai Bank with interest rates 1.00% - 1.5% per annum due February 2024November 2026   415,275    469,087 
           
Current Portion of Long-term debt   (116,432)   (120,284)
           
Balance at end of period  $298,843   $338,803 

 

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
PREFERRED STOCK
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
PREFERRED STOCK

NOTE 4 PREFERRED STOCK

 

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share, 1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
EQUITY

NOTE 5 EQUITY

 

Common Stock

 

We are authorized to issue up to 37,500,000 shares of common stock, par value $0.00001 per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK OPTION PLAN AND WARRANTS
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK OPTION PLAN AND WARRANTS

NOTE 6 STOCK OPTION PLAN AND WARRANTS

 

Stock Options

 

On October 15, 2009, we adopted the 2009 Stock Option Plan (the “2009 Option Plan”), with an aggregate number of 187,500 shares of common stock issuable under the plan. The purpose of the 2009 Option Plan was to assume options that were already issued in the 2006 and 2008 Option plans under Iveda Corporation after the merger with Charmed Homes.

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 125,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 1,625,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020.

 

We adopted a new plan called Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan will have a maximum of 10 million option shares authorized with similar terms and conditions to the 2010 Option Plan. This plan has not been approved by the shareholders.

 

As of December 31, 2021, there were 893,438 options outstanding under all the option plans.

 

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2021, we had approximately $4,500 unrecognized stock-based compensation.

 

Stock option transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   952,025   $5.76    842,650   $6.24 
Granted   141,875    11.76    312,500    2.96 
Exercised   (62,500)   4.72    (158,750)   1.28 
Forfeited or Canceled   (137,963)   7.44    (44,375)   8.96 
Outstanding at End of Year   893,438    6.80    952,025    5.76 
                     
Options Exercisable at Year-End   891,563    6.80    952,025    5.76 
                     
Weighted-Average Fair Value of Options Granted During the Year  $5.68        $2.00      

 

Information with respect to stock options outstanding and exercisable at December 31, 2021 is as follows:

 

   Options Outstanding   Options Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average
Remaining
Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$0.32 - $16.24   893,438    6.2   $6.80    891,563   $6.80 

 

 

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021   2020 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   1.00%   0.18%

 

Warrant transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   543,754   $3.04    695,439   $3.04 
Granted   509,732    2.96    123,732    2.80 
Exercised   (78,102)   2.80           
Forfeited or Canceled   (103,125)   2.80    (275,416)   2.88 
Outstanding at End of Year   872,259    3.04    543,754    3.04 
                     
Warrant Exercisable at Year-End   872,259    3.04    543,754    3.04 
                     
Weighted-Average Fair Value of Warrants Granted During the Year  $1.12 - $3.92        $0.80 - $2.08      

 

Information with respect to warrants outstanding and exercisable at December 31, 2021 is as follows:

 

   Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average Remaining Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$2.80 - $13.20   872,259    1.5   $3.04    872,259   $3.04 

 

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021    2020 
Expected Life   1.5 yrs     1.5 yrs 
Dividend Yield   0%    0%
Expected Volatility   90%    90%
Risk-Free Interest Rate   0.18 - 1.00%    0.19 - 1.59%

 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 7 INCOME TAXES

 

U.S. Federal Corporate Income Tax

 

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2021   2020 
Tax Operating Loss Carryforward - USA  $10,800,000   $9,800,000 
Other   -    - 
Valuation Allowance - USA   (10,800,000)   (9,800,000)
 Deferred Tax Assets, Net  $-   $- 

 

The valuation allowance increased approximately $0.5 million, primarily as a result of the increased net operating losses of our U.S.- based segment.

 

As of December 31, 2021, we had federal net operating loss carryforwards for income tax purposes of approximately $29 million which will begin to expire in 2025. We also have Arizona net operating loss carryforwards for income tax purposes of approximately $2.0 million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.

 

Year Ending  Net Operating   Year of 
December 31,  Loss:   Expiration 
2021  $1,000,000    2041 
2020   590,000    2040 
2019   260,000    2039 
2018   160,000    2038 
2017   140,000    2037 
2016   1,640,000    2036 
2015   3,400,000    2035 
2014   5,230,000    2034 
2013   5,600,000    2033 
2012   2,850,000    2032 
2011   2,427,000    2031 
2010   1,799,000    2030 
2009   1,750,000    2029 
2008   1,308,000    2028 
2007   429,000    2027 
2006   476,000    2026 
2005   414,000    2025 

 

Taiwan (Republic of China) Corporate Tax

 

Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year.

 

According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.

 

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
EARNINGS (LOSS) PER SHARE
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE

NOTE 8 EARNINGS (LOSS) PER SHARE

 

The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”

 

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the three months ended March 31, 2022 and 2021 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the Three months ended March 31, 2022 and 2021.

 

   March 31, 2022
(Unaudited)
   March 31, 2021 (Unaudited) 
         
Basic EPS          
Net Loss  $(666,798)  $(634,714)
Weighted Average Shares   9,672,508    7,209,589 
Basic Loss Per Share  $(0.07)  $(0.09)

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
CONTINGENT LIABILITIES—TAIWAN
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
CONTINGENT LIABILITIES—TAIWAN

NOTE 9 CONTINGENT LIABILITIES—TAIWAN

 

Pursuant to certain contracts with Siemens, Chung-Hsin Electric and Machinery Manufacturing Corp, Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2021 is $61,435.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 10 SUBSEQUENT EVENTS

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements

 

On April 5, 2022 we closed the Stock and Warrant Offering that was committed to by Underwriting Agreement effective March 31, 2022 for $8,011,250.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Nature of Operations

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  Object Search
  Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  License Plate Recognition (100+ Countries), includes make and model
  Intrusion Detection
  Weapon Detection
  Fire Detection
  People Counting
  Vehicle Counting
  Temperature Detection
  Public Health Analytics (Facemask Detection,
  QR and Barcode Detection

 

Key Features

 

  Live Camera View
  Live Tracking
  Abnormality Detection – Vehicle/Person wrong direction detection
  Vehicle/Person Loitering Detection
  Fall Detection
  Illegal Parking Detection
  Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after-the-fact.

 

Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.

 

Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central device management. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.

 

Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.

 

In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

Our Taiwan-based subsidiary Iveda Taiwan, formerly known as MEGAsys, our wholly-owned subsidiary, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and safe city. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

Consolidation

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Taiwan-based Sole Vision Technologies (dba Iveda Taiwan). We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

 

Going Concern

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We generated accumulated losses of approximately $42 million from January 2005 through March 31, 2021 and have insufficient working capital and cash flows to support operations. These factors raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the three months ended March 31, 2022 and year ended December 31, 2021.

 

Basis of Accounting

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 

Revenue and Expense Recognition

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable, and the amount can be reliably estimated.

 

  The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, annual license revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

Comprehensive Loss

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 

Concentrations

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

 

Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. One customer (Chunghwa Telecom) represented approximately 95% of total accounts receivable of $492,752 as of December 31, 2021. This customer is a longtime customer, and we don’t expect any problem with collectability of these accounts receivable.

 

We had revenue from two customers with greater than 10% of total revenues during the three months ended March 31, 2022 and the year ended December 31, 2021 that represented approximately 39% and 55% of total revenues, respectively. We had $58,086 revenues (25%) from Chunghwa Telecom and $29,013 revenues (13%) from Taiwan Stock Exchange Corporation of total revenues of $230,857 for the three months ended March 31, 2022.

We had $786,686 revenues (41%) from Chunghwa Telecom and $260,946 revenues (14%) from Taiwan Stock Exchange Corporation of total revenues of $1,917,848 for the year ended December 31, 2021.

 

No other customers represented greater than 10% of total revenues in the three months ended March 31, 2022 and year ended December 31, 2021.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of March 31, 2022 and December 31, 2021 no allowance for uncollectible accounts was deemed necessary for our U.S.-based segment.

 

Deposits – Current

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 

Other Current Assets

Other Current Assets

 

Other current assets represent cash paid in advance to insurance companies and vendors for service coverage extending into subsequent periods.

 

Inventories

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 as of March 31, 2022 and December 31, 2021.

 

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended March 31, 2022 was $4,657 and for the year ended December 31, 2021 was $15,016.

 

 

Intangible Assets

Intangible Assets

 

Intangible assets consist of trademarks and other intangible assets associated with the purchase price allocation of Iveda Taiwan. Such assets are fully amortized at December 31, 2021.

 

Deposits—Long-Term

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 

Income Taxes

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2021, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2021.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2017 to 2021 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2017 to 2021 are open to examination by the Taiwan Ministry of Finance.

 

Restricted Cash

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

Accounts and Other Payables

Accounts and Other Payables

   March 31, 2022   December 31, 2021 
         
Accounts Payable  $138,228   $62,889 
Accrued Expenses   2,757,814    2,834,726 
Deferred Revenue and Customer Deposits   95,687    58,211 
Accounts and Other Payables  $2,991,729   $2,955,826 

 

Deferred Revenue

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

 

Stock-Based Compensation

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of March 31, 2021 and December 31, 2021, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $67,500 and $801,908 of stock-based compensation expense for the three months ended March 31, 2022 and December 31, 2021, respectively.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2022 and December 31, 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 

Segment Information

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

   March 31, 2022 (Unaudited) 
   Net Revenue   Net Assets (Liabilities) 
United States  $7,882   $(2,606,975)
Republic of China (Taiwan)  $324,698   $763,867 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

Reclassification

Reclassification

 

Certain amounts in 2021 have been reclassified to conform to the 2022 presentation.

 

New Accounting Standards

New Accounting Standards

 

No new relevant accounting standards

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   March 31, 2022   December 31, 2021 
         
Accounts Payable  $138,228   $62,889 
Accrued Expenses   2,757,814    2,834,726 
Deferred Revenue and Customer Deposits   95,687    58,211 
Accounts and Other Payables  $2,991,729   $2,955,826 
SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

   March 31, 2022 (Unaudited) 
   Net Revenue   Net Assets (Liabilities) 
United States  $7,882   $(2,606,975)
Republic of China (Taiwan)  $324,698   $763,867 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTIES (Tables)
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTIONS

   March 31, 2022 (Unaudited)   December 31, 2021 
         
On August 28, 2014, we entered into a debenture agreement with Mr. Gregory Omi, formerly a member of our Board of Directors of the company for $200,000, at 9.5% interest per annum with interest and principal payable on the extended maturity date of December 31, 2016. As consideration for the extension of the debenture, we granted Mr. Omi options to purchase 2,500 shares of our common stock with an exercise price of $6.16 per share. This debenture was extended to December 31, 2022. Mr. Omi is currently the CTO of the company.   200,000    200,000 
           
On November 19, 2012, we entered into a convertible debenture agreement with Mr. Robert Gillen, a member of our Board of Directors, for $100,000 (the “Gillen I Debenture”), under his company Squirrel-Away, LLC. Under the original terms of the agreement, interest is payable at 10% per annum and became due on December 19, 2014. Gillen I Debenture was extended to January 5, 2015. On June 20, 2013, interest of $5,000 was paid on the debenture. As consideration for agreeing to extend the maturity date of the debenture to December 31, 2015, we granted Mr. Gillen options to purchase 1,250 shares of common stock at an exercise price of $6.16 per share This debenture was extended to December 31, 2022.  $100,000   $100,000 
           
Total Due to Related Parties  $300,000    300,000 
Less Current Portion   (300,000)   (300,000)
Total Long-Term  $-   $- 

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
SHORT-TERM AND LONG-TERM DEBT (Tables)
3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
SCHEDULE OF SHORT-TERM DEBT

The short-term debt balances were as follows:

 

   March 31, 2022 (Unaudited)    December 31, 2021 
          
Debenture agreements with a shareholder at 10% interest rate beginning in February 2019 - December 2019, one year maturity, were due February 2020 – December 2020, principal and interest convertible at $2.80 per share into common stock at the option of the holder until repaid. All principal and accrued interest converted during 2021 except one remaining $50,000 debenture and accrued interest of $12,079.  $50,000    $50,000 
Loan Agreement with Shanghai Bank at 2.68% interest rate per annum due January 2023.   69,850     - 
Loan agreement with Hua Nam bank at 2,42% interest rate per annum due September 2022.   104,789     - 
            
Balance at end of period  $224,648    $50,000 
SCHEDULE OF LONG-TERM DEBT

Long-term debt balances were as follows:

 

   March 31, 2022
(Unaudited)
   December 31. 2021 
         
Loans from Shanghai Bank with interest rates 1.00% - 1.5% per annum due February 2024November 2026   415,275    469,087 
           
Current Portion of Long-term debt   (116,432)   (120,284)
           
Balance at end of period  $298,843   $338,803 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK OPTION PLAN AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION TRANSACTIONS

Stock option transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   952,025   $5.76    842,650   $6.24 
Granted   141,875    11.76    312,500    2.96 
Exercised   (62,500)   4.72    (158,750)   1.28 
Forfeited or Canceled   (137,963)   7.44    (44,375)   8.96 
Outstanding at End of Year   893,438    6.80    952,025    5.76 
                     
Options Exercisable at Year-End   891,563    6.80    952,025    5.76 
                     
Weighted-Average Fair Value of Options Granted During the Year  $5.68        $2.00      
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

Information with respect to stock options outstanding and exercisable at December 31, 2021 is as follows:

 

   Options Outstanding   Options Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average
Remaining
Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$0.32 - $16.24   893,438    6.2   $6.80    891,563   $6.80 
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021   2020 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   1.00%   0.18%
SCHEDULE OF WARRANT TRANSACTIONS

Warrant transactions during 2021 and 2020 were as follows:

 

   2021   2020 
   Shares   Weighted-
Average
Exercise
Price
   Shares   Weighted-
Average
Exercise
Price
 
                 
Outstanding at Beginning of Year   543,754   $3.04    695,439   $3.04 
Granted   509,732    2.96    123,732    2.80 
Exercised   (78,102)   2.80           
Forfeited or Canceled   (103,125)   2.80    (275,416)   2.88 
Outstanding at End of Year   872,259    3.04    543,754    3.04 
                     
Warrant Exercisable at Year-End   872,259    3.04    543,754    3.04 
                     
Weighted-Average Fair Value of Warrants Granted During the Year  $1.12 - $3.92        $0.80 - $2.08      
SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION

Information with respect to warrants outstanding and exercisable at December 31, 2021 is as follows:

 

   Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices
  Number
Outstanding
at
December 31,
2021
   Weighted-
Average Remaining Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable
at
December 31,
2021
   Weighted-
Average
Exercise
Price
 
$2.80 - $13.20   872,259    1.5   $3.04    872,259   $3.04 
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2021    2020 
Expected Life   1.5 yrs     1.5 yrs 
Dividend Yield   0%    0%
Expected Volatility   90%    90%
Risk-Free Interest Rate   0.18 - 1.00%    0.19 - 1.59%
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2021   2020 
Tax Operating Loss Carryforward - USA  $10,800,000   $9,800,000 
Other   -    - 
Valuation Allowance - USA   (10,800,000)   (9,800,000)
 Deferred Tax Assets, Net  $-   $- 
SUMMARY OF OPERATING LOSS CARRYFORWARDS

 

Year Ending  Net Operating   Year of 
December 31,  Loss:   Expiration 
2021  $1,000,000    2041 
2020   590,000    2040 
2019   260,000    2039 
2018   160,000    2038 
2017   140,000    2037 
2016   1,640,000    2036 
2015   3,400,000    2035 
2014   5,230,000    2034 
2013   5,600,000    2033 
2012   2,850,000    2032 
2011   2,427,000    2031 
2010   1,799,000    2030 
2009   1,750,000    2029 
2008   1,308,000    2028 
2007   429,000    2027 
2006   476,000    2026 
2005   414,000    2025 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
EARNINGS (LOSS) PER SHARE (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

 

   March 31, 2022
(Unaudited)
   March 31, 2021 (Unaudited) 
         
Basic EPS          
Net Loss  $(666,798)  $(634,714)
Weighted Average Shares   9,672,508    7,209,589 
Basic Loss Per Share  $(0.07)  $(0.09)

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Accounts Payable $ 138,228 $ 62,889
Accrued Expenses 2,757,814 2,834,726
Deferred Revenue and Customer Deposits 95,687 58,211
Accounts and Other Payables $ 2,991,729 $ 2,955,826
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Net Revenue $ 230,857 $ 1,917,848
UNITED STATES    
Net Revenue 7,882  
Net Assets (Liabilities) (2,606,975)  
Republic of China (Taiwan) [Member]    
Net Revenue 324,698  
Net Assets (Liabilities) $ 763,867  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Product Information [Line Items]      
Accumulated deficit $ 42,028,199 $ 41,361,401 $ 42,000,000
CDIC insurance limit 3,000,000    
Revenues 230,857 1,917,848  
Inventory reserve 0 0  
Depreciation expense 4,657 15,016  
Stock-based compensation expense 67,500 801,908  
Chunghwa Telecom [Member]      
Product Information [Line Items]      
Revenues 58,086 786,686  
Taiwan stock [Member]      
Product Information [Line Items]      
Revenues $ 29,013 260,946  
Customer One [Member]      
Product Information [Line Items]      
Account receivable   $ 492,752  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]      
Product Information [Line Items]      
Percentage of concentration risk   95.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]      
Product Information [Line Items]      
Percentage of concentration risk 39.00% 55.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Chunghwa Telecom [Member]      
Product Information [Line Items]      
Percentage of concentration risk 25.00% 41.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Taiwan stock [Member]      
Product Information [Line Items]      
Percentage of concentration risk 13.00% 14.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Other Customers [Member] | Minimum [Member]      
Product Information [Line Items]      
Percentage of concentration risk 10.00% 10.00%  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical) - USD ($)
1 Months Ended 12 Months Ended
Jun. 20, 2013
Aug. 28, 2014
Nov. 19, 2012
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]          
Share based compesatio, award option       141,875 312,500
Debenture Agreement [Member] | Mr Gregory Omi [Member]          
Related Party Transaction [Line Items]          
Debt instrument, face amount   $ 200,000      
Debt instrument, interest rate   9.50%      
Share based compesatio, award option   2,500      
Share price   $ 6.16      
Debenture Agreement [Member] | Mr Gregory Omi [Member] | Extended Maturity [Member]          
Related Party Transaction [Line Items]          
Debt instrument, maturity date   Dec. 31, 2016      
Debenture Agreement [Member] | Mr Robert Gillen [Member]          
Related Party Transaction [Line Items]          
Debt instrument, face amount     $ 100,000    
Debt instrument, interest rate     10.00%    
Debt instrument, maturity date Dec. 31, 2022   Dec. 19, 2014    
Share based compesatio, award option 1,250        
Share price $ 6.16        
Interest expense $ 5,000        
Debenture Agreement [Member] | Mr Robert Gillen [Member] | Extended Maturity [Member]          
Related Party Transaction [Line Items]          
Debt instrument, maturity date Dec. 31, 2015        
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]    
Total Due to Related Parties $ 300,000 $ 300,000
Less Current Portion (300,000) (300,000)
Total Long-Term
Mr Gregory Omi [Member]    
Related Party Transaction [Line Items]    
Total Due to Related Parties 200,000 200,000
Mr Robert Gillen [Member]    
Related Party Transaction [Line Items]    
Total Due to Related Parties $ 100,000 $ 100,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) - USD ($)
1 Months Ended 3 Months Ended
Feb. 28, 2019
Mar. 31, 2022
Shanghai bank [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Interest rate   2.68%
Debt instrument, maturity date   due January 2023
Hua Nan Bank [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Interest rate   2.42%
Debt instrument, maturity date   due September 2022
Debenture Agreement [Member] | Various Shareholders [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Interest rate 10.00%  
Debt instrument, maturity date   one year maturity, were due February 2020 – December 2020
Debt Instrument, Convertible, Conversion Price $ 2.80  
Debt principal amount $ 50,000  
Accrued interest $ 12,079  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF SHORT-TERM DEBT (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Short Term Debt $ 224,648 $ 50,000
Various Shareholders [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short Term Debt 50,000 50,000
Shanghai bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short Term Debt 69,850
Hua Nan Bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short Term Debt $ 104,789
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) - Shanghai bank [Member]
3 Months Ended
Mar. 31, 2022
Debt Instrument [Line Items]  
Debt Instrument, Maturity Date, Description due January 2023
Minimum [Member]  
Debt Instrument [Line Items]  
Debt interest rate 1.00%
Debt Instrument, Maturity Date, Description February 2024
Maximum [Member]  
Debt Instrument [Line Items]  
Debt interest rate 1.50%
Debt Instrument, Maturity Date, Description November 2026
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF LONG-TERM DEBT (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Long Term Debt $ 298,843 $ 338,803
Current Portion of Long-term debt (116,432) (120,284)
Shanghai bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Long Term Debt $ 415,275 $ 469,087
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
PREFERRED STOCK (Details Narrative) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]    
Preferred stock, shares authorized 12,500,000 12,500,000
Preferred stock, par value $ 0.00001 $ 0.00001
Series A Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 1,250,000  
Series B Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 500 500
Preferred stock, par value $ 0.00001 $ 0.00001
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY (Details Narrative) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Common stock, shares authorized 37,500,000 37,500,000
Common stock, par value $ 0.00001 $ 0.00001
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]    
Shares, Outstanding at Beginning of Year 952,025 842,650
Weighted-Average Exercise Price, Outstanding at Beginning of Year $ 5.76 $ 6.24
Shares, Granted 141,875 312,500
Weighted-Average Exercise Price, Granted $ 11.76 $ 2.96
Shares, Exercised (62,500) (158,750)
Weighted-Average Exercise Price, Exercised $ 4.72 $ 1.28
Shares, Forfeited or Canceled (137,963) (44,375)
Weighted-Average Exercise Price, Forfeited or Canceled $ 7.44 $ 8.96
Shares, Outstanding at End of Year 893,438 952,025
Weighted-Average Exercise Price, Outstanding at End of Year $ 6.80 $ 5.76
Shares, Options Exercisable at End of Year 891,563 952,025
Weighted-Average Exercise Price, Options Exercisable at End of Year $ 6.80 $ 5.76
Weighted-Average Fair Value of Options Granted During the Period $ 5.68 $ 2.00
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)
12 Months Ended
Dec. 31, 2021
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit $ 0.32
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 16.24
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares 893,438
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term 6 years 2 months 12 days
Options Outstanding, Weighted-Average Exercise Price $ 6.80
Options Exercisable, Number Exercisable | shares 891,563
Options Exercisable, Weighted-Average Exercise Price $ 6.80
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]    
Expected Life 5 years 5 years
Dividend Yield 0.00% 0.00%
Expected Volatility 90.00% 90.00%
Risk-Free Interest Rate 1.00% 0.18%
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WARRANT TRANSACTIONS (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares, Outstanding at Beginning of Year 543,754 695,439
Weighted-Average Exercise Price, Outstanding at Beginning of Year $ 3.04 $ 3.04
Shares, Granted 509,732 123,732
Weighted-Average Exercise Price, Granted $ 2.96 $ 2.80
Shares, Exercised (78,102)  
Weighted-Average Exercise Price, Exercised $ 2.80  
Shares, Forfeited or Canceled (103,125) (275,416)
Weighted-Average Exercise Price, Forfeited or Canceled $ 2.80 $ 2.88
Shares, Outstanding at End of Year 872,259 543,754
Weighted-Average Exercise Price, Outstanding at End of Year $ 3.04 $ 3.04
Shares, Options Exercisable at End of Year 872,259 543,754
Weighted-Average Exercise Price, Options Exercisable at End of Year $ 3.04 $ 3.04
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-Average Fair Value of Options Granted During the Period 1.12 0.80
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-Average Fair Value of Options Granted During the Period $ 3.92 $ 2.08
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Warrants Outstanding, Number Outstanding   872,259 543,754 695,439
Warrants Outstanding, Weighted-Average Exercise Price   $ 3.04 $ 3.04 $ 3.04
Warrants Exercisable, Number Exercisable   872,259 543,754  
Warrants Exercisable, Weighted-Average Exercise Price   $ 3.04 $ 3.04  
Warrant [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Warrants Outstanding, Number Outstanding   872,259    
Warrants Outstanding, Weighted-Average Remaining Contractual Life   1 year 6 months    
Warrants Outstanding, Weighted-Average Exercise Price   $ 3.04    
Warrants Exercisable, Number Exercisable   872,259    
Warrants Exercisable, Weighted-Average Exercise Price   $ 3.04    
Minimum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Range of Exercise Prices $ 2.80      
Maximum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Range of Exercise Prices $ 13.20      
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected Life 5 years 5 years
Dividend Yield 0.00% 0.00%
Expected Volatility 90.00% 90.00%
Risk-Free Interest Rate 1.00% 0.18%
Warrant [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected Life 1 year 6 months 1 year 6 months
Dividend Yield 0.00% 0.00%
Expected Volatility 90.00% 90.00%
Warrant [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Risk-Free Interest Rate 0.18% 0.19%
Warrant [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Risk-Free Interest Rate 1.00% 1.59%
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK OPTION PLAN AND WARRANTS (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2012
Dec. 31, 2011
Jan. 18, 2010
Oct. 15, 2009
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Options outstanding 893,438 952,025 842,650        
Unrecognized stock- based compensation $ 4,500            
2009 Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized under plan             187,500
2010 Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized under plan       1,625,000 375,000 125,000  
2020 Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Options outstanding 893,438            
2020 Stock Option Plan [Member] | Maximum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized under plan   10,000,000          
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Tax Operating Loss Carryforward - USA $ 10,800,000 $ 9,800,000
Other
Valuation Allowance - USA (10,800,000) (9,800,000)
 Deferred Tax Assets, Net
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Income Tax Disclosure [Abstract]                                  
Net Operating Loss $ 1,000,000 $ 590,000 $ 260,000 $ 160,000 $ 140,000 $ 1,640,000 $ 3,400,000 $ 5,230,000 $ 5,600,000 $ 2,850,000 $ 2,427,000 $ 1,799,000 $ 1,750,000 $ 1,308,000 $ 429,000 $ 476,000 $ 414,000
Year of Expiration 2041 2040 2039 2038 2037 2036 2035 2034 2033 2032 2031 2030 2029 2028 2027 2026 2025
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Operating Loss Carryforwards [Line Items]                                    
Operating loss carryforwards   $ 1,000,000 $ 590,000 $ 260,000 $ 160,000 $ 140,000 $ 1,640,000 $ 3,400,000 $ 5,230,000 $ 5,600,000 $ 2,850,000 $ 2,427,000 $ 1,799,000 $ 1,750,000 $ 1,308,000 $ 429,000 $ 476,000 $ 414,000
Taiwan corporate tax rate Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year                                  
ARIZONA                                    
Operating Loss Carryforwards [Line Items]                                    
Operating loss carryforwards $ 2,000,000.0                                  
Domestic Tax Authority [Member]                                    
Operating Loss Carryforwards [Line Items]                                    
Operating loss carryforwards   $ 29,000,000                                
Operating loss carryforward, limitations on use   which will begin to expire in 2025                                
US Based Segment [Member]                                    
Operating Loss Carryforwards [Line Items]                                    
Valuation allowance increased   $ 500,000                                
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Basic EPS      
Net Loss $ (666,798) $ (634,714) $ (2,998,644)
Weighted Average Shares 9,672,508 7,209,589  
Basic Loss Per Share $ (0.07) $ (0.09)  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.1
CONTINGENT LIABILITIES—TAIWAN (Details Narrative)
12 Months Ended
Dec. 31, 2021
USD ($)
Megasys [Member]  
Concentration risk, credit risk, financial instrument $ 61,435
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS (Details Narrative)
Apr. 05, 2022
USD ($)
Underwriting agreement [Member] | Subsequent Event [Member]  
Subsequent Event [Line Items]  
Stock and warrant offering $ 8,011,250
XML 58 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001397183 2022-01-01 2022-03-31 0001397183 IVDA:CommonStock000001ParValuePerShareMember 2022-01-01 2022-03-31 0001397183 IVDA:CommonStockPurchaseWarrantsMember 2022-01-01 2022-03-31 0001397183 2022-05-06 0001397183 2022-03-31 0001397183 2021-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2022-03-31 0001397183 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001397183 2021-01-01 2021-03-31 0001397183 IVDA:EquipmentSalesMember 2022-01-01 2022-03-31 0001397183 IVDA:EquipmentSalesMember 2021-01-01 2021-03-31 0001397183 IVDA:ServiceRevenueMember 2022-01-01 2022-03-31 0001397183 IVDA:ServiceRevenueMember 2021-01-01 2021-03-31 0001397183 IVDA:OtherRevenueMember 2022-01-01 2022-03-31 0001397183 IVDA:OtherRevenueMember 2021-01-01 2021-03-31 0001397183 us-gaap:CommonStockMember 2020-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001397183 us-gaap:RetainedEarningsMember 2020-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001397183 2020-12-31 0001397183 us-gaap:CommonStockMember 2021-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001397183 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001397183 2021-01-01 2021-12-31 0001397183 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001397183 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001397183 us-gaap:CommonStockMember 2022-03-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001397183 us-gaap:RetainedEarningsMember 2022-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001397183 2021-03-31 0001397183 IVDA:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001397183 IVDA:CustomerOneMember 2021-12-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001397183 IVDA:ChunghwaTelecomMember 2022-01-01 2022-03-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2022-01-01 2022-03-31 0001397183 IVDA:TaiwanStockMember 2022-01-01 2022-03-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanStockMember 2022-01-01 2022-03-31 0001397183 IVDA:ChunghwaTelecomMember 2021-01-01 2021-12-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2021-01-01 2021-12-31 0001397183 IVDA:TaiwanStockMember 2021-01-01 2021-12-31 0001397183 IVDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanStockMember 2021-01-01 2021-12-31 0001397183 IVDA:OtherCustomersMember srt:MinimumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001397183 IVDA:OtherCustomersMember srt:MinimumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001397183 country:US 2022-01-01 2022-03-31 0001397183 country:US 2022-03-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2022-01-01 2022-03-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2022-03-31 0001397183 IVDA:MrGregoryOmiMember IVDA:DebentureAgreementMember 2014-08-28 0001397183 us-gaap:ExtendedMaturityMember IVDA:MrGregoryOmiMember IVDA:DebentureAgreementMember 2014-08-01 2014-08-28 0001397183 IVDA:MrGregoryOmiMember IVDA:DebentureAgreementMember 2014-08-01 2014-08-28 0001397183 IVDA:MrRobertGillenMember IVDA:DebentureAgreementMember 2012-11-19 0001397183 IVDA:MrRobertGillenMember IVDA:DebentureAgreementMember 2012-11-01 2012-11-19 0001397183 IVDA:MrRobertGillenMember IVDA:DebentureAgreementMember 2013-06-19 2013-06-20 0001397183 us-gaap:ExtendedMaturityMember IVDA:MrRobertGillenMember IVDA:DebentureAgreementMember 2013-06-19 2013-06-20 0001397183 IVDA:MrRobertGillenMember IVDA:DebentureAgreementMember 2013-06-20 0001397183 IVDA:MrGregoryOmiMember 2022-03-31 0001397183 IVDA:MrGregoryOmiMember 2021-12-31 0001397183 IVDA:MrRobertGillenMember 2022-03-31 0001397183 IVDA:MrRobertGillenMember 2021-12-31 0001397183 IVDA:VariousShareholdersMember IVDA:DebentureAgreementMember 2019-02-01 2019-02-28 0001397183 IVDA:VariousShareholdersMember IVDA:DebentureAgreementMember 2022-01-01 2022-03-31 0001397183 IVDA:VariousShareholdersMember IVDA:DebentureAgreementMember 2019-02-28 0001397183 IVDA:ShanghaiBankMember 2022-01-01 2022-03-31 0001397183 IVDA:HuaNanBankMember 2022-01-01 2022-03-31 0001397183 IVDA:VariousShareholdersMember 2022-03-31 0001397183 IVDA:VariousShareholdersMember 2021-12-31 0001397183 IVDA:ShanghaiBankMember 2022-03-31 0001397183 IVDA:ShanghaiBankMember 2021-12-31 0001397183 IVDA:HuaNanBankMember 2022-03-31 0001397183 IVDA:HuaNanBankMember 2021-12-31 0001397183 srt:MinimumMember IVDA:ShanghaiBankMember 2022-03-31 0001397183 srt:MaximumMember IVDA:ShanghaiBankMember 2022-03-31 0001397183 srt:MinimumMember IVDA:ShanghaiBankMember 2022-01-01 2022-03-31 0001397183 srt:MaximumMember IVDA:ShanghaiBankMember 2022-01-01 2022-03-31 0001397183 us-gaap:SeriesAPreferredStockMember 2022-03-31 0001397183 IVDA:TwoThousandNineStockOptionPlanMember 2009-10-15 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2011-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2012-12-31 0001397183 srt:MaximumMember IVDA:TwoThousandTwentyStockOptionPlanMember 2020-12-31 0001397183 IVDA:TwoThousandTwentyStockOptionPlanMember 2021-12-31 0001397183 2019-12-31 0001397183 2020-01-01 2020-12-31 0001397183 srt:MinimumMember 2021-01-01 2021-12-31 0001397183 srt:MaximumMember 2021-01-01 2021-12-31 0001397183 srt:MinimumMember 2020-01-01 2020-12-31 0001397183 srt:MaximumMember 2020-01-01 2020-12-31 0001397183 srt:MinimumMember 2022-03-31 0001397183 srt:MaximumMember 2022-03-31 0001397183 us-gaap:WarrantMember 2021-12-31 0001397183 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001397183 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001397183 srt:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001397183 srt:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001397183 srt:MinimumMember us-gaap:WarrantMember 2020-01-01 2020-12-31 0001397183 srt:MaximumMember us-gaap:WarrantMember 2020-01-01 2020-12-31 0001397183 IVDA:UsBasedSegmentMember 2021-12-31 0001397183 us-gaap:DomesticCountryMember 2021-12-31 0001397183 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001397183 stpr:AZ 2022-03-31 0001397183 2019-01-01 2019-12-31 0001397183 2018-12-31 0001397183 2018-01-01 2018-12-31 0001397183 2017-12-31 0001397183 2017-01-01 2017-12-31 0001397183 2016-12-31 0001397183 2016-01-01 2016-12-31 0001397183 2015-12-31 0001397183 2015-01-01 2015-12-31 0001397183 2014-12-31 0001397183 2014-01-01 2014-12-31 0001397183 2013-12-31 0001397183 2013-01-01 2013-12-31 0001397183 2012-12-31 0001397183 2012-01-01 2012-12-31 0001397183 2011-12-31 0001397183 2011-01-01 2011-12-31 0001397183 2010-12-31 0001397183 2010-01-01 2010-12-31 0001397183 2009-12-31 0001397183 2009-01-01 2009-12-31 0001397183 2008-12-31 0001397183 2008-01-01 2008-12-31 0001397183 2007-12-31 0001397183 2007-01-01 2007-12-31 0001397183 2006-12-31 0001397183 2006-01-01 2006-12-31 0001397183 2005-12-31 0001397183 2005-01-01 2005-12-31 0001397183 IVDA:MegasysMember 2021-01-01 2021-12-31 0001397183 us-gaap:SubsequentEventMember IVDA:UnderwritingAgreementMember 2022-04-05 iso4217:USD shares iso4217:USD shares pure 0001397183 false Q1 2022 --12-31 10-Q true 2022-03-31 false 000-53285 IVEDA SOLUTIONS, INC. NV 20-2222203 1744 S Val Vista Suite 213 Mesa AZ 85204 (480) 307-8700 Yes Yes Non-accelerated Filer true false false Common Stock, $0.00001 par value per share IVDA NASDAQ Common Stock Purchase Warrants IVDAW NASDAQ 11561647 746931 1385275 138118 142688 146696 492752 576190 344654 186355 310657 1794290 2676026 37705 38189 256547 273419 256547 273419 2088543 2987634 2991729 2955826 300000 300000 224648 50000 116432 120284 3632809 3426110 298843 338803 0.00001 0.00001 12500000 12500000 0.00001 0.00001 500 500 0 0 0 0 0.00001 0.00001 37500000 37500000 11561647 11561647 9668369 9668369 116 97 47724107 40727518 7370350 -168783 -143493 -42028199 -41361401 -1843109 -777279 2088543 2987634 189521 304105 41336 28298 177 230857 332580 90310 217551 140547 115029 792164 567649 792164 567649 -651616 -452620 172 616 38 12833 182132 -12045 -182094 -663662 -634714 3136 -666798 -634714 -0.07 -0.09 9672508 7209589 6583924 66 257 34769076 -38322456 -153254 -3706568 757655 8 2661992 2662000 -2091101 -2091101 801908 801908 27896 1 99789 99789 628750 6 1932730 1932736 148480 148480 69729 69729 69729 69729 2 23750 23750 1090015 11 -259 432165 432176 -40301 -40301 439527 4 1294576 1294580 140602 1 514696 514697 -2998644 -2998644 9761 9761 9668369 97 0 40727518 -41361401 -143493 -777279 -1105142 -1105142 67500 67500 64 8214 23000 23000 1885000 19 8011231 8011250 -7370350 -666798 -666798 -25290 -25290 11561647 116 0 40353757 -42028199 -168783 -1843109 -666798 -634714 4657 5000 67500 11475 139458 -330272 13840 242576 24454 -31085 162628 -8302 -4722 -302666 186897 -770224 -488084 4696 -4696 -73661 174648 203194 -37177 -29108 815001 145540 1054679 -8964 1528 -638344 568123 1385275 249521 746931 817644 1013 330 1895000 -23750 -139458 -11475 <p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zsMgk7N0OFL2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 <span id="xdx_823_zFhrznSs2YK9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--NatureOfOperationsPolicyTextBlock_zGFENIvM01dd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zolhgrHN3sNg">Nature of Operations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI Functions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Object Search</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Search (No Database Required)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Recognition (from a Database)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Plate Recognition (100+ Countries), includes make and model</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrusion Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weapon Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fire Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">People Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temperature Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Health Analytics (Facemask Detection, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QR and Barcode Detection</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Camera View</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Tracking</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abnormality Detection – Vehicle/Person wrong direction detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle/Person Loitering Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>●</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fall Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illegal Parking Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heatmap Generation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after-the-fact.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central device management. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: rgb(51,51,51)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan-based subsidiary Iveda Taiwan, formerly known as</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> MEGAsys, our wholly-owned subsidiary, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and safe city. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zfmFtAj2NMG2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zZrbX15F1Ucd">Consolidation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 30, 2011, we completed our acquisition of Taiwan-based Sole Vision Technologies (dba Iveda Taiwan). We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_ecustom--GoingConcernPolicyTextBlock_zpCAXgFW6tWa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zNKhJIi1i5Ud">Going Concern</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We generated accumulated losses of approximately $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20210331_z24q77qCGRTa" title="Accumulated deficit">42</span> million from January 2005 through March 31, 2021 and have insufficient working capital and cash flows to support operations. These factors raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zpU2F555PSKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_z8WtDEnOHKxj">Impairment of Long-Lived Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the three months ended March 31, 2022 and year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zK82lYsSZEzh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zXho8SJgE6n3">Basis of Accounting</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zDNAlv2Gdpq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zocfRBEHYTx7">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UtilityRevenueAndExpenseRecognitionPolicy_zNgORrVWN7qb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zPl9LsqzgNs9">Revenue and Expense Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, <i>Revenue from Contracts with Customers</i>, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (<i>i.e.</i>, when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sells its products and services primarily to municipalities and commercial customers in the following manner:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable, and the amount can be reliably estimated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, annual license revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zkQKYhaPEm12" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zf20zy2pODC1">Comprehensive Loss</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zLjsq3nmCeBa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zheWX2rgLaZ5">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD <span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_pn6n6_c20220331_z2sz3EFkjkqb" title="CDIC insurance limit">3</span> million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. One customer (Chunghwa Telecom) represented approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zakW7Q8fyPh7" title="Percentage of concentration risk">95</span>% of total accounts receivable of $<span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--MajorCustomersAxis__custom--CustomerOneMember_z5QCA6TDoweh" title="Account receivable">492,752</span> as of December 31, 2021. This customer is a longtime customer, and we don’t expect any problem with collectability of these accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had revenue from two customers with greater than <span title="Percentage of concentration risk"><span title="Percentage of concentration risk">10</span></span>% of total revenues during the three months ended March 31, 2022 and the year ended December 31, 2021 that represented approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zXuj4lwrknj9" title="Concentration Risk, Percentage">39</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zkH7CWOfvSvj" title="Concentration Risk, Percentage">55</span>% of total revenues, respectively. We had $<span id="xdx_90D_eus-gaap--Revenues_pp0p0_c20220101__20220331__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zAyDakjSTaP" title="Revenues"><span>58,086</span></span> revenues (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zpVEyhPgG1i5" title="Concentration Risk, Percentage">25</span>%) from Chunghwa Telecom and $<span id="xdx_908_eus-gaap--Revenues_pp0p0_c20220101__20220331__dei--LegalEntityAxis__custom--TaiwanStockMember_zTlMC6xmH1Hj" title="Revenues">29,013</span> revenues (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--TaiwanStockMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zMiGxE9SlJbf" title="Concentration Risk, Percentage">13</span>%) from Taiwan Stock Exchange Corporation of total revenues of $<span id="xdx_905_eus-gaap--Revenues_pp0p0_c20220101__20220331_z9bGYBjjdCQd" title="Revenues">230,857 </span>for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had $<span id="xdx_90B_eus-gaap--Revenues_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zbm9agI0NcD9" title="Revenues">786,686</span> revenues (<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zQoFqsMnKLw9" title="Concentration Risk, Percentage">41</span>%) from Chunghwa Telecom and $<span id="xdx_908_eus-gaap--Revenues_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--TaiwanStockMember_zBKbV31hUsxa" title="Revenues">260,946</span> revenues (<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--TaiwanStockMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z4xscAeRK46a" title="Concentration Risk, Percentage">14</span>%) from Taiwan Stock Exchange Corporation of total revenues of $<span id="xdx_90B_eus-gaap--Revenues_pp0p0_c20210101__20211231_zwCW01G9rSZe" title="Revenues">1,917,848</span> for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No other customers represented greater than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zaHWRXUNi2D1" title="Percentage of concentration risk"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zyphNAfJ2cIj" title="Percentage of concentration risk">10</span></span>% of total revenues in the three months ended March 31, 2022 and year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziU4xC54vWNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zmMoxc58aPO4">Cash and Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zyIOu7qRTi9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zDieKUwa9VYj">Accounts Receivable</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of March 31, 2022 and December 31, 2021 no allowance for uncollectible accounts was deemed necessary for our U.S.-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--CurrentDepositsPolicyTextBlock_zktZMKSKWy8l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zKkRKCzPR0X3">Deposits – Current</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--OtherCurrentAssetsPolicyTextBlock_zICE65slHLL4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zTtaJbg08hPa">Other Current Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets represent cash paid in advance to insurance companies and vendors for service coverage extending into subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_zAmNFwVWJng1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zoos3CVA2qnj">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $<span id="xdx_903_eus-gaap--InventoryValuationReserves_iI_c20220331_zXpzvGSib1kj" title="Inventory reserve"><span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_c20211231_zS9gULiGvw19" title="Inventory reserve">0</span></span> as of March 31, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFXHhgyIfbc3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zII3hy1QFXf8">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended March 31, 2022 was $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20220101__20220331_zkmRqWyEDjue" title="Depreciation expense">4,657</span> and for the year ended December 31, 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zYbpesUby1d" title="Depreciation expense">15,016</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zUSKGWV4Aghl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zV0Pr4gQ92Bc">Intangible Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of trademarks and other intangible assets associated with the purchase price allocation of Iveda Taiwan. Such assets are fully amortized at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--LongTermDepositsPolicyTextBlock_zickpN07gvnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zT3I73L6GLP3">Deposits—Long-Term</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zP2fAeX7hixg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_z6CCe379ngke">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2021, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to U.S. federal income tax as well as state income tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2017 to 2021 are open to examination by federal, local, and state authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2017 to 2021 are open to examination by the Taiwan Ministry of Finance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zU5e57BiKwhi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zGL2I3f5ecqd">Restricted Cash</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--AccountsAndOtherPayablesPolicyTextBlock_z3CenSLtOelg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zm2ybfJDd8v">Accounts and Other Payables</span></span></b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqiwV88nYPmc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBp7wC8RI9Z2" style="display: none"> SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220331_zDxt4At2pleg" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zQ3sXNPt3YJf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableCurrent_iI_maAPAOAzGgx_zqIZ8KVkeZni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Accounts Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">138,228</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">62,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAOAzGgx_zFGIWDD9rOPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,757,814</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,834,726</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredRevenueCurrent_iI_maAPAOAzGgx_zFKx46YIvrd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,687</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtAPAOAzGgx_zMfK1ZeZhbB3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,991,729</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,955,826</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zktzN4BXIp9l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKYOVminqM8j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zvemKfooawBh">Deferred Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments received from customers on future installation projects are recorded as deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z7NiQ8Ge7Y0l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_z7af61g2YbGg">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of March 31, 2021 and December 31, 2021, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $<span id="xdx_904_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20220331_zZi6Y0zwhRn8" title="Stock-based compensation expense">67,500</span> and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231_zT1xiUnGuQ3d" title="Stock-based compensation expense">801,908</span> of stock-based compensation expense for the three months ended March 31, 2022 and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zggbnRbVHCA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zCYWxM3SLGcc">Fair Value of Financial Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2022 and December 31, 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_ztaOaKkLtuQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zjIHZsTsP19g">Segment Information</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z2aEbWPB8zTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbnglDQODzg4" style="display: none"> SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Revenue</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Assets (Liabilities)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20220101__20220331__srt--StatementGeographicalAxis__country--US_z9YMAyE8vVpj" style="width: 16%; text-align: right" title="Net Revenue">7,882</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsNet_iI_pp0p0_c20220331__srt--StatementGeographicalAxis__country--US_zO42a1qwNhd" style="width: 16%; text-align: right" title="Net Assets (Liabilities)">(2,606,975</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Republic of China (Taiwan)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20220101__20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zap084NShaY2" style="text-align: right" title="Net Revenue">324,698</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zhgvzipvW9O1" style="text-align: right" title="Net Assets (Liabilities)">763,867</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zQN2rLt6g7dd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zG4b0KdNTCAk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zidjkNixKqpe">Reclassification</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in 2021 have been reclassified to conform to the 2022 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zEmDgTIXdjJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_zrnAmSfjnVs2">New Accounting Standards</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No new relevant accounting standards</span></p> <p id="xdx_85C_ziXM8RWDibMg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_846_ecustom--NatureOfOperationsPolicyTextBlock_zGFENIvM01dd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zolhgrHN3sNg">Nature of Operations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI Functions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Object Search</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Search (No Database Required)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Recognition (from a Database)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Plate Recognition (100+ Countries), includes make and model</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrusion Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weapon Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fire Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">People Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temperature Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Health Analytics (Facemask Detection, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QR and Barcode Detection</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Camera View</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Tracking</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abnormality Detection – Vehicle/Person wrong direction detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle/Person Loitering Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>●</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fall Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illegal Parking Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heatmap Generation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live-streaming video data from any IP camera.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Users can set up alerts instead of watching hours of video recording after-the-fact.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda offers many IoT sensors and devices for a variety of applications such as energy management, smart home, smart building, smart community, and patient/elder care. Together, our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central device management. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: rgb(51,51,51)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the last few years, smart city has been a hot topic among municipalities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan-based subsidiary Iveda Taiwan, formerly known as</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> MEGAsys, our wholly-owned subsidiary, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and safe city. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zfmFtAj2NMG2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zZrbX15F1Ucd">Consolidation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 30, 2011, we completed our acquisition of Taiwan-based Sole Vision Technologies (dba Iveda Taiwan). We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_ecustom--GoingConcernPolicyTextBlock_zpCAXgFW6tWa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zNKhJIi1i5Ud">Going Concern</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We generated accumulated losses of approximately $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20210331_z24q77qCGRTa" title="Accumulated deficit">42</span> million from January 2005 through March 31, 2021 and have insufficient working capital and cash flows to support operations. These factors raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -42000000 <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zpU2F555PSKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_z8WtDEnOHKxj">Impairment of Long-Lived Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the three months ended March 31, 2022 and year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zK82lYsSZEzh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zXho8SJgE6n3">Basis of Accounting</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zDNAlv2Gdpq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zocfRBEHYTx7">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UtilityRevenueAndExpenseRecognitionPolicy_zNgORrVWN7qb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zPl9LsqzgNs9">Revenue and Expense Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, <i>Revenue from Contracts with Customers</i>, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (<i>i.e.</i>, when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sells its products and services primarily to municipalities and commercial customers in the following manner:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable, and the amount can be reliably estimated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, annual license revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zkQKYhaPEm12" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zf20zy2pODC1">Comprehensive Loss</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zLjsq3nmCeBa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zheWX2rgLaZ5">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD <span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_pn6n6_c20220331_z2sz3EFkjkqb" title="CDIC insurance limit">3</span> million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. One customer (Chunghwa Telecom) represented approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zakW7Q8fyPh7" title="Percentage of concentration risk">95</span>% of total accounts receivable of $<span id="xdx_907_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--MajorCustomersAxis__custom--CustomerOneMember_z5QCA6TDoweh" title="Account receivable">492,752</span> as of December 31, 2021. This customer is a longtime customer, and we don’t expect any problem with collectability of these accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had revenue from two customers with greater than <span title="Percentage of concentration risk"><span title="Percentage of concentration risk">10</span></span>% of total revenues during the three months ended March 31, 2022 and the year ended December 31, 2021 that represented approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zXuj4lwrknj9" title="Concentration Risk, Percentage">39</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zkH7CWOfvSvj" title="Concentration Risk, Percentage">55</span>% of total revenues, respectively. We had $<span id="xdx_90D_eus-gaap--Revenues_pp0p0_c20220101__20220331__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zAyDakjSTaP" title="Revenues"><span>58,086</span></span> revenues (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zpVEyhPgG1i5" title="Concentration Risk, Percentage">25</span>%) from Chunghwa Telecom and $<span id="xdx_908_eus-gaap--Revenues_pp0p0_c20220101__20220331__dei--LegalEntityAxis__custom--TaiwanStockMember_zTlMC6xmH1Hj" title="Revenues">29,013</span> revenues (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--TaiwanStockMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zMiGxE9SlJbf" title="Concentration Risk, Percentage">13</span>%) from Taiwan Stock Exchange Corporation of total revenues of $<span id="xdx_905_eus-gaap--Revenues_pp0p0_c20220101__20220331_z9bGYBjjdCQd" title="Revenues">230,857 </span>for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had $<span id="xdx_90B_eus-gaap--Revenues_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zbm9agI0NcD9" title="Revenues">786,686</span> revenues (<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zQoFqsMnKLw9" title="Concentration Risk, Percentage">41</span>%) from Chunghwa Telecom and $<span id="xdx_908_eus-gaap--Revenues_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--TaiwanStockMember_zBKbV31hUsxa" title="Revenues">260,946</span> revenues (<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--TaiwanStockMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z4xscAeRK46a" title="Concentration Risk, Percentage">14</span>%) from Taiwan Stock Exchange Corporation of total revenues of $<span id="xdx_90B_eus-gaap--Revenues_pp0p0_c20210101__20211231_zwCW01G9rSZe" title="Revenues">1,917,848</span> for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No other customers represented greater than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zaHWRXUNi2D1" title="Percentage of concentration risk"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zyphNAfJ2cIj" title="Percentage of concentration risk">10</span></span>% of total revenues in the three months ended March 31, 2022 and year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3000000 0.95 492752 0.39 0.55 58086 0.25 29013 0.13 230857 786686 0.41 260946 0.14 1917848 0.10 0.10 <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziU4xC54vWNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zmMoxc58aPO4">Cash and Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zyIOu7qRTi9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zDieKUwa9VYj">Accounts Receivable</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of March 31, 2022 and December 31, 2021 no allowance for uncollectible accounts was deemed necessary for our U.S.-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--CurrentDepositsPolicyTextBlock_zktZMKSKWy8l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zKkRKCzPR0X3">Deposits – Current</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--OtherCurrentAssetsPolicyTextBlock_zICE65slHLL4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zTtaJbg08hPa">Other Current Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets represent cash paid in advance to insurance companies and vendors for service coverage extending into subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--InventoryPolicyTextBlock_zAmNFwVWJng1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zoos3CVA2qnj">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $<span id="xdx_903_eus-gaap--InventoryValuationReserves_iI_c20220331_zXpzvGSib1kj" title="Inventory reserve"><span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_c20211231_zS9gULiGvw19" title="Inventory reserve">0</span></span> as of March 31, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFXHhgyIfbc3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zII3hy1QFXf8">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended March 31, 2022 was $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20220101__20220331_zkmRqWyEDjue" title="Depreciation expense">4,657</span> and for the year ended December 31, 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zYbpesUby1d" title="Depreciation expense">15,016</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 4657 15016 <p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zUSKGWV4Aghl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zV0Pr4gQ92Bc">Intangible Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of trademarks and other intangible assets associated with the purchase price allocation of Iveda Taiwan. Such assets are fully amortized at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--LongTermDepositsPolicyTextBlock_zickpN07gvnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zT3I73L6GLP3">Deposits—Long-Term</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zP2fAeX7hixg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_z6CCe379ngke">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2021, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to U.S. federal income tax as well as state income tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2017 to 2021 are open to examination by federal, local, and state authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2017 to 2021 are open to examination by the Taiwan Ministry of Finance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zU5e57BiKwhi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zGL2I3f5ecqd">Restricted Cash</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--AccountsAndOtherPayablesPolicyTextBlock_z3CenSLtOelg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zm2ybfJDd8v">Accounts and Other Payables</span></span></b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqiwV88nYPmc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBp7wC8RI9Z2" style="display: none"> SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220331_zDxt4At2pleg" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zQ3sXNPt3YJf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableCurrent_iI_maAPAOAzGgx_zqIZ8KVkeZni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Accounts Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">138,228</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">62,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAOAzGgx_zFGIWDD9rOPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,757,814</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,834,726</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredRevenueCurrent_iI_maAPAOAzGgx_zFKx46YIvrd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,687</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtAPAOAzGgx_zMfK1ZeZhbB3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,991,729</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,955,826</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zktzN4BXIp9l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqiwV88nYPmc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBp7wC8RI9Z2" style="display: none"> SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220331_zDxt4At2pleg" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zQ3sXNPt3YJf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableCurrent_iI_maAPAOAzGgx_zqIZ8KVkeZni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Accounts Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">138,228</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">62,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAOAzGgx_zFGIWDD9rOPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,757,814</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,834,726</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredRevenueCurrent_iI_maAPAOAzGgx_zFKx46YIvrd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,687</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtAPAOAzGgx_zMfK1ZeZhbB3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,991,729</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,955,826</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 138228 62889 2757814 2834726 95687 58211 2991729 2955826 <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKYOVminqM8j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zvemKfooawBh">Deferred Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments received from customers on future installation projects are recorded as deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z7NiQ8Ge7Y0l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_z7af61g2YbGg">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of March 31, 2021 and December 31, 2021, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $<span id="xdx_904_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20220331_zZi6Y0zwhRn8" title="Stock-based compensation expense">67,500</span> and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231_zT1xiUnGuQ3d" title="Stock-based compensation expense">801,908</span> of stock-based compensation expense for the three months ended March 31, 2022 and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 67500 801908 <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zggbnRbVHCA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zCYWxM3SLGcc">Fair Value of Financial Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2022 and December 31, 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_ztaOaKkLtuQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zjIHZsTsP19g">Segment Information</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z2aEbWPB8zTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbnglDQODzg4" style="display: none"> SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Revenue</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Assets (Liabilities)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20220101__20220331__srt--StatementGeographicalAxis__country--US_z9YMAyE8vVpj" style="width: 16%; text-align: right" title="Net Revenue">7,882</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsNet_iI_pp0p0_c20220331__srt--StatementGeographicalAxis__country--US_zO42a1qwNhd" style="width: 16%; text-align: right" title="Net Assets (Liabilities)">(2,606,975</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Republic of China (Taiwan)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20220101__20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zap084NShaY2" style="text-align: right" title="Net Revenue">324,698</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zhgvzipvW9O1" style="text-align: right" title="Net Assets (Liabilities)">763,867</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zQN2rLt6g7dd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z2aEbWPB8zTg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zbnglDQODzg4" style="display: none"> SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Revenue</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net Assets (Liabilities)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20220101__20220331__srt--StatementGeographicalAxis__country--US_z9YMAyE8vVpj" style="width: 16%; text-align: right" title="Net Revenue">7,882</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsNet_iI_pp0p0_c20220331__srt--StatementGeographicalAxis__country--US_zO42a1qwNhd" style="width: 16%; text-align: right" title="Net Assets (Liabilities)">(2,606,975</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Republic of China (Taiwan)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20220101__20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zap084NShaY2" style="text-align: right" title="Net Revenue">324,698</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220331__us-gaap--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zhgvzipvW9O1" style="text-align: right" title="Net Assets (Liabilities)">763,867</td><td style="text-align: left"> </td></tr> </table> 7882 -2606975 324698 763867 <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zG4b0KdNTCAk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zidjkNixKqpe">Reclassification</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in 2021 have been reclassified to conform to the 2022 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zEmDgTIXdjJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_zrnAmSfjnVs2">New Accounting Standards</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No new relevant accounting standards</span></p> <p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zaEQeSWkpHde" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 <span id="xdx_825_zeTEfYIhuvEc">RELATED PARTIES</span></b></span></p> <p id="xdx_899_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zoLBiMpYOJUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z0HK0FuZgnkk" style="display: none"> SCHEDULE OF RELATED PARTY TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">On August 28, 2014, we entered into a debenture agreement with Mr. Gregory Omi, formerly a member of our Board of Directors of the company for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z4HxOtvQBLwd" title="Debt instrument, face amount">200,000</span>, at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zLdFCyW3QRp7" title="Debt instrument, interest rate">9.5</span>% interest per annum with interest and principal payable on the extended maturity date of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20140801__20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_zRnHlBJmPBx9" title="Debt instrument, maturity date">December 31, 2016</span>. As consideration for the extension of the debenture, we granted Mr. Omi options to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20140801__20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z3lqX4lBm5Oe" title="Share based compesatio, award option">2,500</span> shares of our common stock with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--SharePrice_iI_pid_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z6mfq6STGzh9" title="Share price">6.16</span> per share. This debenture was extended to December 31, 2022. Mr. Omi is currently the CTO of the company.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zk0c53V9Qjza" style="width: 16%; text-align: right" title="Due to Related Parties">200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zUMfBLw9tsv6" style="width: 16%; text-align: right" title="Due to Related Parties">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">On November 19, 2012, we entered into a convertible debenture agreement with Mr. Robert Gillen, a member of our Board of Directors, for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zPfjmxv0vkb1" title="Debt instrument, face amount">100,000</span> (the “Gillen I Debenture”), under his company Squirrel-Away, LLC. Under the original terms of the agreement, interest is payable at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zmOTLpSjSgf9" title="Debt instrument, interest rate">10</span>% per annum and became due on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20121101__20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zcJX51PpQtRb" title="Debt instrument, maturity date">December 19, 2014</span>. Gillen I Debenture was extended to January 5, 2015. On June 20, 2013, interest of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--InterestExpenseDebt_pp0p0_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zOTlvI4mlGI5" title="Interest expense">5,000</span> was paid on the debenture. As consideration for agreeing to extend the maturity date of the debenture to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_z67XSlTyHKs" title="Debt instrument, maturity date">December 31, 2015</span>, we granted Mr. Gillen options to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zj7J0L2e0nS3" title="Share based compesatio, award option">1,250</span> shares of common stock at an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zx3tI6L0fGHg" title="Share price">6.16</span> per share This debenture was extended to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zMTr5nDPJFr9" title="Debt instrument, maturity date">December 31, 2022</span>.</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zLFnhVgIVxR2" style="text-align: right" title="Due to Related Parties">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zXvfL4OwuNt1" style="text-align: right" title="Due to Related Parties">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Due to Related Parties</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331_z5Fxd6t3zNz7" style="text-align: right" title="Total Due to Related Parties">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zQWJTz1yirmc" style="text-align: right" title="Total Due to Related Parties">300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less Current Portion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DueToRelatedPartiesCurrent_iNI_pp0p0_di_c20220331_zAVu8BllpCRi" style="text-align: right" title="Less Current Portion">(300,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrent_iNI_pp0p0_di_c20211231_zefIin2TQ7Ch" style="text-align: right" title="Less Current Portion">(300,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Long-Term</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DueToRelatedPartiesNoncurrent_iI_pp0p0_c20220331_zkEMHK9FDgv8" style="text-align: right" title="Total Long-Term"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DueToRelatedPartiesNoncurrent_iI_pp0p0_c20211231_ze20ReEdpOHf" style="text-align: right" title="Total Long-Term"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zoLBiMpYOJUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z0HK0FuZgnkk" style="display: none"> SCHEDULE OF RELATED PARTY TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">On August 28, 2014, we entered into a debenture agreement with Mr. Gregory Omi, formerly a member of our Board of Directors of the company for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z4HxOtvQBLwd" title="Debt instrument, face amount">200,000</span>, at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zLdFCyW3QRp7" title="Debt instrument, interest rate">9.5</span>% interest per annum with interest and principal payable on the extended maturity date of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20140801__20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_zRnHlBJmPBx9" title="Debt instrument, maturity date">December 31, 2016</span>. As consideration for the extension of the debenture, we granted Mr. Omi options to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20140801__20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z3lqX4lBm5Oe" title="Share based compesatio, award option">2,500</span> shares of our common stock with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--SharePrice_iI_pid_c20140828__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_z6mfq6STGzh9" title="Share price">6.16</span> per share. This debenture was extended to December 31, 2022. Mr. Omi is currently the CTO of the company.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zk0c53V9Qjza" style="width: 16%; text-align: right" title="Due to Related Parties">200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrGregoryOmiMember_zUMfBLw9tsv6" style="width: 16%; text-align: right" title="Due to Related Parties">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">On November 19, 2012, we entered into a convertible debenture agreement with Mr. Robert Gillen, a member of our Board of Directors, for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zPfjmxv0vkb1" title="Debt instrument, face amount">100,000</span> (the “Gillen I Debenture”), under his company Squirrel-Away, LLC. Under the original terms of the agreement, interest is payable at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zmOTLpSjSgf9" title="Debt instrument, interest rate">10</span>% per annum and became due on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20121101__20121119__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zcJX51PpQtRb" title="Debt instrument, maturity date">December 19, 2014</span>. Gillen I Debenture was extended to January 5, 2015. On June 20, 2013, interest of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--InterestExpenseDebt_pp0p0_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zOTlvI4mlGI5" title="Interest expense">5,000</span> was paid on the debenture. As consideration for agreeing to extend the maturity date of the debenture to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_z67XSlTyHKs" title="Debt instrument, maturity date">December 31, 2015</span>, we granted Mr. Gillen options to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zj7J0L2e0nS3" title="Share based compesatio, award option">1,250</span> shares of common stock at an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zx3tI6L0fGHg" title="Share price">6.16</span> per share This debenture was extended to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20130619__20130620__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zMTr5nDPJFr9" title="Debt instrument, maturity date">December 31, 2022</span>.</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zLFnhVgIVxR2" style="text-align: right" title="Due to Related Parties">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrRobertGillenMember_zXvfL4OwuNt1" style="text-align: right" title="Due to Related Parties">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Due to Related Parties</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220331_z5Fxd6t3zNz7" style="text-align: right" title="Total Due to Related Parties">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zQWJTz1yirmc" style="text-align: right" title="Total Due to Related Parties">300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less Current Portion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DueToRelatedPartiesCurrent_iNI_pp0p0_di_c20220331_zAVu8BllpCRi" style="text-align: right" title="Less Current Portion">(300,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrent_iNI_pp0p0_di_c20211231_zefIin2TQ7Ch" style="text-align: right" title="Less Current Portion">(300,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Long-Term</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DueToRelatedPartiesNoncurrent_iI_pp0p0_c20220331_zkEMHK9FDgv8" style="text-align: right" title="Total Long-Term"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DueToRelatedPartiesNoncurrent_iI_pp0p0_c20211231_ze20ReEdpOHf" style="text-align: right" title="Total Long-Term"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000 0.095 2016-12-31 2500 6.16 200000 200000 100000 0.10 2014-12-19 5000 2015-12-31 1250 6.16 2022-12-31 100000 100000 300000 300000 300000 300000 <p id="xdx_80E_eus-gaap--ShortTermDebtTextBlock_zXWCTii8rtn8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 <span id="xdx_828_zjZPLbX0OM08">SHORT-TERM AND LONG-TERM DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfShortTermDebtTextBlock_zsUtNBG40Wrf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The short-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zcDadRVbg7p3" style="display: none">SCHEDULE OF SHORT-TERM DEBT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Debenture agreements with a shareholder at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20190201__20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zmTd0vZli84" title="Interest rate">10%</span> interest rate beginning in February 2019 - December 2019, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_z1jl8C9OTwKb" title="Debt maturity date, description">one year maturity, were due February 2020 – December 2020</span>, principal and interest convertible at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zEtWNFXCdsa5">2.80</span> per share into common stock at the option of the holder until repaid. All principal and accrued interest converted during 2021 except one remaining $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zG33GxdO5uK3" title="Debt principal amount">50,000</span> debenture and accrued interest of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_z0SuI5WPNWp9" title="Accrued interest">12,079</span>.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zWSqXyN7WqRk" style="width: 16%; text-align: right" title="Short Term Debt">50,000</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zM5N2QwnL6j6" style="width: 16%; text-align: right" title="Short Term Debt">50,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loan Agreement with Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zkBvdR5Q2H07" title="Interest rate">2.68%</span> interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zPPOTGlEgjbd" title="Debt instrument, maturity date">due January 2023</span>.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zKPlD5QSZwh3" style="text-align: right" title="Short Term Debt">69,850</td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zohrh5uVZCg2" style="text-align: right" title="Short Term Debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Loan agreement with Hua Nam bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zWaoxY4WAffc" title="Interest rate">2,42%</span> interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zCY1pIj315Oh" title="Debt instrument, maturity date">due September 2022</span>.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_z0MbUqYNo8a1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Short Term Debt">104,789</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zHv5bmpCUde9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Short Term Debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermBorrowings_iI_c20220331_zoZV2s5YuPf2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short Term Debt">224,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermBorrowings_iI_c20211231_znvPUFkIj9Y8" style="border-bottom: Black 2.5pt double; text-align: right" title="Short Term Debt">50,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z2tpSqhuYoZ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zCBRVh5xwD6g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zEP6i2JJb8F4" style="display: none">SCHEDULE OF LONG-TERM DEBT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 <br/>(Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31. 2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loans from Shanghai Bank with interest rates <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zj5werjUpInj" title="Debt interest rate">1.00%</span> - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zxpxnf1nT4m" title="Debt interest rate">1.5%</span> per annum due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zH15tFY22HIj" title="Debt Instrument, Maturity Date, Description">February 2024</span> – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zbmJBv4Hqmy2" title="Debt Instrument, Maturity Date, Description">November 2026</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zg4zwZAThtqd" style="width: 16%; text-align: right" title="Long Term Debt">415,275</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zcs7bSw0RsW3" style="width: 16%; text-align: right" title="Long Term Debt">469,087</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current Portion of Long-term debt</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebtCurrent_iNI_di_c20220331_zKQdliD4gnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current Portion of Long-term debt">(116,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zTAjUtZf78dd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current Portion of Long-term debt">(120,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20220331_z3rS5gs3iG48" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt">298,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zmMsZVT9I8f7" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt">338,803</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zJ4d8v47KRnf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfShortTermDebtTextBlock_zsUtNBG40Wrf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The short-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zcDadRVbg7p3" style="display: none">SCHEDULE OF SHORT-TERM DEBT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 (Unaudited)</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Debenture agreements with a shareholder at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20190201__20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zmTd0vZli84" title="Interest rate">10%</span> interest rate beginning in February 2019 - December 2019, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_z1jl8C9OTwKb" title="Debt maturity date, description">one year maturity, were due February 2020 – December 2020</span>, principal and interest convertible at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zEtWNFXCdsa5">2.80</span> per share into common stock at the option of the holder until repaid. All principal and accrued interest converted during 2021 except one remaining $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zG33GxdO5uK3" title="Debt principal amount">50,000</span> debenture and accrued interest of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20190228__us-gaap--TypeOfArrangementAxis__custom--DebentureAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_z0SuI5WPNWp9" title="Accrued interest">12,079</span>.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zWSqXyN7WqRk" style="width: 16%; text-align: right" title="Short Term Debt">50,000</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VariousShareholdersMember_zM5N2QwnL6j6" style="width: 16%; text-align: right" title="Short Term Debt">50,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loan Agreement with Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zkBvdR5Q2H07" title="Interest rate">2.68%</span> interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zPPOTGlEgjbd" title="Debt instrument, maturity date">due January 2023</span>.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zKPlD5QSZwh3" style="text-align: right" title="Short Term Debt">69,850</td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zohrh5uVZCg2" style="text-align: right" title="Short Term Debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Loan agreement with Hua Nam bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zWaoxY4WAffc" title="Interest rate">2,42%</span> interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zCY1pIj315Oh" title="Debt instrument, maturity date">due September 2022</span>.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_z0MbUqYNo8a1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Short Term Debt">104,789</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShortTermBorrowings_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNanBankMember_zHv5bmpCUde9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Short Term Debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermBorrowings_iI_c20220331_zoZV2s5YuPf2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short Term Debt">224,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermBorrowings_iI_c20211231_znvPUFkIj9Y8" style="border-bottom: Black 2.5pt double; text-align: right" title="Short Term Debt">50,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.10 one year maturity, were due February 2020 – December 2020 2.80 50000 12079 50000 50000 0.0268 due January 2023 69850 0.0242 due September 2022 104789 224648 50000 <p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zCBRVh5xwD6g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zEP6i2JJb8F4" style="display: none">SCHEDULE OF LONG-TERM DEBT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 <br/>(Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31. 2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loans from Shanghai Bank with interest rates <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zj5werjUpInj" title="Debt interest rate">1.00%</span> - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zxpxnf1nT4m" title="Debt interest rate">1.5%</span> per annum due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zH15tFY22HIj" title="Debt Instrument, Maturity Date, Description">February 2024</span> – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDateDescription_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zbmJBv4Hqmy2" title="Debt Instrument, Maturity Date, Description">November 2026</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zg4zwZAThtqd" style="width: 16%; text-align: right" title="Long Term Debt">415,275</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zcs7bSw0RsW3" style="width: 16%; text-align: right" title="Long Term Debt">469,087</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current Portion of Long-term debt</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebtCurrent_iNI_di_c20220331_zKQdliD4gnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current Portion of Long-term debt">(116,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zTAjUtZf78dd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current Portion of Long-term debt">(120,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20220331_z3rS5gs3iG48" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt">298,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zmMsZVT9I8f7" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt">338,803</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.0100 0.015 February 2024 November 2026 415275 469087 116432 120284 298843 338803 <p id="xdx_801_eus-gaap--PreferredStockTextBlock_zGs4ANglAXDf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 <span id="xdx_823_zuZ3hwfUVKS3">PREFERRED STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are currently authorized to issue up to <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331_zJ9NgfcslkWc" title="Preferred stock, shares authorized">12,500,000</span> shares of preferred stock, par value $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220331_zEBeZ20SceB6" title="Preferred stock, par value">0.00001</span> per share, <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zDIoJGXMuTXb" title="Preferred stock, shares authorized">1,250,000</span> shares of which are designated as Series A Preferred Stock and <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbgghaUxa8ak" title="Preferred stock, shares authorized">500</span> shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 12500000 0.00001 1250000 500 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z4LWrkR6kMH3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 <span id="xdx_828_zbqcWBLFK8e4">EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue up to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220331_zDKTT3QlIkSl" title="Common stock, shares authorized">37,500,000</span> shares of common stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zzkypj0ri9K4" title="Common stock, par value">0.00001</span> per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 37500000 0.00001 <p id="xdx_803_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zzm0tvwyBNc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 <span id="xdx_82C_zPzdyofBZAz5">STOCK OPTION PLAN AND WARRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Stock Options</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 15, 2009, we adopted the 2009 Stock Option Plan (the “2009 Option Plan”), with an aggregate number of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20091015__us-gaap--PlanNameAxis__custom--TwoThousandNineStockOptionPlanMember_zuw3P1ZWVlCd" title="Number of shares authorized under plan">187,500</span> shares of common stock issuable under the plan. The purpose of the 2009 Option Plan was to assume options that were already issued in the 2006 and 2008 Option plans under Iveda Corporation after the merger with Charmed Homes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20100118__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_zvneq9oClbK3" title="Number of shares authorized under plan">125,000</span> shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20111231__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_ztlTWBg22mJe" title="Number of shares authorized under plan">375,000</span> shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20121231__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_zAYQuCbWyyl2" title="Number of shares authorized under plan">1,625,000</span> shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted a new plan called Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan will have a maximum of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pn6n6_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyStockOptionPlanMember__us-gaap--RangeAxis__us-gaap--MaximumMember_zZBWmibZ90Pl" title="Number of shares authorized under plan">10</span> million option shares authorized with similar terms and conditions to the 2010 Option Plan. This plan has not been approved by the shareholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, there were <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyStockOptionPlanMember_zsiFYQKQgn38" title="Options outstanding">893,438</span> options outstanding under all the option plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2021, we had approximately $<span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20211231_znkmDXLnXnCc" title="Unrecognized stock- based compensation">4,500</span> unrecognized stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUqgLRCASlfl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions during 2021 and 2020 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zIHIJuye3DQk" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Outstanding at Beginning of Year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zmLJSXsFBNKe" style="width: 11%; text-align: right" title="Shares, Outstanding at Beginning of Year">952,025</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210101__20211231_zPhf21Sd0479" style="width: 11%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">5.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_zvzTy6G4x7ij" style="width: 11%; text-align: right" title="Shares, Outstanding at Beginning of Year">842,650</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20200101__20201231_zEIVUMIaF1L8" style="width: 11%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">6.24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_zXte3NDmAi4d" style="text-align: right" title="Shares, Granted">141,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zMxwjWookum6" style="text-align: right" title="Weighted-Average Exercise Price, Granted">11.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200101__20201231_zu9eTAfid1Z8" style="text-align: right" title="Shares, Granted">312,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zHc3BOre6GN6" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zpY7F97fceMd" style="text-align: right" title="Shares, Exercised">(62,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zSEtPJQSJAcd" style="text-align: right" title="Weighted-Average Exercise Price Exercised">4.72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zvgeXyoF1FJf" style="text-align: right" title="Shares, Exercised">(158,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zqNHy27dxBCd" style="text-align: right" title="Weighted-Average Exercise Price, Exercised">1.28</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231_zS41yfLAYzi3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(137,963</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zxGoiWYcvYAk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">7.44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200101__20201231_zHpEC2R0OLze" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(44,375</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_zYQMEbsTT0f4" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">8.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zoy4SDRoUKt3" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">893,438</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zC0XyzNsxpC4" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">6.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zGYvNBvKPjZg" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">952,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zswIJiYQHvg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">5.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Options Exercisable at Year-End</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20211231_zSwYahgEIUcd" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">891,563</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20211231_zVNJAAGGLTr5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">6.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20200101__20201231_zo8ecrP7vBx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">952,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231_zpY5HzK8U60h" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">5.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Options Granted During the Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z4AEayAExrD8" title="Weighted-Average Fair Value of Options Granted During the Period">5.68</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zljUQ4eoCHE3" title="Weighted-Average Fair Value of Options Granted During the Period">2.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zO6ueu0nWmzh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zH4xl06HReS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to stock options outstanding and exercisable at December 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zf2ixIEr3Axf" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Options Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Range of <br/> Exercise<br/> Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number<br/> Outstanding <br/> at<br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20210101__20211231_zfaoMUYy7Eyl">0.32</span> - $<span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20210101__20211231_z13lndMU8tnd">16.24</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20211231_zcgr0eKPMFr" style="width: 16%; text-align: right">893,438</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z6C0a1SGvpZ6">6.2</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20211231_zD1Ln48c5zkh" style="width: 8%; text-align: right" title="Options Outstanding, Weighted-Average Exercise Price">6.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20211231_zWjVWTiiS5j7" style="width: 16%; text-align: right" title="Options Exercisable, Number Exercisable">891,563</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20211231_zEWEpZLcrph1" style="width: 8%; text-align: right" title="Options Exercisable, Weighted-Average Exercise Price">6.80</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zvZw7Q7vNrfk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcTTmTsU3RZ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zSGHnJuTe3ej" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zudCVXDVyj7e" title="Expected Life">5</span> yrs</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zfsCPChaJ2Tf" title="Expected Life">5</span> yrs</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Dividend Yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20211231_zseqcZacibi1" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20200101__20201231_z4fPRoDYWbY5" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231_zRTbNRJcHIk2" title="Expected Volatility">90</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20200101__20201231_zk7hbGNIIW02" title="Expected Volatility">90</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231_zKZnOsvKpDD1" title="Risk-Free Interest Rate">1.00</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231_zSdvwqy64BTf" title="Risk-Free Interest Rate">0.18</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_zQMwd4rK5y3e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfPlKjPQ8n33" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant transactions during 2021 and 2020 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zzuUOBMu83gd" style="display: none">SCHEDULE OF WARRANT TRANSACTIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Outstanding at Beginning of Year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zTMKM00Ekige" style="width: 14%; text-align: right" title="Shares, Outstanding at Beginning of Year">543,754</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zqbCQrCApqGd" style="width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200101__20201231_z3fLccloJigf" style="width: 14%; text-align: right" title="Shares, Outstanding at Beginning of Year">695,439</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zDi4iU3wLRbd" style="width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_z3bevYGVxEgf" style="text-align: right" title="Shares, Granted">509,732</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20210101__20211231_zN6toHjMKcTj" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200101__20201231_zAYpQNf9umba" style="text-align: right" title="Shares, Granted">123,732</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20200101__20201231_zvi899emnAJk" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zeAPXcktvsWl" style="text-align: right" title="Shares, Exercised">(78,102</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20210101__20211231_zZgaR9TP7S67" style="text-align: right" title="Weighted-Average Exercise Price, Exercised">2.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20210101__20211231_zUk6PeRDxFkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(103,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20210101__20211231_zDI560Yzl1g4" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.80</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20200101__20201231_zY1kMQwCAh4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(275,416</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20200101__20201231_zie3JuqrPrIl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.88</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210101__20211231_zqH4mcyV7Hpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">872,259</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zek6bVTirxH1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200101__20201231_zdvy7l2NlZP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">543,754</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zlb9cVIFTlH1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Warrant Exercisable at Year-End</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210101__20211231_z0Gn320hL1Sa" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">872,259</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20211231_zOkRyYiobQl1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20200101__20201231_zfj7FOjxGCB4" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">543,754</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231_zxbIUUISmFuk" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Warrants Granted During the Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--RangeAxis__us-gaap--MinimumMember_zbNNjXgpcJv9" title="Weighted-Average Fair Value of Options Granted During the Period">1.12</span> - $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--RangeAxis__us-gaap--MaximumMember_zSlhOIVs53l4" title="Weighted-Average Fair Value of Options Granted During the Period">3.92</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--RangeAxis__us-gaap--MinimumMember_zhvHB1VYt3i3" title="Weighted-Average Fair Value of Options Granted During the Period">0.80</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--RangeAxis__us-gaap--MaximumMember_zmCDywwLK3Oj" title="Weighted-Average Fair Value of Options Granted During the Period">2.08</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zGTNGoaf9vli" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock_zVlocybj9A1k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to warrants outstanding and exercisable at December 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zxH8Wg2tRGy2" style="display: none">SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Range of <br/> Exercise <br/> Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Outstanding <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average Remaining Contractual <br/> Life</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__srt--RangeAxis__srt--MinimumMember_zdL0CJ4fTp51" title="Range of Exercise Prices">2.80</span> - $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__srt--RangeAxis__srt--MaximumMember_zf13LEYRf66c" title="Range of Exercise Prices">13.20</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdPyRU051Ysk" style="width: 16%; text-align: right" title="Warrants Outstanding, Number Outstanding">872,259</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zl0sHkOMfqA" title="Warrants Outstanding, Weighted-Average Remaining Contractual Life">1.5</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zLlFAp2Tye95" style="width: 8%; text-align: right" title="Warrants Outstanding, Weighted-Average Exercise Price">3.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z1HTl5ggFVAe" style="width: 16%; text-align: right" title="Warrants Exercisable, Number Exercisable">872,259</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0iV6ZUbsSuh" style="width: 8%; text-align: right" title="Warrants Exercisable, Weighted-Average Exercise Price">3.04</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zXuEvzDSmt2b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock_zSj0B4cXC88j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zqQ4pfSNE3ff" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8OzJmYtk5Bc" title="Expected Life">1.5</span> yrs</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7W2Z91hCJHh" title="Expected Life">1.5</span> yrs</span></td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Dividend Yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7xhL8zsxCwd" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zuHx42kP0JPe" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zgQOec1dRS2b" title="Expected Volatility">90</span></td><td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUlzPIMXFkec" title="Expected Volatility">90</span></td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zzJZcVTVfrwf" title="Risk-Free Interest Rate">0.18</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MaximumMember_zkYhMwqOsZvg" title="Risk-Free Interest Rate">1.00</span></span></td><td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zX4CO0uSLBa8" title="Risk-Free Interest Rate">0.19</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MaximumMember_zcKpmXso13v1" title="Risk-Free Interest Rate">1.59</span></span></td><td style="text-align: left">%</td> </tr> </table> <p id="xdx_8AC_zPNAPgl88Iq5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 187500 125000 375000 1625000 10000000 893438 4500 <p id="xdx_89C_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zUqgLRCASlfl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions during 2021 and 2020 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zIHIJuye3DQk" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Outstanding at Beginning of Year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zmLJSXsFBNKe" style="width: 11%; text-align: right" title="Shares, Outstanding at Beginning of Year">952,025</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210101__20211231_zPhf21Sd0479" style="width: 11%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">5.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_zvzTy6G4x7ij" style="width: 11%; text-align: right" title="Shares, Outstanding at Beginning of Year">842,650</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20200101__20201231_zEIVUMIaF1L8" style="width: 11%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">6.24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_zXte3NDmAi4d" style="text-align: right" title="Shares, Granted">141,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zMxwjWookum6" style="text-align: right" title="Weighted-Average Exercise Price, Granted">11.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200101__20201231_zu9eTAfid1Z8" style="text-align: right" title="Shares, Granted">312,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zHc3BOre6GN6" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zpY7F97fceMd" style="text-align: right" title="Shares, Exercised">(62,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zSEtPJQSJAcd" style="text-align: right" title="Weighted-Average Exercise Price Exercised">4.72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zvgeXyoF1FJf" style="text-align: right" title="Shares, Exercised">(158,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zqNHy27dxBCd" style="text-align: right" title="Weighted-Average Exercise Price, Exercised">1.28</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231_zS41yfLAYzi3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(137,963</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zxGoiWYcvYAk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">7.44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200101__20201231_zHpEC2R0OLze" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(44,375</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_zYQMEbsTT0f4" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">8.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zoy4SDRoUKt3" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">893,438</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zC0XyzNsxpC4" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">6.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zGYvNBvKPjZg" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">952,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zswIJiYQHvg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">5.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Options Exercisable at Year-End</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20211231_zSwYahgEIUcd" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">891,563</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20211231_zVNJAAGGLTr5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">6.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20200101__20201231_zo8ecrP7vBx1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">952,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231_zpY5HzK8U60h" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">5.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Options Granted During the Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z4AEayAExrD8" title="Weighted-Average Fair Value of Options Granted During the Period">5.68</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zljUQ4eoCHE3" title="Weighted-Average Fair Value of Options Granted During the Period">2.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 952025 5.76 842650 6.24 141875 11.76 312500 2.96 62500 4.72 158750 1.28 137963 7.44 44375 8.96 893438 6.80 952025 5.76 891563 6.80 952025 5.76 5.68 2.00 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zH4xl06HReS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to stock options outstanding and exercisable at December 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zf2ixIEr3Axf" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Options Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Options Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Range of <br/> Exercise<br/> Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number<br/> Outstanding <br/> at<br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20210101__20211231_zfaoMUYy7Eyl">0.32</span> - $<span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20210101__20211231_z13lndMU8tnd">16.24</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20211231_zcgr0eKPMFr" style="width: 16%; text-align: right">893,438</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z6C0a1SGvpZ6">6.2</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20211231_zD1Ln48c5zkh" style="width: 8%; text-align: right" title="Options Outstanding, Weighted-Average Exercise Price">6.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20211231_zWjVWTiiS5j7" style="width: 16%; text-align: right" title="Options Exercisable, Number Exercisable">891,563</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20211231_zEWEpZLcrph1" style="width: 8%; text-align: right" title="Options Exercisable, Weighted-Average Exercise Price">6.80</td><td style="width: 1%; text-align: left"> </td></tr> </table> 0.32 16.24 893438 P6Y2M12D 6.80 891563 6.80 <p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcTTmTsU3RZ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zSGHnJuTe3ej" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zudCVXDVyj7e" title="Expected Life">5</span> yrs</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zfsCPChaJ2Tf" title="Expected Life">5</span> yrs</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Dividend Yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20211231_zseqcZacibi1" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20200101__20201231_z4fPRoDYWbY5" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231_zRTbNRJcHIk2" title="Expected Volatility">90</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20200101__20201231_zk7hbGNIIW02" title="Expected Volatility">90</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231_zKZnOsvKpDD1" title="Risk-Free Interest Rate">1.00</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231_zSdvwqy64BTf" title="Risk-Free Interest Rate">0.18</span></td><td style="text-align: left">%</td></tr> </table> P5Y P5Y 0 0 0.90 0.90 0.0100 0.0018 <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfPlKjPQ8n33" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant transactions during 2021 and 2020 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zzuUOBMu83gd" style="display: none">SCHEDULE OF WARRANT TRANSACTIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Outstanding at Beginning of Year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zTMKM00Ekige" style="width: 14%; text-align: right" title="Shares, Outstanding at Beginning of Year">543,754</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zqbCQrCApqGd" style="width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200101__20201231_z3fLccloJigf" style="width: 14%; text-align: right" title="Shares, Outstanding at Beginning of Year">695,439</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zDi4iU3wLRbd" style="width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_z3bevYGVxEgf" style="text-align: right" title="Shares, Granted">509,732</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20210101__20211231_zN6toHjMKcTj" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200101__20201231_zAYpQNf9umba" style="text-align: right" title="Shares, Granted">123,732</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20200101__20201231_zvi899emnAJk" style="text-align: right" title="Weighted-Average Exercise Price, Granted">2.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zeAPXcktvsWl" style="text-align: right" title="Shares, Exercised">(78,102</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20210101__20211231_zZgaR9TP7S67" style="text-align: right" title="Weighted-Average Exercise Price, Exercised">2.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20210101__20211231_zUk6PeRDxFkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(103,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20210101__20211231_zDI560Yzl1g4" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.80</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20200101__20201231_zY1kMQwCAh4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited or Canceled">(275,416</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20200101__20201231_zie3JuqrPrIl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.88</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210101__20211231_zqH4mcyV7Hpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">872,259</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zek6bVTirxH1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200101__20201231_zdvy7l2NlZP9" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Outstanding at End of Year">543,754</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zlb9cVIFTlH1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Warrant Exercisable at Year-End</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210101__20211231_z0Gn320hL1Sa" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">872,259</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20211231_zOkRyYiobQl1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20200101__20201231_zfj7FOjxGCB4" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Options Exercisable at End of Year">543,754</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231_zxbIUUISmFuk" style="padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">3.04</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Warrants Granted During the Year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--RangeAxis__us-gaap--MinimumMember_zbNNjXgpcJv9" title="Weighted-Average Fair Value of Options Granted During the Period">1.12</span> - $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--RangeAxis__us-gaap--MaximumMember_zSlhOIVs53l4" title="Weighted-Average Fair Value of Options Granted During the Period">3.92</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--RangeAxis__us-gaap--MinimumMember_zhvHB1VYt3i3" title="Weighted-Average Fair Value of Options Granted During the Period">0.80</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--RangeAxis__us-gaap--MaximumMember_zmCDywwLK3Oj" title="Weighted-Average Fair Value of Options Granted During the Period">2.08</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 543754 3.04 695439 3.04 509732 2.96 123732 2.80 78102 2.80 103125 2.80 275416 2.88 872259 3.04 543754 3.04 872259 3.04 543754 3.04 1.12 3.92 0.80 2.08 <p id="xdx_896_ecustom--SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock_zVlocybj9A1k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to warrants outstanding and exercisable at December 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zxH8Wg2tRGy2" style="display: none">SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Range of <br/> Exercise <br/> Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Outstanding <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average Remaining Contractual <br/> Life</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__srt--RangeAxis__srt--MinimumMember_zdL0CJ4fTp51" title="Range of Exercise Prices">2.80</span> - $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__srt--RangeAxis__srt--MaximumMember_zf13LEYRf66c" title="Range of Exercise Prices">13.20</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdPyRU051Ysk" style="width: 16%; text-align: right" title="Warrants Outstanding, Number Outstanding">872,259</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zl0sHkOMfqA" title="Warrants Outstanding, Weighted-Average Remaining Contractual Life">1.5</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zLlFAp2Tye95" style="width: 8%; text-align: right" title="Warrants Outstanding, Weighted-Average Exercise Price">3.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z1HTl5ggFVAe" style="width: 16%; text-align: right" title="Warrants Exercisable, Number Exercisable">872,259</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0iV6ZUbsSuh" style="width: 8%; text-align: right" title="Warrants Exercisable, Weighted-Average Exercise Price">3.04</td><td style="width: 1%; text-align: left"> </td></tr> </table> 2.80 13.20 872259 P1Y6M 3.04 872259 3.04 <p id="xdx_894_ecustom--ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock_zSj0B4cXC88j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zqQ4pfSNE3ff" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8OzJmYtk5Bc" title="Expected Life">1.5</span> yrs</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7W2Z91hCJHh" title="Expected Life">1.5</span> yrs</span></td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Dividend Yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7xhL8zsxCwd" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zuHx42kP0JPe" title="Dividend Yield">0</span></td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zgQOec1dRS2b" title="Expected Volatility">90</span></td><td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUlzPIMXFkec" title="Expected Volatility">90</span></td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zzJZcVTVfrwf" title="Risk-Free Interest Rate">0.18</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MaximumMember_zkYhMwqOsZvg" title="Risk-Free Interest Rate">1.00</span></span></td><td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MinimumMember_zX4CO0uSLBa8" title="Risk-Free Interest Rate">0.19</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--RangeAxis__us-gaap--MaximumMember_zcKpmXso13v1" title="Risk-Free Interest Rate">1.59</span></span></td><td style="text-align: left">%</td> </tr> </table> P1Y6M P1Y6M 0 0 0.90 0.90 0.0018 0.0100 0.0019 0.0159 <p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zvsZlOkKHLLc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 <span id="xdx_828_zQ55x76hj2N1">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">U.S. Federal Corporate Income Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zYMkkLw8Olg8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zw3Vph2X00G4" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20211231_zluS30NUI3wa" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_zN400OcdkIx1" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTALNzZAr_maDTALNz6nP_zDTDzEon3fKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Tax Operating Loss Carryforward - USA</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,800,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pp0p0_maDTALNzZAr_maDTALNz6nP_z0tTM3RCyLkh" style="vertical-align: bottom; background-color: White"> <td>Other</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1021"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1022"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzZAr_msDTALNz6nP_zOuFdpYqBCDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation Allowance - USA</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,800,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,800,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNz6nP_zxTTpSrdrpR5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred Tax Assets, Net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zB5xrgj5tpR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation allowance increased approximately $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pn5n6_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UsBasedSegmentMember_zBZUcTK3r6S9" title="Valuation allowance increased">0.5</span> million, primarily as a result of the increased net operating losses of our U.S.- based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, we had federal net operating loss carryforwards for income tax purposes of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zwwVKHOJsqPl" title="Operating loss carryforward">29</span> million <span id="xdx_906_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z4qxmR5jDTVe" title="Operating loss carryforward, limitations on use">which will begin to expire in 2025</span>. We also have Arizona net operating loss carryforwards for income tax purposes of approximately $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20220331__srt--StatementGeographicalAxis__stpr--AZ_zwnLbTESqT75" title="Operating loss carryforwards">2.0</span> million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.</span></p> <p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zssymQQw0sRe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BC_zuEMMuBURjsi" style="display: none">SUMMARY OF OPERATING LOSS CARRYFORWARDS</span></span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center">Year Ending</td><td> </td> <td colspan="2" style="text-align: center">Net Operating</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Year of</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Loss:</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Expiration</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: center">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20211231_pp0p0" style="width: 24%; text-align: right" title="Net Operating Loss">1,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--YearOfExpiration_c20210101__20211231" style="width: 24%; text-align: right" title="Year of Expiration">2041</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0" style="text-align: right" title="Net Operating Loss">590,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--YearOfExpiration_c20200101__20201231" style="text-align: right" title="Year of Expiration">2040</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2019</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_c20191231_pp0p0" style="text-align: right" title="Net Operating Loss">260,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--YearOfExpiration_c20190101__20191231" style="text-align: right" title="Year of Expiration">2039</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2018</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_c20181231_pp0p0" style="text-align: right" title="Net Operating Loss">160,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--YearOfExpiration_c20180101__20181231" style="text-align: right" title="Year of Expiration">2038</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2017</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20171231_pp0p0" style="text-align: right" title="Net Operating Loss">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--YearOfExpiration_c20170101__20171231" style="text-align: right" title="Year of Expiration">2037</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2016</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20161231_pp0p0" style="text-align: right" title="Net Operating Loss">1,640,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--YearOfExpiration_c20160101__20161231" style="text-align: right" title="Year of Expiration">2036</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2015</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20151231_pp0p0" style="text-align: right" title="Net Operating Loss">3,400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--YearOfExpiration_c20150101__20151231" style="text-align: right" title="Year of Expiration">2035</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2014</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20141231_pp0p0" style="text-align: right" title="Net Operating Loss">5,230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--YearOfExpiration_c20140101__20141231" style="text-align: right" title="Year of Expiration">2034</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20131231_pp0p0" style="text-align: right" title="Net Operating Loss">5,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--YearOfExpiration_c20130101__20131231" style="text-align: right" title="Year of Expiration">2033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20121231_pp0p0" style="text-align: right" title="Net Operating Loss">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--YearOfExpiration_c20120101__20121231" style="text-align: right" title="Year of Expiration">2032</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2011</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20111231_pp0p0" style="text-align: right" title="Net Operating Loss">2,427,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--YearOfExpiration_c20110101__20111231" style="text-align: right" title="Year of Expiration">2031</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2010</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20101231_pp0p0" style="text-align: right" title="Net Operating Loss">1,799,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--YearOfExpiration_c20100101__20101231" style="text-align: right" title="Year of Expiration">2030</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2009</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_c20091231_pp0p0" style="text-align: right" title="Net Operating Loss">1,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--YearOfExpiration_c20090101__20091231" style="text-align: right" title="Year of Expiration">2029</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2008</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20081231_pp0p0" style="text-align: right" title="Net Operating Loss">1,308,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--YearOfExpiration_c20080101__20081231" style="text-align: right" title="Year of Expiration">2028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2007</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20071231_pp0p0" style="text-align: right" title="Net Operating Loss">429,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--YearOfExpiration_c20070101__20071231" style="text-align: right" title="Year of Expiration">2027</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2006</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20061231_pp0p0" style="text-align: right" title="Net Operating Loss">476,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--YearOfExpiration_c20060101__20061231" style="text-align: right" title="Year of Expiration">2026</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2005</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20051231_pp0p0" style="text-align: right" title="Net Operating Loss">414,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--YearOfExpiration_c20050101__20051231" style="text-align: right" title="Year of Expiration">2025</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zJdBHI5ZYeOd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Taiwan (Republic of China) Corporate Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--TaiwanCorporateTaxRate_c20220101__20220331_z9Wj7g0vkwPi" title="Taiwan corporate tax rate">Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zYMkkLw8Olg8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zw3Vph2X00G4" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20211231_zluS30NUI3wa" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_zN400OcdkIx1" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTALNzZAr_maDTALNz6nP_zDTDzEon3fKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Tax Operating Loss Carryforward - USA</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,800,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pp0p0_maDTALNzZAr_maDTALNz6nP_z0tTM3RCyLkh" style="vertical-align: bottom; background-color: White"> <td>Other</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1021"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1022"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzZAr_msDTALNz6nP_zOuFdpYqBCDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation Allowance - USA</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,800,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,800,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNz6nP_zxTTpSrdrpR5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred Tax Assets, Net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10800000 9800000 10800000 9800000 500000 29000000 which will begin to expire in 2025 2000000.0 <p id="xdx_896_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zssymQQw0sRe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BC_zuEMMuBURjsi" style="display: none">SUMMARY OF OPERATING LOSS CARRYFORWARDS</span></span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center">Year Ending</td><td> </td> <td colspan="2" style="text-align: center">Net Operating</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Year of</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Loss:</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Expiration</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: center">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20211231_pp0p0" style="width: 24%; text-align: right" title="Net Operating Loss">1,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--YearOfExpiration_c20210101__20211231" style="width: 24%; text-align: right" title="Year of Expiration">2041</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0" style="text-align: right" title="Net Operating Loss">590,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--YearOfExpiration_c20200101__20201231" style="text-align: right" title="Year of Expiration">2040</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2019</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_c20191231_pp0p0" style="text-align: right" title="Net Operating Loss">260,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--YearOfExpiration_c20190101__20191231" style="text-align: right" title="Year of Expiration">2039</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2018</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_c20181231_pp0p0" style="text-align: right" title="Net Operating Loss">160,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--YearOfExpiration_c20180101__20181231" style="text-align: right" title="Year of Expiration">2038</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2017</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20171231_pp0p0" style="text-align: right" title="Net Operating Loss">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--YearOfExpiration_c20170101__20171231" style="text-align: right" title="Year of Expiration">2037</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2016</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20161231_pp0p0" style="text-align: right" title="Net Operating Loss">1,640,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--YearOfExpiration_c20160101__20161231" style="text-align: right" title="Year of Expiration">2036</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2015</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20151231_pp0p0" style="text-align: right" title="Net Operating Loss">3,400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--YearOfExpiration_c20150101__20151231" style="text-align: right" title="Year of Expiration">2035</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2014</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20141231_pp0p0" style="text-align: right" title="Net Operating Loss">5,230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--YearOfExpiration_c20140101__20141231" style="text-align: right" title="Year of Expiration">2034</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20131231_pp0p0" style="text-align: right" title="Net Operating Loss">5,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--YearOfExpiration_c20130101__20131231" style="text-align: right" title="Year of Expiration">2033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20121231_pp0p0" style="text-align: right" title="Net Operating Loss">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--YearOfExpiration_c20120101__20121231" style="text-align: right" title="Year of Expiration">2032</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2011</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20111231_pp0p0" style="text-align: right" title="Net Operating Loss">2,427,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--YearOfExpiration_c20110101__20111231" style="text-align: right" title="Year of Expiration">2031</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2010</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20101231_pp0p0" style="text-align: right" title="Net Operating Loss">1,799,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--YearOfExpiration_c20100101__20101231" style="text-align: right" title="Year of Expiration">2030</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2009</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_c20091231_pp0p0" style="text-align: right" title="Net Operating Loss">1,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--YearOfExpiration_c20090101__20091231" style="text-align: right" title="Year of Expiration">2029</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2008</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_c20081231_pp0p0" style="text-align: right" title="Net Operating Loss">1,308,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--YearOfExpiration_c20080101__20081231" style="text-align: right" title="Year of Expiration">2028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2007</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_c20071231_pp0p0" style="text-align: right" title="Net Operating Loss">429,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--YearOfExpiration_c20070101__20071231" style="text-align: right" title="Year of Expiration">2027</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2006</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_c20061231_pp0p0" style="text-align: right" title="Net Operating Loss">476,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--YearOfExpiration_c20060101__20061231" style="text-align: right" title="Year of Expiration">2026</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2005</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_c20051231_pp0p0" style="text-align: right" title="Net Operating Loss">414,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--YearOfExpiration_c20050101__20051231" style="text-align: right" title="Year of Expiration">2025</td><td style="text-align: left"> </td></tr> </table> 1000000 2041 590000 2040 260000 2039 160000 2038 140000 2037 1640000 2036 3400000 2035 5230000 2034 5600000 2033 2850000 2032 2427000 2031 1799000 2030 1750000 2029 1308000 2028 429000 2027 476000 2026 414000 2025 Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year <p id="xdx_805_eus-gaap--EarningsPerShareTextBlock_z4qkQrawcWG6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 <span id="xdx_828_zy40IDMhpYO5">EARNINGS (LOSS) PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the three months ended March 31, 2022 and 2021 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the Three months ended March 31, 2022 and 2021.</span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z2rPFLD9L5C8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zMlO6kc0rs1e" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220331_z7ehyBDUnW8d" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 <br/> (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20210331_zbdzVWN9TtD" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2021 (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAbstract_iB_zXBj23zO5bGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Net Loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(666,798</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(634,714</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Weighted Average Shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,672,508</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,209,589</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Basic Loss Per Share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z2rPFLD9L5C8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zMlO6kc0rs1e" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220331_z7ehyBDUnW8d" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022 <br/> (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20210331_zbdzVWN9TtD" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2021 (Unaudited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAbstract_iB_zXBj23zO5bGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Net Loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(666,798</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(634,714</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Weighted Average Shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,672,508</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,209,589</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Basic Loss Per Share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -666798 -634714 9672508 7209589 -0.07 -0.09 <p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zbCN34OHftt4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 <span id="xdx_822_z472UW8ZVwHd">CONTINGENT LIABILITIES—TAIWAN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to certain contracts with Siemens, Chung-Hsin Electric and Machinery Manufacturing Corp, Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2021 is $<span id="xdx_90A_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c20210101__20211231__dei--LegalEntityAxis__custom--MegasysMember_zn45eJA0JlRb" title="Concentration risk, credit risk, financial instrument">61,435</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 61435 <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zKiU03rgQYTd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 <span id="xdx_829_zPHAvYPe9Wq">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2022 we closed the Stock and Warrant Offering that was committed to by Underwriting Agreement effective March 31, 2022 for $<span id="xdx_90E_ecustom--StockAndWarrantOffering_iI_c20220405__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziP9hVRWDNV9" title="Stock and warrant offering">8,011,250</span>.</span></p> 8011250 EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 145 251 1 false 41 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://iveda.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://iveda.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://iveda.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://iveda.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://iveda.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://iveda.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://iveda.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - RELATED PARTIES Sheet http://iveda.com/role/RelatedParties RELATED PARTIES Notes 8 false false R9.htm 00000009 - Disclosure - SHORT-TERM AND LONG-TERM DEBT Sheet http://iveda.com/role/Short-termAndLong-termDebt SHORT-TERM AND LONG-TERM DEBT Notes 9 false false R10.htm 00000010 - Disclosure - PREFERRED STOCK Sheet http://iveda.com/role/PreferredStock PREFERRED STOCK Notes 10 false false R11.htm 00000011 - Disclosure - EQUITY Sheet http://iveda.com/role/Equity EQUITY Notes 11 false false R12.htm 00000012 - Disclosure - STOCK OPTION PLAN AND WARRANTS Sheet http://iveda.com/role/StockOptionPlanAndWarrants STOCK OPTION PLAN AND WARRANTS Notes 12 false false R13.htm 00000013 - Disclosure - INCOME TAXES Sheet http://iveda.com/role/IncomeTaxes INCOME TAXES Notes 13 false false R14.htm 00000014 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://iveda.com/role/EarningsLossPerShare EARNINGS (LOSS) PER SHARE Notes 14 false false R15.htm 00000015 - Disclosure - CONTINGENT LIABILITIES???TAIWAN Sheet http://iveda.com/role/ContingentLiabilitiestaiwan CONTINGENT LIABILITIES???TAIWAN Notes 15 false false R16.htm 00000016 - Disclosure - SUBSEQUENT EVENTS Sheet http://iveda.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://iveda.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - RELATED PARTIES (Tables) Sheet http://iveda.com/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://iveda.com/role/RelatedParties 19 false false R20.htm 00000020 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables) Sheet http://iveda.com/role/Short-termAndLong-termDebtTables SHORT-TERM AND LONG-TERM DEBT (Tables) Tables http://iveda.com/role/Short-termAndLong-termDebt 20 false false R21.htm 00000021 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables) Sheet http://iveda.com/role/StockOptionPlanAndWarrantsTables STOCK OPTION PLAN AND WARRANTS (Tables) Tables http://iveda.com/role/StockOptionPlanAndWarrants 21 false false R22.htm 00000022 - Disclosure - INCOME TAXES (Tables) Sheet http://iveda.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://iveda.com/role/IncomeTaxes 22 false false R23.htm 00000023 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://iveda.com/role/EarningsLossPerShareTables EARNINGS (LOSS) PER SHARE (Tables) Tables http://iveda.com/role/EarningsLossPerShare 23 false false R24.htm 00000024 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Sheet http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Details 24 false false R25.htm 00000025 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) Sheet http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) Details 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical) Sheet http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical) Details 27 false false R28.htm 00000028 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) Sheet http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) Details 28 false false R29.htm 00000029 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) Sheet http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) Details 29 false false R30.htm 00000030 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) Sheet http://iveda.com/role/ScheduleOfShort-termDebtDetails SCHEDULE OF SHORT-TERM DEBT (Details) Details 30 false false R31.htm 00000031 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) Sheet http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) Details 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) Sheet http://iveda.com/role/ScheduleOfLong-termDebtDetails SCHEDULE OF LONG-TERM DEBT (Details) Details 32 false false R33.htm 00000033 - Disclosure - PREFERRED STOCK (Details Narrative) Sheet http://iveda.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details Narrative) Details http://iveda.com/role/PreferredStock 33 false false R34.htm 00000034 - Disclosure - EQUITY (Details Narrative) Sheet http://iveda.com/role/EquityDetailsNarrative EQUITY (Details Narrative) Details http://iveda.com/role/Equity 34 false false R35.htm 00000035 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Sheet http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Details 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Sheet http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Details 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) Sheet http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) Details 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details) Sheet http://iveda.com/role/ScheduleOfWarrantTransactionsDetails SCHEDULE OF WARRANT TRANSACTIONS (Details) Details 38 false false R39.htm 00000039 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) Sheet http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Sheet http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Details 40 false false R41.htm 00000041 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative) Sheet http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative STOCK OPTION PLAN AND WARRANTS (Details Narrative) Details http://iveda.com/role/StockOptionPlanAndWarrantsTables 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 42 false false R43.htm 00000043 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) Sheet http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) Details 43 false false R44.htm 00000044 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://iveda.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://iveda.com/role/IncomeTaxesTables 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Sheet http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Details 45 false false R46.htm 00000046 - Disclosure - CONTINGENT LIABILITIES???TAIWAN (Details Narrative) Sheet http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative CONTINGENT LIABILITIES???TAIWAN (Details Narrative) Details http://iveda.com/role/ContingentLiabilitiestaiwan 46 false false R47.htm 00000047 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://iveda.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://iveda.com/role/SubsequentEvents 47 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm ivda-20220331.xsd ivda-20220331_cal.xml ivda-20220331_def.xml ivda-20220331_lab.xml ivda-20220331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 17, "contextCount": 145, "dts": { "calculationLink": { "local": [ "ivda-20220331_cal.xml" ] }, "definitionLink": { "local": [ "ivda-20220331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "ivda-20220331_lab.xml" ] }, "presentationLink": { "local": [ "ivda-20220331_pre.xml" ] }, "schema": { "local": [ "ivda-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 406, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 32, "http://iveda.com/20220331": 11, "http://xbrl.sec.gov/dei/2022": 5, "total": 48 }, "keyCustom": 35, "keyStandard": 216, "memberCustom": 23, "memberStandard": 18, "nsprefix": "IVDA", "nsuri": "http://iveda.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://iveda.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - PREFERRED STOCK", "role": "http://iveda.com/role/PreferredStock", "shortName": "PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - EQUITY", "role": "http://iveda.com/role/Equity", "shortName": "EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - STOCK OPTION PLAN AND WARRANTS", "role": "http://iveda.com/role/StockOptionPlanAndWarrants", "shortName": "STOCK OPTION PLAN AND WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INCOME TAXES", "role": "http://iveda.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - EARNINGS (LOSS) PER SHARE", "role": "http://iveda.com/role/EarningsLossPerShare", "shortName": "EARNINGS (LOSS) PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - CONTINGENT LIABILITIES\u2014TAIWAN", "role": "http://iveda.com/role/ContingentLiabilitiestaiwan", "shortName": "CONTINGENT LIABILITIES\u2014TAIWAN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - SUBSEQUENT EVENTS", "role": "http://iveda.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "IVDA:NatureOfOperationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "IVDA:NatureOfOperationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RELATED PARTIES (Tables)", "role": "http://iveda.com/role/RelatedPartiesTables", "shortName": "RELATED PARTIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://iveda.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables)", "role": "http://iveda.com/role/Short-termAndLong-termDebtTables", "shortName": "SHORT-TERM AND LONG-TERM DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables)", "role": "http://iveda.com/role/StockOptionPlanAndWarrantsTables", "shortName": "STOCK OPTION PLAN AND WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - INCOME TAXES (Tables)", "role": "http://iveda.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)", "role": "http://iveda.com/role/EarningsLossPerShareTables", "shortName": "EARNINGS (LOSS) PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "role": "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails", "shortName": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details)", "role": "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "shortName": "SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_country_US", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "IVDA:GoingConcernPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "-6", "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical)", "role": "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2014-08-28_custom_DebentureAgreementMember_custom_MrGregoryOmiMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "role": "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_ShanghaiBankMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical)", "role": "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "shortName": "SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_ShanghaiBankMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://iveda.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details)", "role": "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "shortName": "SCHEDULE OF SHORT-TERM DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31_custom_VariousShareholdersMember", "decimals": "0", "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_ShanghaiBankMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical)", "role": "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "shortName": "SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31_custom_ShanghaiBankMember_srt_MinimumMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details)", "role": "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "shortName": "SCHEDULE OF LONG-TERM DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31_custom_ShanghaiBankMember", "decimals": "0", "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - PREFERRED STOCK (Details Narrative)", "role": "http://iveda.com/role/PreferredStockDetailsNarrative", "shortName": "PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - EQUITY (Details Narrative)", "role": "http://iveda.com/role/EquityDetailsNarrative", "shortName": "EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "role": "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "shortName": "SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "role": "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "shortName": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)", "role": "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "shortName": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details)", "role": "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "shortName": "SCHEDULE OF WARRANT TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details)", "role": "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails", "shortName": "SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "IVDA:SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://iveda.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)", "role": "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "IVDA:ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_WarrantMember", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative)", "role": "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "shortName": "STOCK OPTION PLAN AND WARRANTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "role": "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details)", "role": "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails", "shortName": "SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31", "decimals": null, "lang": "en-US", "name": "IVDA:YearOfExpiration", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://iveda.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "lang": "en-US", "name": "IVDA:TaiwanCorporateTaxRate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "role": "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "shortName": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31_custom_MegasysMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - CONTINGENT LIABILITIES\u2014TAIWAN (Details Narrative)", "role": "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "shortName": "CONTINGENT LIABILITIES\u2014TAIWAN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-12-31_custom_MegasysMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-04-05_custom_UnderwritingAgreementMember_us-gaap_SubsequentEventMember", "decimals": "0", "first": true, "lang": null, "name": "IVDA:StockAndWarrantOffering", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://iveda.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-04-05_custom_UnderwritingAgreementMember_us-gaap_SubsequentEventMember", "decimals": "0", "first": true, "lang": null, "name": "IVDA:StockAndWarrantOffering", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity", "role": "http://iveda.com/role/StatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://iveda.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://iveda.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - RELATED PARTIES", "role": "http://iveda.com/role/RelatedParties", "shortName": "RELATED PARTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SHORT-TERM AND LONG-TERM DEBT", "role": "http://iveda.com/role/Short-termAndLong-termDebt", "shortName": "SHORT-TERM AND LONG-TERM DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 41, "tag": { "IVDA_AccountsAndOtherPayablesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts and other payables [Policy Text Block]", "label": "Accounts and other payables [Policy Text Block]", "verboseLabel": "Accounts and Other Payables" } } }, "localname": "AccountsAndOtherPayablesPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_AdditionalPaidInCapitalAccumulatedDeficitDividendsPreferredStockStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends - P/S Series B", "label": "Dividends - P/S Series B" } } }, "localname": "AdditionalPaidInCapitalAccumulatedDeficitDividendsPreferredStockStock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_AdjustmentsToAdditionalPaidInCapitalConvertibleDebentureValuation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to convertible debenture valuation.", "label": "Convertible Debenture Value" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebentureValuation", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_AdjustmentsToAdditionalPaidInCapitalWarrantsForInterestExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants for Interest Expense.", "label": "Warrants for Interest Expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantsForInterestExpense", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_AdjustmentsToAdditionalPaidInSubscriptionReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Subscription Receivable" } } }, "localname": "AdjustmentsToAdditionalPaidInSubscriptionReceivable", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_ChunghwaTelecomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chunghwa Telecom [Member]", "label": "Chunghwa Telecom [Member]" } } }, "localname": "ChunghwaTelecomMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_CommonStock000001ParValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, $0.00001 Par Value Per Share [Member]", "label": "Common Stock, $0.00001 Par Value Per Share [Member]" } } }, "localname": "CommonStock000001ParValuePerShareMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "domainItemType" }, "IVDA_CommonStockIssuedForConsultingAgreementsRelatedToCostOfCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued for consulting agreements related to cost of capital", "label": "Common Stock issued for Consulting Agreements related to Cost of Capital" } } }, "localname": "CommonStockIssuedForConsultingAgreementsRelatedToCostOfCapital", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_CommonStockPurchaseWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Purchase Warrants [Member]", "label": "Common Stock Purchase Warrants [Member]" } } }, "localname": "CommonStockPurchaseWarrantsMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "domainItemType" }, "IVDA_CommonStockWarrantsIssuedForInterestValue": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock warrants issued for interest value", "label": "Common Stock Warrants Issued for Interest" } } }, "localname": "CommonStockWarrantsIssuedForInterestValue", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_CurrentDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current deposits [Policy Text Block]", "label": "Deposits \u2013 Current" } } }, "localname": "CurrentDepositsPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_DebentureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Agreement [Member]", "label": "Debenture Agreement [Member]" } } }, "localname": "DebentureAgreementMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_DividendsPaidWithSeriesBPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividends paid with series B preferred stock", "label": "DividendsPaidWithSeriesBPreferredStock", "negatedLabel": "Dividends Paid with Series B Preferred Stock" } } }, "localname": "DividendsPaidWithSeriesBPreferredStock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equipment Sales [Member]" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "IVDA_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going concern [Policy Text Block]", "label": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_HuaNanBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hua Nan Bank [Member]", "label": "Hua Nan Bank [Member]" } } }, "localname": "HuaNanBankMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_InterestValueOfConvertibleDebtIssued": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest value of convertible debt issued", "label": "Interest Value of Convertible Debt Issued" } } }, "localname": "InterestValueOfConvertibleDebtIssued", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_LongTermDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term deposits [Policy Text Block]", "label": "Deposits\u2014Long-Term" } } }, "localname": "LongTermDepositsPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_LongTermDividendPayable": { "auth_ref": [], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term dividend payable", "label": "LONG-TERM DIVIDENDS PAYABLE" } } }, "localname": "LongTermDividendPayable", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "IVDA_MegasysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Megasys [Member]", "label": "Megasys [Member]" } } }, "localname": "MegasysMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_MiscellaneousIncomeExpense": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous income expense", "label": "Miscellaneous Income (Expense)" } } }, "localname": "MiscellaneousIncomeExpense", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "IVDA_MrGregoryOmiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr Gregory Omi [Member]", "label": "Mr Gregory Omi [Member]" } } }, "localname": "MrGregoryOmiMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_MrRobertGillenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr Robert Gillen [Member]", "label": "Mr Robert Gillen [Member]" } } }, "localname": "MrRobertGillenMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_NatureOfOperationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of operations [Policy Text Block]", "label": "Nature of Operations" } } }, "localname": "NatureOfOperationsPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_OtherCurrentAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other current assets [Policy Text Block]", "label": "Other current assets [Policy Text Block]", "verboseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsPolicyTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "IVDA_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]" } } }, "localname": "OtherCustomersMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_OtherRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Revenue [Member]" } } }, "localname": "OtherRevenueMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "IVDA_ProceedsFromRestrictedCash": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds from restricted cash", "label": "ProceedsFromRestrictedCash", "negatedLabel": "Changes in Restricted Cash" } } }, "localname": "ProceedsFromRestrictedCash", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_RepublicOfChinaTaiwanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Republic of China (Taiwan) [Member].", "label": "Republic of China (Taiwan) [Member]" } } }, "localname": "RepublicOfChinaTaiwanMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "xbrltype": "domainItemType" }, "IVDA_ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of warrants outstanding and exercisable [Table Text Block]", "label": "SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE" } } }, "localname": "ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "IVDA_ServiceRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Service Revenue [Member]" } } }, "localname": "ServiceRevenueMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "IVDA_ShanghaiBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai bank [Member]", "label": "Shanghai bank [Member]" } } }, "localname": "ShanghaiBankMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non option equity instruments exercisable number.", "label": "Warrants Exercisable, Number Exercisable", "periodEndLabel": "Shares, Options Exercisable at End of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "sharesItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average ExercisePrice.", "label": "Warrants Exercisable, Weighted-Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Options Exercisable at End of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "perShareItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice", "verboseLabel": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, forfeited.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice", "verboseLabel": "Weighted-Average Exercise Price, Forfeited or Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, Granted.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice", "verboseLabel": "Weighted-Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average ExercisePrice.", "label": "Warrants Outstanding, Weighted-Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at End of Year", "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at Beginning of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "perShareItemType" }, "IVDA_StockAndWarrantOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock and warrant offering", "label": "Stock and warrant offering" } } }, "localname": "StockAndWarrantOffering", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "IVDA_StockIssuedDuringPeriodSharesCommonStockForCostsOfFinancingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares common stock for costs of financing shares", "label": "Common stock for costs of Financing, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonStockForCostsOfFinancingShares", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "IVDA_StockIssuedDuringPeriodSharesCommonStockIssuedForConversionError": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares common stock issued for conversion error", "label": "Common Stock issued for conversion error, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonStockIssuedForConversionError", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "IVDA_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesInterestToCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares conversion of convertible securities interest to common stock shares", "label": "Conversion of Debt & Interest to Common Stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesInterestToCommonStockShares", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "IVDA_StockIssuedDuringPeriodValueCommonStockForCostsOfFinancing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common Stock for Costs of Financing.", "label": "Common Stock for Costs of Financing" } } }, "localname": "StockIssuedDuringPeriodValueCommonStockForCostsOfFinancing", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_StockIssuedDuringPeriodValueCommonStockIssuedForConversionError": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value common stock issued for conversion error", "label": "Common Stock issued for conversion error" } } }, "localname": "StockIssuedDuringPeriodValueCommonStockIssuedForConversionError", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesInterestToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of Debt & Interest to Common Stock.", "label": "Conversion of Debt & Interest to Common Stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesInterestToCommonStock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "IVDA_SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of warrants outstanding and exercisable information [Table Text Block]", "label": "SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION" } } }, "localname": "SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "IVDA_TaiwanCorporateTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taiwan corporate tax rate.", "label": "Taiwan corporate tax rate" } } }, "localname": "TaiwanCorporateTaxRate", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "IVDA_TaiwanStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taiwan stock [Member]", "label": "Taiwan stock [Member]" } } }, "localname": "TaiwanStockMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_TwoCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two customers [Member]", "label": "Two Customers [Member]" } } }, "localname": "TwoCustomersMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_TwoThousandNineStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2009 Stock Option Plan [Member].", "label": "2009 Stock Option Plan [Member]" } } }, "localname": "TwoThousandNineStockOptionPlanMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_TwoThousandTenStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2010 Stock Option Plan [Member]", "label": "2010 Stock Option Plan [Member]" } } }, "localname": "TwoThousandTenStockOptionPlanMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_TwoThousandTwentyStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Stock Option Plan [Member]", "label": "2020 Stock Option Plan [Member]" } } }, "localname": "TwoThousandTwentyStockOptionPlanMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting agreement [Member]", "label": "Underwriting agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_UsBasedSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Based Segment [Member]", "label": "US Based Segment [Member]" } } }, "localname": "UsBasedSegmentMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "IVDA_VariousShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Various Shareholders [Member]", "label": "Various Shareholders [Member]" } } }, "localname": "VariousShareholdersMember", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "IVDA_WarrantsIssuedForInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants issued for interest", "label": "WarrantsIssuedForInterest", "negatedLabel": "Warrants Issued for Interest" } } }, "localname": "WarrantsIssuedForInterest", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_WarrantsIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants issued for services", "label": "WarrantsIssuedForServices", "negatedLabel": "Warrants Issued for Services" } } }, "localname": "WarrantsIssuedForServices", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "IVDA_YearOfExpiration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year of Expiration.", "label": "Year of Expiration" } } }, "localname": "YearOfExpiration", "nsuri": "http://iveda.com/20220331", "presentation": [ "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails" ], "xbrltype": "gYearItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r529", "r531", "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://iveda.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r168", "r293", "r296", "r487" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r208", "r209", "r210", "r211", "r231", "r260", "r305", "r306", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r484", "r488", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r208", "r209", "r210", "r211", "r231", "r260", "r305", "r306", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r484", "r488", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r168", "r293", "r296", "r487" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r165", "r209", "r210", "r293", "r294", "r440", "r483", "r485" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r165", "r209", "r210", "r293", "r294", "r440", "r483", "r485" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r202", "r208", "r209", "r210", "r211", "r231", "r260", "r298", "r305", "r306", "r342", "r343", "r344", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r484", "r488", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r202", "r208", "r209", "r210", "r211", "r231", "r260", "r298", "r305", "r306", "r342", "r343", "r344", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r484", "r488", "r515", "r516" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r166", "r167", "r293", "r295", "r486", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r166", "r167", "r293", "r295", "r486", "r500", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "xbrltype": "stringItemType" }, "stpr_AZ": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ARIZONA" } } }, "localname": "AZ", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Payables", "totalLabel": "Accounts and Other Payables" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r29", "r428" ], "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r469", "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Account receivable" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r21", "r40", "r41", "r42", "r473", "r493", "r494" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r39", "r42", "r48", "r49", "r50", "r90", "r91", "r92", "r388", "r417", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r90", "r91", "r92", "r352", "r353", "r354", "r392" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r308", "r355", "r356" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock Based Compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts": { "auth_ref": [ "r227" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing.", "label": "Costs of Capital" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r226", "r274", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Warrants for Services" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r12", "r84", "r144", "r156", "r163", "r178", "r213", "r214", "r215", "r217", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r385", "r389", "r401", "r426", "r428", "r454", "r470" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r28", "r84", "r178", "r213", "r214", "r215", "r217", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r385", "r389", "r401", "r426", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r4", "r496", "r497", "r498", "r499" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets (Liabilities)" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER ASSETS" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets, excluding property, plant, and equipment and other property and investments, that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Charges and Other Assets.", "label": "Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment", "totalLabel": "Total Other Assets" } } }, "localname": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r313", "r314", "r315", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r10", "r73" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r74", "r453" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r67", "r73", "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF PERIOD", "periodStartLabel": "Cash and Cash Equivalents- Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r67", "r402" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "CDIC insurance limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r16", "r17", "r18", "r81", "r84", "r105", "r106", "r107", "r109", "r111", "r120", "r121", "r122", "r178", "r213", "r218", "r219", "r220", "r224", "r225", "r258", "r259", "r263", "r267", "r274", "r401", "r534" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/Cover", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Range of Exercise Prices" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r205", "r206", "r207", "r212", "r503" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "CONTINGENT LIABILITIES\u2014TAIWAN" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwan" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsShares": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.", "label": "Preferred Stock - Series B Shares and Dividend Payable to Common Stock, shares" } } }, "localname": "CommonStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r90", "r91", "r392" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r18", "r274" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r18", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, $0.00001 par value; 37,500,000 shares authorized; 11,561,647 and 9,668,369, shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "verboseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r129", "r130", "r168", "r398", "r399", "r502" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r129", "r130", "r168", "r398", "r399", "r495", "r502" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r129", "r130", "r168", "r398", "r399", "r495", "r502" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r125", "r468" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": { "auth_ref": [ "r400" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.", "label": "Concentration risk, credit risk, financial instrument" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r129", "r130", "r168", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Percentage of concentration risk" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r129", "r130", "r168", "r398", "r399", "r502" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r78", "r387" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r58", "r84", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r401" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "COST OF REVENUE" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r128", "r168" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r230", "r247" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r228", "r250", "r251", "r413", "r415", "r416" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount", "verboseLabel": "Debt principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r34", "r241", "r413" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r34", "r248", "r413", "r415" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt instrument, interest rate", "verboseLabel": "Debt interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r35", "r231", "r395" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "verboseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r36", "r83", "r88", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r250", "r251", "r252", "r253", "r275", "r278", "r279", "r280", "r412", "r413", "r415", "r416", "r467" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue and Customer Deposits" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r366" ], "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Deferred Tax Assets, Net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Tax Operating Loss Carryforward - USA" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.", "label": "Other" } } }, "localname": "DeferredTaxAssetsOtherLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r365" ], "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation Allowance - USA" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r71", "r198" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r71", "r139" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and Amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r312", "r313", "r347", "r348", "r350", "r357" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK OPTION PLAN AND WARRANTS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r311", "r351" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "SCHEDULE OF STOCK OPTION TRANSACTIONS" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r281", "r466" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Preferred Stock - Series B Shares and Dividend Payable to Common Stock" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r281", "r466" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Preferred Stock - Series B for Dividend" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r29", "r87", "r216", "r218", "r219", "r223", "r224", "r225", "r421" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties", "negatedLabel": "Less Current Portion" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r87", "r216", "r218", "r219", "r223", "r224", "r225", "r421", "r458", "r478" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Total Due to Related Parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesNoncurrent": { "auth_ref": [ "r37", "r87", "r216", "r218", "r219", "r223", "r224", "r225", "r421" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.", "label": "Total Long-Term" } } }, "localname": "DueToRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r56", "r95", "r96", "r97", "r98", "r99", "r103", "r105", "r109", "r110", "r111", "r115", "r116", "r393", "r394", "r462", "r481" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "BASIC AND DILUTED LOSS PER SHARE", "verboseLabel": "Basic Loss Per Share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic EPS" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r112", "r113", "r114", "r117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r402" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "EFFECT OF EXCHANGE RATE CHANGES ON CASH" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r349" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized stock- based compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r48", "r49", "r50", "r90", "r91", "r92", "r94", "r100", "r102", "r119", "r179", "r274", "r281", "r352", "r353", "r354", "r374", "r375", "r392", "r403", "r404", "r405", "r406", "r407", "r409", "r417", "r489", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedMaturityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan modification for an extension of the term of a loan in which it must be paid.", "label": "Extended Maturity [Member]" } } }, "localname": "ExtendedMaturityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r57", "r84", "r144", "r155", "r159", "r162", "r164", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r401" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r197", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r84", "r93", "r144", "r155", "r159", "r162", "r164", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r384", "r394", "r401" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "LOSS BEFORE INCOME TAXES" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r85", "r361", "r363", "r368", "r376", "r378", "r380", "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r86", "r101", "r102", "r142", "r360", "r377", "r379", "r482" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "BENEFIT (PROVISION) FOR INCOME TAXES" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r47", "r358", "r359", "r363", "r364", "r367", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Tax Paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts Receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Increase) Decrease in Operating Assets" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Accounts and Other Payables" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other Current Assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other Assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r194", "r196" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r52", "r138", "r411", "r414", "r463" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r62", "r242", "r249", "r252", "r253" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r66", "r68", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r459", "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r26", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r9", "r25", "r79", "r118", "r180", "r181", "r183", "r439" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r26", "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r60", "r137" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Interest Income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r71" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Common Stock Warrants Issued for Services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r84", "r178", "r401", "r428", "r457", "r475" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r8", "r33", "r84", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r386", "r389", "r390", "r401", "r426", "r427", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoanRestructuringModificationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by concessions made to the terms of loan contracts.", "label": "Loan Restructuring Modification [Axis]" } } }, "localname": "LoanRestructuringModificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LoanRestructuringModificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concessions made to the terms of loan contracts, including but not limited to, interest rate reductions, maturity extensions, principal forgiveness, and payment deferral." } } }, "localname": "LoanRestructuringModificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r15", "r236", "r246", "r250", "r251", "r456", "r472" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "LONG-TERM DEBT", "verboseLabel": "Long Term Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfLong-termDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Current Portion of Long-Term Debt", "negatedLabel": "Current Portion of Long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfLong-termDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r67" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r67" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Provided by (Used in) Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r67", "r69", "r72" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r43", "r45", "r50", "r54", "r72", "r84", "r93", "r95", "r96", "r97", "r98", "r101", "r102", "r108", "r144", "r155", "r159", "r162", "r164", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r394", "r401", "r460", "r479" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://iveda.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "totalLabel": "NET LOSS" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://iveda.com/role/StatementsOfCashFlows", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r144", "r155", "r159", "r162", "r164" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net Operating Loss", "verboseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating loss carryforward, limitations on use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance increased" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r27", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Current Assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r11" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r44", "r46", "r48", "r49", "r51", "r55", "r274", "r403", "r408", "r409", "r461", "r480" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Comprehensive Loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r65" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment of Financing and Stock Issuance Costs", "negatedLabel": "Payments for Deferred Finance Costs" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r63" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of Property and Equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r313", "r314", "r315", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r313", "r314", "r315", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendsShares": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Preferred Stock - Series B for Dividend, shares" } } }, "localname": "PreferredStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r17", "r258" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, par value", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r17", "r258" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/PreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r17", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, $0.00001 par value; 12,500,000 shares authorized Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r64" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Common Stock Issued, Net of (Cost of Capital)" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.", "label": "Proceeds from (Payments to) Long-Term Debt" } } }, "localname": "ProceedsFromRepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Payments to) Due to Related Parties" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "auth_ref": [], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from (Payments on) Short-Term Notes Payable/Debt" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r199", "r428", "r465", "r476" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r199", "r504", "r505" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r299", "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r299", "r420", "r423", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r418", "r419", "r421", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTIES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r10", "r76" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r281", "r428", "r474", "r492", "r494" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r90", "r91", "r92", "r94", "r100", "r102", "r179", "r352", "r353", "r354", "r374", "r375", "r392", "r489", "r491" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r135", "r136", "r154", "r160", "r161", "r165", "r166", "r168", "r292", "r293", "r440" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "TOTAL REVENUE" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r80", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r297" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Deferred Revenue" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r53", "r84", "r135", "r136", "r154", "r160", "r161", "r165", "r166", "r168", "r178", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r224", "r225", "r401", "r464" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Net Revenue", "verboseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "REVENUE" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r129", "r168" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r36", "r88", "r250", "r252", "r275", "r278", "r279", "r280", "r412", "r413", "r416", "r467" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "SCHEDULE OF LONG-TERM DEBT" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r300", "r301", "r302", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r422", "r423" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF RELATED PARTY TRANSACTIONS" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r144", "r147", "r158", "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r307", "r309", "r313", "r314", "r315", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "SCHEDULE OF SHORT-TERM DEBT" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r16", "r17", "r18", "r81", "r120", "r121", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r263", "r267", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r282", "r310" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANT TRANSACTIONS" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r154", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r164", "r168", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r203", "r204", "r483" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r148", "r149", "r150", "r151", "r152", "r153", "r166" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r59" ], "calculation": { "http://iveda.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "General & Administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r16", "r17", "r274" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r16", "r17", "r274" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r70" ], "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock Option Compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Weighted-Average Fair Value of Options Granted During the Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Shares, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "negatedLabel": "Shares, Forfeited or Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r317", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Warrants Outstanding, Number Outstanding", "periodEndLabel": "Shares, Outstanding at End of Year", "periodStartLabel": "Shares, Outstanding at Beginning of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized under plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Shares, Options Exercisable at End of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Options Exercisable at End of Year", "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at Beginning of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Shares, Forfeited or Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share based compesatio, award option", "verboseLabel": "Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted-Average Fair Value of Options Granted During the Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r317", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Options outstanding", "periodEndLabel": "Shares, Outstanding at End of Year", "periodStartLabel": "Shares, Outstanding at Beginning of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r317", "r319" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at End of Year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r313", "r314", "r315", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted-Average Exercise Price, Forfeited or Canceled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted-Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Options Exercisable, Number Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected Life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Options Exercisable, Weighted-Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Options Outstanding, Weighted-Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r13", "r428", "r455", "r471" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short Term Debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "SHORT-TERM AND LONG-TERM DEBT" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77", "r89" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r154", "r155", "r156", "r157", "r159", "r160", "r161", "r162", "r163", "r164", "r168", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r200", "r203", "r204", "r483" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r16", "r17", "r18", "r81", "r84", "r105", "r106", "r107", "r109", "r111", "r120", "r121", "r122", "r178", "r213", "r218", "r219", "r220", "r224", "r225", "r258", "r259", "r263", "r267", "r274", "r401", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/Cover", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r38", "r48", "r49", "r50", "r90", "r91", "r92", "r94", "r100", "r102", "r119", "r179", "r274", "r281", "r352", "r353", "r354", "r374", "r375", "r392", "r403", "r404", "r405", "r406", "r407", "r409", "r417", "r489", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/Cover", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r90", "r91", "r92", "r119", "r440" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/Cover", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r17", "r18", "r274", "r281" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common Stock Offering for Cash, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common stock for accounts payable, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r17", "r18", "r274", "r281", "r323" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of options and warrants, shares", "negatedLabel": "Shares, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r17", "r18", "r274", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common Stock Offering for Cash" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common Stock for Accounts Payable" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r38", "r274", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of options and warrants" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r18", "r22", "r23", "r84", "r176", "r178", "r401", "r428" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r82", "r259", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r273", "r281", "r283", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": { "auth_ref": [ "r17", "r18", "r22", "r256" ], "calculation": { "http://iveda.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.", "label": "Stockholders' Equity Note, Subscriptions Receivable", "negatedLabel": "Subscription Receivable" } } }, "localname": "StockholdersEquityNoteSubscriptionsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r410", "r430" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r410", "r430" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r410", "r430" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r410", "r430" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r429", "r431" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "SUMMARY OF OPERATING LOSS CARRYFORWARDS" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r171", "r172", "r173", "r174", "r175", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfRelatedPartyTransactionsDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r123", "r124", "r126", "r127", "r131", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_UtilityRevenueAndExpenseRecognitionPolicy": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policies and anticipated effects of regulatory rulings and on rate-setting regarding revenues and expenses incurred and recovered, including billed and unbilled revenues, revenues collected subject to refund, taxes collected from customers and remitted to governmental authorities, and postretirement benefits.", "label": "Revenue and Expense Recognition" } } }, "localname": "UtilityRevenueAndExpenseRecognitionPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants Outstanding, Weighted-Average Remaining Contractual Life" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r104", "r111" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r103", "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "WEIGHTED AVERAGE SHARES" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "20A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=SL6757427-112606" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r357": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=126950214&loc=d3e40187-110364" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r523": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r525": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r526": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r527": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r528": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r529": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r530": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r531": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r532": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r533": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r534": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r535": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r536": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r537": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r538": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" } }, "version": "2.1" } ZIP 65 0001493152-22-013530-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-013530-xbrl.zip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

B#A6WHG0VB,:@;!:"083E$8"9,$.PR; M'@Z&[I"L#V=@,,APD,9="8Y@TH M6A)IA7>O;S+>I0J-X> A>*A%B_R)"#)D+'-%1Q4X2$7Z&9Z),U((03UZG+!F4DZ@./F_L7% MNCGL43P#00- =@.Z&1@='NR]Z.N$BV3WT>3,Q==A(:$XIC\FRVR)(I-%4YA, MD<1[X6@0R-$52#$.4_)!U&8HHOV \ED\=7!&$P%B M3\8*==H7CJ4N\Y0F%C>W)J(CLZ^KK@UBQ<=P;$%TXU?C5YB@.(L&4)A\R(.1 M^$8@O@YR.6 .0*3@ EQ"LNX DX9RLYX"/9AAU>Q-[E-(#BZ4M\T0#8(M&:*Q M4!#_?R0>C)$SRDQ-*"V4#6*!4*10OC)ZU1*>PL>XK[OCK+K)\Q%8G-NYXW3UA*J$;A]PA;A#NB %2=*6+0:_E4HY?_5%.'0LO]AL^44X=*R_ MV(?ZB^]C>X%^8A#]R.Y:XJRGMA.QP'<_AJA%,"*L.G'+ K!\])9K T\+WXO_ M'BA!CPV]YYAPZ"QY[.B]\C2W(1I@G,/#8#_+*+8YP%U@V$2%KR)Y*"U)9W ML)23+6Q7X4_7L?I%SH_#7N$N"'P4\"!8ZPIJK2 KEB? FR2+F7DRK!\1.!=6 M3S^6KNL>C89.#)(2P PPD_3:HTX6%AZ'#TU2#&:P1&:7&X^!,-&IP/M(FG # M-<4^Y)DX('UM>YS8AG "Z9BVSZZ! *=J(,H*N4[9U%D6>5L'+Q.EB>%P[IX) MY_1MY-BK8.@3PY37WI#@"U92V(*H[\FP0$?I[@6XJ\8D">@F,[#Q-(8"EBD& MP>:S,K#MC :R6EJH1Q*XOY4Q>2B+XV%-.#GL.) ^6H",S6XRV&T=WT4XSTA+:-I75Z MH@2N,(, M T0'UM'UEWD<+J(]I$^$\IV")B<7NM<\XI-E;2NX"+#'>Z N0#P!LE"0B<:M:T\%%O MR28/*$ % TWE(=. ,@N#0SK9])5A ;0L M#\BR?*AZ(#=IM)T@*JDB YV>8%=:-B!6'XD.B>6$(_A-@AM._-:/CD8G8H7Q M+,<7SP2U(X\ D0H@C CFQ<-Q#&%V'$'0:<:..AL[!Q?8JF2U]K=V: Z M4=.)4>Z(&$JZUK,L9(N,3OS#@&TMTS 4R#"#)XA9B@\)JC&J3(BLG9&<-=+< M6!D&A'X/ C]V RWX+211&22:P[D#(9*Q.< +L7N7LJ8_=T6MO6#H[,LOUI M?:$;F'41A^GA&Y>$\FGPQ^IK2)P9W-)U0UNSN@S2]5G&IIE,DA X##86=1 V M5U@;.$NYYX87$;'LQZ#4JWU1H3.A;[$>H7Z3AN,ID+"(Y:+P'Y%+@R8$4)>8 M*( 1##D30=)/E)7Y#5@J%G1FH5B3I/<,MWK85GUGA^LVP'(=/? *Q":?ISHZ MZ0+.G6^(^NCM_N:Y(Y;SW? 11#>52-9'K4AH-(ST2KEL&'Q:KGZAMYIQK/,[ MB,6-;2RXWXA2CEJRU9O6=E\Z_4+O?;#$ ).B9S*/Y)@#"S1^#JN%-5RJA=,> MM0[=E?C>Z'=8/8?N8[Q= H!ZX E!!\( ;:3)>GFRZX25!W(T#H>;CN:1<4^5 MHQ[1L.I41&.L[:^KXR9S 9Z>^+['+B<4_8H)V65H\-Q WD6;I'>*79:/K)+L M'#P-UAO"IRB1-@=CRZ"!&#)?8M.P!$;OI$D:)DFAT!%F&_9\!GX1F3B:>(E$ MG\5PG+Q Q+I=-V*AA/'B.IHVWJ+H4!9Z)4C[@:A85>%X-(E!LK)RN$>!<'Z## )VB&'Y MQB]RA2S!*M9)JAPTRS#/A!P=R]E#TW_>+.1L)3IE8;B?67*Q*'R8TY."]8*L M!LVOR*7SB^KZ7?%3[O:[ L5%I-E1Q5I.&$>O=J)49#%U8>8%^N8,H4)=YGC5 M %8=86#5QBB:OWA[?0.0"@96G?59\RRT:M\W^@)41U8 J';C4D=GP5+/Y@2V M>9-VGU#"VAQLU)+M/]!3>M BB"%,&) ;XPC\03=NE?1E0Q)-]/A -).%*GI6 M>/63Q,\HCB=#VX16G8B :>/;'SR[!,#TR4(>8!Y>, :IYLA*=&G)&>MUZ2E8 MMN6(E:!#YF4'1%F1'O,E4-T#6J4KV,A7G462V4Y?;7<^1*%&^XH"Q('M2!A# MPQ\7)^?33,JRE:L9KO=DJ2[UZOTRIB&#P.<#\^QMM'! MO/"6^90-QT_Y?E6LW;HC\*'31P-=9VP@7MSH^34?S]#-8/ .\@&L.D@Z!.\J MPC_&Q&7/C,2WI^1]JC4L=Y*6U"R/Y:\Z7D=8::8$G4+D'W[^A##U)Y"_PA$L M4OFBZQ.)QW\PBRATZ77/RN<4VH7BA26U@Q&'V 8>^?$G'9\DN/\A@I>D]?H8 M2?"EIVF#TT?O77<1T6NO%^J%*'..L>2"&Q^_SV82M9SV@3K.W@X,QH6_==96 M^\YS0C<'NK,K;DC(VHZ0I[E#.A)(QB=W>!#)9>A%[Z7IU7;U-U0P0UDRB6W9 M>#!,I$J:R@0VD*L(';6Q.FKRZG+Y^?AF[V,_#(;>7SR& K/BQU-Q1[;/SWL6N>SABW<-4UU_J'JY"*APK)<%":F>7<.U#L[[APOAO M_S6F?.AOZFO:MEUP=]7KN8&CZ53#GZM]%GW6H?AYY*"$Y&+P%8)4\X!<-Q[0_9CTQXXGO>6:8$]]> MJS6Q;&TY?Q>[?6;V]6*_GD^><,W/;S:K:W_Q5""42DS:"ZX#6E?ASVDD/\R; M:1DF64Z:]![SPTZY?1F6XP=ZG?E3:\.B)C)9U/QBZ*%L6J5ZT;K0,6(EU(;%B&3^9F+$!9'(',2\I^L5-(1S/&Q*_V\6?'% M9,PHW;A\/G]]E;+WTD9$ACM9:679$ T%4O&DAY@\_7E6;O%;*9M7:9"H12$S6:Z?<0LF#MW2W MI]#>:Q?OQIUZ<_NQ,__,ALWCG2BTL?"\"JVPBCZ[H$CQT6?/;QJ/T7#GP?@4 MMR1.-J'/)D*!=&P949+YYJ)D70IM[--H9E#E)I80#U2,;%^AC6U H24Y#:LJ M+J./[%,H?)G6JR]HPT)C==D0#J3#R4 JEIHH';A&>VR$>F"+*VJ\ML@.7CH# M>CXQ3/M,Q [>U3%3T)> =N.BWGY!!<3-V$OO9!42(:TIYAI74>:A=?=I4-MV.GD2R5,V[J+%NNYGK^6]K)-RD"^AN>J MG1J\\LOHX)@TQQ[F^U;Q*!J=C"K!?_)V[=3T(OWH6-[[S.?K(_DA]IF-QP9/ MQ?:Q"C)Q7A]U[[3/9CPEEDNQ'W^ >K0M(_PE. AYK(@\A,5= ,96KZ\#)+55 MZ6"7G/,JQI:B?4"=I-V0D%3.=^0V@*TH,F8+"0ON!@419G65%IX9*U2'=B:Z MC%>'Q2\6_GW=2NS$HO?TA,E>;"31+E"D*GZ\=/(H9-.0C:1J(]R,KIY^!#3C\^OSGH4FW)'\7H( MBWLB[V0(1:I(>SZEF03L% ;9#G 1=,8@_PQZ4^J,P4ITL5L%$A2.*0 3[;_>+5X M1PCB%ZO&LHJQ*)8F[:^'">-L76=U]^KS7FD9\IF/F>!-\E:ULYTJR)21W89T+3G MZJ,W\^7NIGKS-$PIQXLND:N/;MXJ-]E1N1+Z&_WQAY/M](04 (5_"XR>Q]ON M$!97ZD.[3P:/)?&R>,L3CE]/ +2L;TA_1V8<0$-5A?5.[EH@*02:V=W&BP6C M'(4X#9F =$#]&*G7)G#S*IXU-'8GK798!Y.C];!.$E MZ,Q'ZZ-"-I^(&\K5[6WL*$@3X?JH9HK7C78HU2F+^*0! 4]/& D%2L.C$#V$ MQ;&MM5 &R=8ZA"CQB!#(6P *E 9$HR2 BARCHTFPXGD[Q $6NH R[^P"9L&' M$"@#(CQE%8]A]!L&HIHTQ2LX2LPU^UL*'*Y^NJQT8OA->J0^RG2+%Q^/3]=J M.WR4D8EH?:1I1C3[F(F\JZ\__G"ZX8-PE(R'L+@GTB><^D'ZNM7Y 00=Z1G% MT'ITZ&.O09\HNX^&ICMA62U/ +AD5%$9$FSNEM.#TC= /!)8;]6!U0*_LEK\ MG)ZT^M!) BNT>/I2 .CQADQ/URA184U#!@C:! M@?\1[&JDC3N!NF)/ )PA;X.!E^+)NXKZB9-'OJ@*@GL!&0".X4"#^ML;#2ZK MA"A,>\B91A!=Z%TOTJJ;;#[?RY> CG)[ZKJFQ\,EO6P/VE"?? M:ZUS63@+S3V7A0/A#,EC'M?540-8KP90QD8ITLUA61&Q\:-*>=Z);[I&X$S0 MGG>(^NCB[U6G/2RT&LWH44, ^/E"(=H9AN\O_K92/_YP.E*_N$7%H[9P"(MS M;Z[=[Y+T]#)):R>1-KDD$(XZEJ[TBF<]FONTS2/O-=\WN+O)W=B#]90EP0J[ M#2.^YB&PHY#&A7:(&TPLR#LB(0U\P^=)CUD9E BJ%>A:WR2C.CHRTZY3V.+3 MYVNEZ5H,_X6KFLZ*M?OF.4$$PJ-!..L7G"^85H_XUJV\/PWSN=>^G;WM-[E9 M=ZGSF>W5)\8""9_J1.O^5*6Y\KG]J7DQFYJ>7/CG1@\9#XUA6-HL,3>1&A\/ MA,(3JV:^E8*Q -QUY AWO6&XZ\@1[GH?X*ZQ2L=7[56U-J^07VJ:!$V^L")= M4$U1;8-93CWJX__V38=RENDO/%9]]%"]N7QZC&7:G6/$F 0Z'D-E/=:^3T?. MF^#$XU0[/3E&.0YG<92MA[ XLIW0U/GTQ$JU<0A7T>IYP%M<,UQ[!8FL", I)SD6O=9J M@4 %DP#1N,;,=)[3D_GS>42#A#UXDN583@]/BR5H_*I).IF;5NN\#M:+'7FH M5LZHW*+=/1H0+#< .AKU\%-'$;[NF#8T/ZB)GS/S?QR!(?]'ZJ-RI)5!?Y,= M^?-8CI5*I.NC1#:+HLFTVGY#H#;1_I&8H]F$L+L=Z24,,E_39-&%OK4;5 MK/4HJU(%,0ZN'2+\_'I[VHY>\9/\FCDUB*AEX6KB? 9!*\DM_&[Z=0.9'PBI MIR?\X0:_#+BRC<6W(E,\?IY;A'\K.WN,TAZF)#K-.NQ8H7:DBDTBL?'0BOA! MGX=Y]TF(%S[6H?G2F5!#7< 5T8?X^G),4-1E@\'$&U"IC&\1,X@OI0!<0)9+ M,^#LS:V:W"M*+RP5X?NEA^#_H]]$]OM@"8Q6[$)ES6'< .\&25YHX,&M> %0F723\1T+/QV@MYLB MOY'V+.264S7\L=V<'#/H"+S_!8N)+-\_:]P*'_7$(7'VN5S7'*:>X;HX,FOI M+:KZS8N&51P,<2;DZ(-@)9%201VQQ E$QQ]X"4WK8'Q63=KY(E!B:,-@(*&J M6;UW&TA%+9)(;G2T/K[]W8UZCT@K![JX)]8[F;?GQ <-:F*$%I*@Z9%@BU!0 M*#\0/AWXOT0\.KX[;OT77!PI+B";[=AD'>$;C776<_ $RQ*CU6[X?2H5.XTA M9Y0 Y0EZ+=#2 [%O=C2=B;(2*[9RO81)E=,3>H%&0N$DO(R$^6 "^&I1:536 M_Y7D/0'KXD.N5Q[HKAT^2S+[=2ENA#N*/0_X*(:IDX)XVJ8843;TC.^ZW2@; MDLR"67PXXV4'ND?[A5Y2P2H??@/6B*:ADWC+#V> FLPW;'WT$$?QY+E\\]&1 MC\8U>$4O;R.%:"N.FN_2CS\V%4]/@(!'^_H0%N?<55([X[#$L/F%;/\E&":L M?1])U()&H *V+W23>%.Q+:N^X4M<5(DQ/:F(_2A(UQ@@XL@8'&&D3.W7&8&B MC!THFG. ^BB:16KUUBPAY>AW)&'X;F38:%WGI-3 "5 "2@PAI, I.5M*KO]R MK38[2.HKJ-3B,V.SP=N,/\%/2+>V9Z(&WTS@E;0S%6^58>NC=_GC,952G\O= MYJ%PD)LKSB/UT7DO^9%-50KIEXBU2$DV>HJ(Q\>[C+B@J&:O\KF'V[Q0NA R MV6SIH5BK"IEB3BC5KO(5H9QYSIS?YJOCW,-89J&4M/F)/#MY+1G_YP?)N9J2 MKD:WY =/S9J6I6:+3<@GLW_)5F7M+LG:<_W8'AS/$8CSOQ^8XGPO8NF,(]$V M]VG&,F:DIZ#V>)[>E.1 O]FZ4X$7G_5:EYAR9+_>1XV_Q;(9?;YNK;A$CR-P MB55"8N#FF&0FC:;\?I['EYN):]'6)KE*R\:D)JM.AU*OKI@I9TJ9T67[$PO* MPDOJYO$-O:BV%>)//GQB\9ZV=3RJ!*=6T_\5]';C9R04"T2BJ4 D'O_E0V)V MEN.0A^I-*^6SY#?8^/ZSIR/_3&!6]\_"ON_XOTF#CO]JG<6>(T/G5D$\V0^]-G$Z<*FJHG RG? M1@N3U^&WWJ] K!7/"CXJT5@@&?&K%UF$6/YG).6JO*%Q1X9Y/?& W'S&$L^% M@2ZE-W-=^6CQOX4)6@B?L\ F3;S*'&];X'E]J^AB2RE7T]AML9'F8DC_G=O$ MT4W' XF47QG8' 2>GT3?>']6E!9Q?*K"?CVPUK _"RN\#AS<29=O#0L7TR%< M[EHWX1?TTFF<1S=X^TX4)Y8N[.?7V0F/>E2\#;#GHMNV&9T@G0[C:VZV5O@U M9,N7V;>5U9-T/!Y(S:&>K"9S6-FAKY/=X;_,Q !S=%2,G?\M]-*'4D&VJZ M MNZ_@\:P&34Z:YI-L=KA^-3WJD/8V-YMSH/KHYKGTV)75][O4ZX%LX8I-* :H M>]/2-/'CO.-,D65T/49F#V%Q&0I>>'K2$X9G"=T,")Z3YVF4BFI6[#.TE M1$6A22T@18F##$ /1(\3 $6+@WZS6 M!:>G2''@2-%=5C-FU;N&7>T(YQJA/DH6Y?O4)4H^APY%&5Q%D\#:<5)L)<+M MR'/CLOWC#VEA&SR'?)W3$R=-CQK%(2RNI)Z>7(MJ'RIT2'0WE""5***D]7@5 M2DN4=5**8E6,<%UB(!L V@E)L9EJ5DB&4P$!JE\CH=_5#E8Q*-^ @X0T*R%? MA7^SRE0=$,8 Q@O>X1B8-$(6;2"NL9I;QVR@"(BP)TTG:SJX4Q _1%TRSH0G M)$ 7=[Z6KB;)+9D"W$/3$@(QBJT-U:"+8N!DHH%U+"BE,>'!QI O[TQX(!6\ M9@=*A,8?"TR>CE59I)*;P?#_EB"63ACB]*2-WV?2VC#\.[%%&^0B 6K;^ 0) M>A;?/*N4#'Y%G@Z2WSI(: .PR3273Y=(E9&-#C&^RZ8?JG)_.R@,#)UL/#X7=I :'1 MA](H4Q@B4QA@"E 5>!S=,^R/[@G'0T=.3%L;Z([Q?I=V[F0DIKS!>1^JMC'3 M-W6Y03G+:O V_3PQ3PZ\";C$(98%IU0^8^\Y/<&4THD"%"!E8+[,:/B4@!F( M$\Z'(ZQC\.2J'O/ M3E;-!-)0&;JG.@T&+P7.?$<&GUT*FK*0FZKSF"Q69XP M_UEL#QPOD0S$0WZHLS8ZGH>*V46HZ(&_JX4_Y0?ULG\?E79!Q0V@XJ5"X4 Z M-+E=O%L8G)Y,E+'SMZ_U.?[X]+*+0QE^*S-Y"VK_!1;MQ+XNM2YXC73![H_I M6^P1>"W*^/_'ZU M""DX*'G4_@]A<1<.38HK-(8@R4:S;\ 5 2H$: $Z+QI& MO]LCZ/U$9 *&L QM YR=% 5Q(,H*\6EA/;YOC"M+7:$IZOH0 M-"$R?7;&'M:U/"B7 (!DLG=@X(\H37!6^ MSS(5GK25"0A6&T*[D6) "''8 /(]2>)BUP]O<,# 'J =)*EWI"8.X/F0:EK' MQAA4WR14IE:0<_+CI+"5./_)-U!3[!MDT4-:=6E7Z\APVQ.?L8U4P<<_/>%3 MGDHZ,$P\K[ I U]S0 5-95T@CG?HFDL]:%55A2.+T$MONN/,I6G.\WQ]9(HE M\>;MUNS?B\<[%/HVOA:N7HR:40ZGP6U&B7AZ4K!EX#>_,S=9U#3.LPZJGP_9 MEY/JF<*^]4P+C5@?1<1\XZE\GAK5#J48#H!#H"]/OVE! &FTCG,@ZK*&K_ V MTMJZV.O@W=11FS9#AIO:\6LV #A8.&0.S[RD:$D$:]1&:P)_!5Z00.Y4TJ<( M7R"G)X:,UR#JW 78 (\+M !:=/@';$[B?U5-AIN$/P*$(Q;S-"S((P:I\],! MUO/K](3T%"897P:>([0[%K&2XZ4"Q=R#NQA >XQ_#_24C]>ZQ>NCAMI6E MW*@=F[_6K9BO"97\8[[XD"?E;O#O3+6:KU6%G[>%S'GAME KY*N_A(M2A=7" M50N7Q<)%(9LIUH3+?.FRDBE?%;)XE,M"J;AW%7+IT!(56&P>!#M3Y*/]]E MAOG4X+%G-X]S\-J/\5DGEBG@XK.>YO>VM2\^P?I#=77G;3*02D7VOTS.WNV$ M,VV=G!F\'5#KXMSQQ?>Y%(N(X?>/8D=R;;/?J9QWSW_.2 +FDY^6E;WB7H-& M]+\?06_N;R*4"*23\=4V_M<:1,[\=7=8Y^\WL+4+?J5L1U9%X2>%+;'$Y()% M97[<%5M0EM@FRA0^8Q >? &E%ID^G?P=<:K51V(OE(H5JQWQ.3)5SFQ$J7PO.+FL5+#.:3 M+EO8[60B&D@E9I>>K;F>(%D?W1_1U,.,!(3AP>L)\ M\#-]'+PMBD$3I ABH0'X^#*+:E T8(/YT?$O ;N2^@0XBB4%SD3XH&A=Z@3C M?8^A\T#7>I>I(U7"+P(\:N Y^*,E2R03EODRZ"!#.BZ$;'1$WJD/!:/'6M23 ME!<*/DWP@+OB4.B( SQ[ ?SW.D0'1 G?H08>K]5"3?/T1*- 72Q[W$$5VE71 MZ"OF$7OS*RZ.(P&SO#L22@)?!6!N\O 90U*'5HT(HDF>HH(&ZHA*"S0CNU&% M(+8Q8W*$EOLB:5]D/PK\QQ\F.6(TZ0N? )(>1EUT M8Y."-2BH#8\"'+E! UOL-7RR 1()HXF&^+0RIJ>/:?@&:K.<.@BG-<'AA[]E MQ"#1RC;@T@GG+)2%1Y TDC*&#YG(#J![6@''CWB$D""4\[@9?HK75O#L*5V" M.;%;>,@0TVT8=-:\E,Z*^3AUI,AH@&CW$?ZD0!ZT:D+@J:XH(2_I!5_*?Z_3 MO(U^U5CJE@DC5U!3P5Q*?,7 6!D)U@GTSY$<0!(VGU(5M^A0]=%EK!&ZD8JU M;.;M0%215<)RH?I(EE[?BO+GS7L/@6GG)N(W#\D=R.*R]/:RZ"DVI5,Q#.T,YC+.E9=^UB7=23ES5_8 ML^A0]5&^FVO7"G^E5P<4WM?>QE5D8K8^TM5,M]IZ51^-",0$/DY/'.GE51,K M&I ?A2.A["XHG9ZHN)?8\T1#2!@+=I;;7BV>H) <)S%..8?^>]=JO*4DQMW MAY+ML&I=<.Q8%[SANN#8L2[X6!?\+ZOD+8NZ.:Q!_1WU\1HYV6@JFM'7)\%6 MAS*N@,O59_>>E<2.A!AA_>P6*KE3T\BPIAR$(G71ZB6;ST7.OU! MOHD-IOQMII;/">5,!9)P=H19/FF_IN*4IWWS^N8;JC[2;L_EN]YSZ?KA8'3& M,3TP7Q^%KFY"%_V7MOKV-G^^EI,EGH5:)5.L9K*U?4R\HK?-LK#3REKB%];=-HY?-"DF\S:\N29R55R/3;^%]") 4; M$XX1SSFA-$G4!8^\(*$&_H24HK1U1(Q[6H!\IY\)ESIJ0P?44E66AE=AV@@/.@.V>?XTC)\92Q>7Y^IGIP/G=^X MA[W3&5DP57@"0.SJLV0.[L]O/^Q<(UB3HR(($Q OBP4'B^J*6OWBH/-RW'_(7U<>+ MM_;CQ?5Y32F>WXES=%/-: ^7%\.7IWA(O'P,B4_% M3B/[EID-C^J_$WXY!^%8,)0*XBUA.0<3"5 M7G(R1\ILN:2]\5?AR1E[M%-&+10O+%8-1AR\"ASSXT_ZS"\]CS#J/_9F]!#T M/<;OH(+8^IR4?.JRVI1[ &)A5_>1)(5/DY;6=Z&P$$*5$NO>/,[]\8G MS>$G.7O3W+C]971[P%M-5$E#M7[3)-V>[P@"#8OAD7&LW^89M?B*^:FIJ%?* M^76W?/Z9GGQJ7!3>@U,SV1*D? _)@*N? $Z\NC_MW <$*$, 'R1Q"*U D3IN M)E:<\UID2W]9ZHUBY'G?08\Q%G8#Y*< M,AYH.X3Y( 5--AP&*0"L66H-ELSCCH;(F26_\7--BJNNT&;2V5IIS @]VT0U MRYAKQDY"3SJ5K#ZJ:0Y>M$'@,ZI4U-2FW=QE5$M-Y*_\]?#"[M2_'76BNSMM3!:_8/M]E/;)G9;-J9.\F!6]0&],H+IXDE%/%SX6+. M)I,!;\!4=VY%PT.9PJ6L*$@-S.''#?A[;I,+>VZQN FG]T#KHQ2@!. 2J]QZ M[7X.0H.W1O@[^6XCP3"6?^GYU4(O[587C^'IWEOAIP/KE;Y9* C65!D"ZZ\ M3<(30'WD(8WL&9X4T.3SPW_SA\R. U!J"X+B(8 M>)@@XTP)#6SGMK\YZ#X\?)4'%LV*O"=5^%D@'R2=0A8_Q\3^<.-N;GFC7TA34XM)%H M* &\2_^*A/:4BTLU95"(=97+0MSB8KXN"T5Z]WP[0<[Z[("O=S0:#"4P1_._ M\&[L5"&)3U5'@&5[HFPA_5O:]H1(!%$H"&2]QEB=MD88#]&YQH(?3T-YGR&B MOP1SKS=JETC^K2JUX=6-<1#B?JU'8H=AN_B$V\ 3@6.7PSQ!N(O-!N&^Q.$9 MO2:O0[<1%%*KT6,8;MXPW"XN&O] 7#@0B<\3B',%X41SSA!FUV37(_M']T_7M5%X*.O=YAYOX]K:!JYG&[<$ M/GP+?2T8C80R]!X!E*KU\E%X+CZJRT7..Y+LE *9QW[J7%%ZV8ILL8_?M*>Q MS0S(ZLFSVM<3ORPV],1-RB^Y2>R,HU9!5B.U^V2VLR>;M ?G>1TXXBO<\[>: MV@[6D-Y=X]4>FLXF,R[TM_S=U4WZ(M<>I,9N FNN4X6_$YP@:*!F4/X,=F1) M0O@W>'X1^;.A*Z%D+/KC3]""!=BZS11;CD;\)$5"%927>J6KUD9I%%^61E[$ M:A? 3D^13=[4C>/JA$)A"E.T)92K[4/8;:'/'G1.A-T';](DU!FWW]OO 6PW M/V5KLIS236AW?1A0(QQ@)NH!F$G51Z\OY=O&WU#I+I3Z\:=Z5:K4@K5\Y8XT M?[HM%2_IOW+Y\]IWA9[;:*N\.=@VG?+%SIG$P,:#63R_C(6>](/!RFG\J76@ M\9S='54"9SOK+6OU9'7T>-L5BZX?(FB-?#W6(NZB/FKF1*GRV&@G>]%)D$-. ML"&'>' )A"/0T#Z"[FP::&A-I#O"#?FN?*87U7>DS0R_>Z"BG+=FQ6!%QS0D MW=$42-SWR;_/SY5_GR.)92S-![(@7)GWZ5"$Y33CO_:@-OF1-D2IVBLWK$3\ MFA0:O"AR*N;-"%TV[;Y8J(6O'VX?*Q2+R- MI=S_PS,H7 400@-AS4&%W$]9%2Y00R>YS; @(6A7,L._ TLBM#B;$4QO9+9W M?!Q^55+9=*GV<3.6H.]*JPC@?;%;-^R&M6=;!M[(^ H\.F_RA*NG!5;E!,B^ ML*@7H$HSE'LX."\2(I54X?!O)_]%0A.S-&VL(:@AL=C;66Z(1?+4!#3W"K+V MD_1/ &@A.5-A9W[:WHOAO/E4O/B;E0PQOL\2=PJY?7/4=B%J?1/5(F>IR?F1 M=J(:*7\=3Y(DU7WD8/#$>J8] !"[(N@(\O?/A(RBC/&WV&QB:][+Y_@CB5Q7 MM-$%^H1&9 *<.1UU19F(>,\9R,U9(?LEV/TR&KW\E$KQ_DW4+:T=!%RZ,G9; MAV%&->R6>=];=S*]#M91UNW'JO.60Y5I)>ND\/67X,90M5^(/Y6+3ST[/3,S M1I#]8L0YJ+^7/!F.!$+)]"2>W B>CE],R=>Q?Z[INO:!9:_!&''(GI>#8"3$>@]6WK #3Q6>(\Z9C;DTC+ 9=,XH.ULTMT/G99 M1W+F%':YBQ(UL1_L,I:2N>_LLK4D( U?FADW5$H5NLMV1%DX%]4W M/Z]39'&OD]/C-,527X8+^71AMA;*U_E JL3O(U>AY&%[BB9;X5ZRK,<%%#E+ M>-N<3W "V2@,\X.?+^?B61?CE,NEVJ62;[\VI@"9KUS\LB/'C!]++.5Q <\* MARO KXFNN7!E8J9:8GNJD!]SW)257/R^^O+1BB?>?WS)MB-+[;@SRNV*/;- ]EK"YU-2O9(A M9ZK7*AE?VP-^^RWX1C"9KC(&ZW;5%R'1#+_<7U69[(C:A:J"9UL452>#/8G: MYW/L*=-J-;^KHC).%(_\ C'%Y):L+J*I!&*1U365=0>CUL,WV>=PK_ :#<=+ MG*-;B_[ M(*'TAOALY]I7:J;VM0P;?9>:W349$U^K<(2)4))S3=&!0<0%%36N!QH)5 MK5G\%%E2HI#G!$GK-Q0TK^?Y8I%;:Z2]/$:,^'._W)IM6BTXQ4W<,\O>)Y%( M+)"(>3UFYJ]L\?YRHA]RJY4M_VWHPG_^3*EO66[B^[AR1V7+F6]ERY)+_0*- MM+]6Y8J=.H E-[Y(QS(&W%U;P;UJ>+RJYW/YY2##+_ MZ&_)O^]D5>[VNQ88;1Q?8J\/O8+Z.NZ)7YRL/UP][ MT0!B=@02Z%1WD6E-U2=G/KJTY= />I@L](693/QT,MEG[U-MA=5:K'OD,2>/ M.:FT+A[SMJC^QYE[3Z-$$%N8OZWZ3G-:YI)B5^&X>?$>!!@_4;54L,E9:#2I#8A5?S3..=DOQ3ENT=3H7I\/8E?O MW6'D&W*.6P MQ3E6CSO\UDF=OC>1:SXQ*N3$" ;+G>-P;#J]JAT;?;QD:AWS MWO.V78N:;MIEC%PO% ).F]8);.$MY!-U\_CMA4^E732#:J'Z&*\13= M+4>,98^OD2,2Z4 HE=S3O/']C0WNV6RVC?,WT>\QAKD(@4++^4J A?8MU24V M0;0X42?=H* W]Y(BYV)MU;XE9JYZM42"&>B4/M/>1"0Q'$X$8E%O1MO2*07S M0>5LD1'FOI0JJ5W,N-7E&N1_$A3H4VM-$+9XPDZZ/KF)0:Q)(W%?50$#=]@5!I ML@CZ;"I]"?UQHAJ7Q39FE"IZ[R,L*_$@\=_"HZCT\9\1BFQ,3H0D#^97*V:1 M)4$2!A:*N<\72??+2YA\Y^#Y^;'4C(BL*W#OPH=F-/PM *C&OT)&%QMRDP-% M YV+&E T''<^]1_^&'QE\S'GX?_^!U/>;Q-T)+X%&P@?0SQXCVRBD^P)?VXD MV3ML"/HM^YAS3<_]1N=$805TD@Y66C:%Q8^RUG(X'XQ+X>XSUH>^.K[(FZ,(#K?SKHF7MM95$OZ543/-]$=2@CG:F4^9=:K-V:> M\V!\=.1FAXHB"1E8VI$V7J(AT,D)&<$F596"$ZJ29Y\_'M_=,*/5UK-)C T*A(Q34IJ;W-)VT,L>< MPE=/0"GAFB*^)_S#B=*69A+R]T, ,4"M=/Q?X";ZF# IFHYVF&!NJ8 M-'R&J8&7[ 01/<,;1WZ)!N!%QX_QO0J0C\>71>?3P#J'*2O W ',['<-DV3\!X"'1*&+, D)D279P"/H8AN6#.4!BCCDJ\>O@CG FD2A M"3%7 #TE9T?7%'B:31[S[O#L0!6^^9H0;:#2Q<$H>SV27^K)-[NKJ*'9J+%_5H3-=Z;3^>W%SWI"#LAQW[_TXKA%/K\=[LQ+ MIYPP4>5EF/#<0LS=U&K1>Z7P5E7L>+?C\EY"4YTR@8V9X-'D B9XT[6^*?9W MUI^L(N4<0[X@#KB^]]4>':)H'I-DU=;O1-A+7LF@5$[SLX,31 U<-D)\<' M\.6Q.HL<[)0VO6-5, MN@RLJ_85$4H4N#Y-EW0FX+TSL V"]7#M] 1&!T56?-5(8C-[\WRT="V53ISI MW IJ\J05R3(_FIC-R3= /XFZ^O3$SPA2D LXTA;"LP_UE!GPM4"=*>D)EN) M;0NL;'.#!0M N86W=4@T^*XX!)4?,Z,BZLSD.CV9:',);I-KW,!P64+8(# T MI4__@=?Q(5-J8E'JWLD <, KL7TTAV4"JQ$5EWGE,('P]/LB*;P M@TD/(E/$<*SL]LIB"W,X%C<#+N, M0/!C118;V,""-K(NXQ=6*W@7.[[MIR>N"1)65S67W8D^J8V%"2NK;S"1%E99 ML,F-)&S]6AL"IJXH&_99_TGM3$P\/'H?O 8.!K&LU!&\[)P#[UR/'DKT6J-IO0")]@W(\["TCJ8&:D&R/:74T"]=K M%MK&6ZF%[[D>4@W"=BRQ.ZL9)D75/A<-R/,>3D-'"#F!SE8<&=_@W9 Y^!B> M%YL'U]TVX3$AL_51>20-M=;Y2V84__&'Q/:$4KE6*!6%\FVF2)KMHS9 H6*# M UZ';])Q ROM@GCBDM@IJQU]?0,\H70X%(X[@C

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end